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ABSTRACT 
 
 
 
Endocytosis has been originally considered as a fundamental mechanism involved in the 
internalization of nutrients and membrane-bound molecules into the cell. However, recent 
studies demonstrate that endocytosis is a more complex network that regulates the delivery 
of specific time- and space-resolved signals to the cell. 
The small GTPase RAB5A, a master regulator of endocytosis, is emerging as a key player 
in tumor progression and metastatic dissemination. Consistently, the expression of RAB5A 
has been shown to promote a tumor mesenchymal invasive program and to correlate with 
the metastatic potential of different tumors. In Drosophila, however, loss-of-function 
mutant of RAB5 transforms imaginal disc epithelia into highly proliferative tissues, 
pointing to a tumor suppressor function of RAB5. 
To dissect the complex role of this GTPase in tumor development, we investigated the 
impact of RAB5A deregulation on MCF-10A, an immortalized non-transformed mammary 
epithelial cell line that forms hollow acinar-like spheroids recapitulating the 
morphogenesis of the human mammary gland, when cultured on 3D reconstituted 
basement membrane.  
We generated stable and inducible MCF-10A cells expressing either RAB5A WT or its 
dominant negative form (RAB5AS34N). We found that the expression of RAB5AS34N is 
sufficient to sustain MCF-10A cells proliferation in the absence of EGF. We identified 
Amphiregulin, a known EGFR ligand, as the secreted diffusible factor responsible for 
EGF-independent proliferation. Conversely, the expression of RAB5A WT delayed cell 
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cycle progression of cells grown in 2D, albeit it promoted the formation of hyper-
proliferative acini when these cells were grown in 3D, without affecting acini 
morphological architecture or polarity establishment. Thus, RAB5A may either be 
implicated in growth factor independent growth, or may promote proliferation in 3D.  
Both clinical data and in vitro studies showed that RAB5A is required for invasion and 
metastasis formation, suggesting its involvement in tumor progression. In particular, the 
overexpression of RAB5A has been shown to be predictive of aggressive behavior and 
metastatic ability in human breast cancer. To further explore this function, we investigated 
the role of RAB5A in MCF-10A cells motility. We demonstrated that RAB5A expression 
does not affect single cell migration, but specifically enhances collective locomotion, the 
typical motility mode frequently observed in invasive cancer of epithelial origin, such as 
breast carcinoma. Indeed, RAB5A expression promotes increased speed and coordination 
of the epithelial cell sheet motility, related both to the increase in the area and persistence 
of migratory protrusions in cells at the leading front, and possibly to a tightening of cell-to-
cell contacts, which improves cohesiveness of the migrating epithelial sheet. 
In conclusion, our data suggest a temporally distinct dual role of RAB5A in tumor 
development. On one hand, RAB5A may exploit a tumor suppressor function controlling 
epithelial tissue morphogenesis and homeostasis, which impairment may induce tumor 
initiation. On the other hand, RAB5A promotes not only a mesenchymal program of 
individual cell invasion, as previously shown by our group, but also it enhances 
coordinated collective epithelial migration, thus promoting cancer progression and 
dissemination. 
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INTRODUCTION 
 
1. The endocytic network. 
 
1.1 Endocytic pathways. 
 
  Endocytosis has traditionally been regarded as a mechanism exploited by the cell to 
internalize nutrients and membrane-bound proteins. However, emerging recent evidences 
point to the notion that the function of endocytosis goes well beyond this canonical view. 
Indeed, endocytic networks are better described as a highly interconnected infrastructure of 
various cellular circuitries that is essential for the execution of different cellular programs 
(Scita and Di Fiore 2010). In general, signaling outputs are rendered interpretable to the 
cell by the resolution of the signal, in space and time, executed through endocytosis and 
membrane trafficking (Sorkin and von Zastrow 2009; Scita and Di Fiore 2010; Sigismund, 
Confalonieri et al. 2012). Accordingly, activated membrane receptors are internalized and 
transported as cargoes onto endocytic vesicles. Receptor-loaded endosomes may act either 
as specialized and spatially confined signaling hubs, or as a sorting station for the 
subsequent recycling of cargos back to the plasma membrane (PM) to initiate a new round 
of signaling or for directing cargos to lysosomal degradation to extinguish signals (Sorkin 
and von Zastrow 2009; Scita and Di Fiore 2010; Sigismund, Confalonieri et al. 2012). This 
process ensures control over signal duration, intensity, and ultimately has a major impact 
on biological outputs. This concept is summarized by the term “endocytic matrix”, which 
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was coined a few years ago to indicate the pervasiveness of endocytic control over 
virtually every aspect of the life of a cell (Scita and Di Fiore 2010). In this framework, it is 
not surprising that cell migration and invasion might exploit the diffuse interconnectivity 
of the “matrix” to execute part of its program, with particular regard to the ability of a cell 
to perceive, transduce and adapt to soluble cues as well as spatial information, ultimately 
affecting cell polarity, motility and invasiveness.  
In the course of more than 3 decades of studying membrane trafficking, a very large 
number of critical molecular determinants have come into view, betraying the complexity 
of the process and its pervasive nature as a “hidden matrix” at the core of the cell blueprint.  
Among these players, the RAB (Ras-related in brain) family of small GTPases (guanosine 
triphosphatase) exerts a fundamental role by orchestrating virtually every aspect of vesicles 
trafficking. There are more than 63 members of this family in mammalian, constituting the 
more numerous group among small G proteins. 
   
The complexity of the endocytic system starts at the plasma membrane, where 
cargos can be internalized through different entry portals, which can be categorized in two 
main categories: the clathrin mediated endocytosis (CME) and the non-clathrin mediated 
endocytosis (NCE), the former being by far the most widely investigated. The best-
characterized CME pathway involves the internalization of a wide variety of 
transmembrane receptors and their ligands in clathrin-coated pits, mediated by the adaptor 
protein AP-2 that bridges cargos with clathrin in vesicle formation at the plasma 
membrane. Subsequent vesicle release from the plasma membrane into the cytoplasm is 
mediated by dynamin, a severing GTPase that promotes the scission of the invaginated pits 
from the PM to form a coated vesicle (Disanza, Frittoli et al. 2009; Sigismund, 
Confalonieri et al. 2012).  This seemingly simple process is aided and optimally tuned and 
regulated by a vast plethora of endocytic adaptors, which help in sensing membrane 
curvature as well as in deforming the PM (Itoh, Erdmann et al. 2005)
 19 
adaptor molecules link the invaginated membrane to the underlying actin cytoskeleton that 
is harnessed to produce sufficient forces to complete internalization (Yarar, Waterman-
Storer et al. 2005), or form macromolecular complexes for the recruitment of cargos and 
accessory molecules not necessarily required in the early endocytic steps, but that will be 
exploited in the subsequent trafficking events (Scita and Di Fiore 2010). 
NCE, on the other hand, includes all entry routes that are insensitive to inhibition of the 
CME pathway. Among the diverse NCE pathways, it is worth to mention: i) the caveolin-
dependent endocytosis, characterized by the invagination of membrane fraction enriched in 
sphingolipids and cholesterol, coated with members of the caveolin protein family; ii) the 
RhoA (Ras homolog gene family, member A)-dependent pathway that mediates the 
internalization of interleukine-2 receptor β chain (IL-2R- β); iii) the ARF6 (Adenosine 
diphosphate-ribosylation factor 6)-mediated and dynamin-independent endocytosis of 
several protein such as β1 integrin and class I major histocompatibility complex molecules 
(MHC I); iv) whereas, fluid phase markers and bulk membranes enter the cells through 
tubular intermediates, the clathrin- and dynamin-independent carriers (CLICs). Lastly, 
phagocytosis, the common mechanism mediating pathogens or apoptotic cells elimination, 
and macropynocytosis for fluid uptake are processes that has been shown to be dependent 
on and triggered by actin remodeling of the plasma membrane, leading to the formation of 
large vesicles that internalize relatively large amount of plasma membrane (Mayor and 
Pagano 2007).  
 
Internalized cargos, either by CME or NCE, are then routed to RAB5-positive early 
endosomes, which represent the first, nearly obligatory endosomal sorting station. From 
this compartment, cargos final destiny is decided. Cargo can, indeed, be directed to late 
endosomes/multivesicular bodies (MVBs), or recycled back to the plasma membrane 
through a variety of frequently ill-defined, but molecular distinct routes. In the former 
case, cargo can traffic to a RAB7-dependent lysosomal degradative route and are 
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subsequently targeted by ubiquitin to degradation in lysosome. In the latter case and in a 
simplified view, recycling may be executed either through a fast (RAB4-dependent) or a 
relatively slow (RAB8- and RAB11-dependent) routes (Disanza, Frittoli et al. 2009; Scita 
and Di Fiore 2010) (Fig.1). 
 
 
Figure 1. The endocytic circuitry of signaling receptors. 
(1) Plasma membrane and ligand-bound receptors (for example RTKs, receptor tyrosine kinases) can be 
internalized through clathrin-mediated (CME) or non-clathrin-mediated (NCE) endocytosis. (2) After 
internalization, both routes converge into RAB5-positive early endosomes. (3-4) From this sorting station, 
cargos can be recycled to the plasma membrane through a fast (which depends on RAB4), or a slow (which 
depends on RAB8 and RAB11) recycling routes. (5) Alternatively, cargo can be targeted to a RAB7-
mediated degradative route, via late endosomes and multivescicular bodies, before being degraded into 
lysosome. Ubiquitylation (ub) and endosomal sorting complex required for transport (ESCRT) play a crucial 
role in the degradative pathway. (6) In addition, cargos such as major histocompatibility complex class I 
molecules (MHC-I) or the interleukin receptors that do not enter through CME, can be redelivered back to 
the plasma membrane through ARF6-dependent pathways. 
Adapted from (Scita and Di Fiore 2010). 
 
 
 
 
 
(1) (1)
(2)
(3)(4)
(5)
(6)
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1.2 The family of RAB GTPases. 
 
 RAB GTPases is the most numerous family of Ras-like small GTPases. These 
proteins are invariably found in all eukaryotes, demonstrating their fundamental role in the 
cell biology of complex organisms. More than 63 members have been identified in 
mammals, classified in subfamilies depending on the degree of conservation of specific 
sequence motifs (Zerial and McBride 2001).  
The central role exerted by RAB family protein is highlighted by the observation that they 
have been shown to control each aspect of vesicular trafficking from vesicle biogenesis, 
fusion and maturation, to actin- or microtubule-dependent vesicle motility, tethering and 
fusion to the PM (Zerial and McBride 2001). Like all GTPases, they act as molecular 
switches, cycling between two different conformations, an “inactive” GDP (guanosine 
diphosphate)- and an “active” GTP (guanosine triphosphate)-bound form. The nucleotide-
bound status determines not only their ability to transduce signals but also their location 
and activity (Stenmark, Parton et al. 1994; Stenmark and Olkkonen 2001; Zerial and 
McBride 2001). In the GTP-bound “active” conformation, they can recruit a vast set of 
specific downstream effector proteins, which are invariably necessary to carry out their 
trafficking functions.  Importantly their site of action is confined to membrane organelles 
and consequently the ability to associate to the lipid bilayer is an essential built-in 
component in their regulation. As a consequence, RABs are variably post-translationally 
modified through the appendage of hydrophobic moiety, among which prenylation is key 
to direct them to various organelles, the identity of which is frequently dictated by the 
presence of different charge lipids, such as phosphoinositydes. 
Newly synthetized RAB-GDP associates with RAB escort protein (REP) that directs it to 
geranylgeranyl transferase (GGT) and to its target membrane. The delivery of RAB to the 
membrane is catalyzed by the GDI dissociation factor (GDF) that catalyzes the release of 
RAB-GDP from the GDP dissociation inhibitor (GDI). The guanine-nucleotide exchange 
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factor (GEF) is essential to convert the inactive RAB-GDP into its active form GTP-
bound, allowing subsequent interaction with specific effectors. RAB GTPase activity is 
then accelerated by the binding with GTPase activating protein (GAP), that enhance the 
intrinsic GTPase activity hydrolyzing GTP into GDP, which concomitantly shut off RAB 
activity, priming it for the subsequent cycle (Stenmark 2009) (Fig.2). 
             
Figure 2. The RAB GTPase cycle. 
(1) RAB-GDP interacts with RAB escort protein (REP) and the geranylgeranyl tranferase (GGT). (2) The 
GDI dissociation factor (GDF) promotes the dissociation of the geranylgeranyl-RAB-GDP from the GDP 
dissociation inhibitor (GDI). (3) Conversion from the GDP to the GTP-bound active form of RAB is 
catalyzed by a guanine nucleotide exchange factor (GEF). (4) Then RAB-GTP can interact with its effector 
proteins. (5) Conversion from GTP- to GDP-bound form occurs by GTP hydrolysis, catalyzed by a GTPase 
activating protein (GAP). Pi, inorganic phosphate.  
Adapted from (Stenmark 2009). 
 
 
RAB GTPases function as specific regulators of intracellular trafficking and each transport 
step requires the recruitment of effector molecules that bind preferentially to the GTP-
loaded active form of RABs. Indeed, like all small GTPases, the two nucleotide bound 
forms show evident conformational differences in the switch I and switch II regions, 
possessing higher affinity for effector targets in the GTP-bound conformation. Many 
different effectors have been identified and each pathway (vesicle formation, movement, 
tethering and fusion) has its unique set of effectors. Crosstalk between multiple RABs 
through common effectors or through the recruitment of RAB activators ensures a tightly 
(3)
(4)
(5)
(1)
(2)
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controlled regulation of vesicle trafficking. Spatiotemporal coordination of RABs 
functions is indeed ensured by diverse strategies based on positive feedback loops, effector 
coupling or activation coupling and RAB conversion (Stenmark 2009) (Fig.3). 
 
Figure 3. The coordination of RABs function. 
(A) The RAB effector contains the specific GEF for the same RAB that has recruited the effector, generating 
a positive feedback loop. (B) The effector contains separate binding sites for two RABs, thus promoting the 
tethering between two micro-domains within the same vesicle, or membranes of two different compartments, 
such as Rabenosyn-5 coupling of RAB4 and RAB5. (C) The effector of the upstream RAB includes the GEF 
for the downstream one. (D) The effector complex activates through a GEF a second RAB which effector 
contains a GAP for the first RAB, generating a negative feedback loop. Pi, inorganic phosphate.  
Adapted from (Stenmark 2009). 
 
 
1.3 The role of RAB5 GTPases in endocytosis. 
 
 RAB5 subfamily of GTPase includes RAB5A, B and C, RAB21, RAB22A and 
RAB22B (also known as RAB31). Among them we focused our attention on RAB5 
isoforms, a well-characterized set of master regulator of endocytosis, that show 
overlapping functions in the endocytic pathway. 
Three RAB5 isoforms have been identified in mammals, named RAB5A, RAB5B and 
RAB5C, transcribed by 3 different genes and ubiquitously expressed (Bucci, Lutcke et al. 
1995). More in detail, these proteins play an essential role in: i) the regulation of the initial 
A- B-
C-
D-
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step of endocytosis, ii) promoting the biogenesis of early endosomes, iii) controlling 
homotypic fusion of these vesicles, their motility and subsequent maturation, ultimately iv) 
regulating the progression of intracellular trafficking. Such a variety of RAB5 functions is 
mediated by well defined sets of different interacting proteins and effectors (Stenmark, 
Vitale et al. 1995; Simonsen, Lippe et al. 1998; Christoforidis, McBride et al. 1999).  
The machinery downstream of RAB5 has an extraordinary complexity and diverse studies 
show that RAB5 effectors function in a cooperative fashion. The first RAB5 effector 
identified was Rabaptin-5, a fundamental mediator of early endosome fusion which 
complexes with Rabex-5, a GEF of RAB5. Upon activation of RAB5, the Rabaptin-5–
Rabex-5 complex induces its own membrane recruitment through Rabaptin-5, generating a 
positive-feedback loop that creates a membrane domain enriched in active RAB5. A 
second class of RAB5 effector are phosphatidylinositol-3-OH kinases (PI(3)Ks). Active 
RAB5 interacts with the hVPS34-p150 PI(3)K, coupling RAB5 localization to 
phosphatidylinositol-3-phosphate (PtdIns(3)P, PI3P) production. The concomitant 
presence of RAB5 and PtdIns(3)P allows the recruitment of the RAB5 effectors early 
endosome antigen 1 (EEA-1) and Rabenosyn-5, both involved in vesicles tethering (Zerial 
and McBride 2001). In particular, this latter RAB5 effector, Rabenosyn-5, shows two 
distinct binding sites for RAB5 and RAB4 and act as a linker between the two RABs 
proteins, thus promoting a physical connection of RAB5-mediated entry site and RAB4-
recycling on early endosomes (Vitale, Rybin et al. 1998; Deneka and van der Sluijs 2002). 
Collectively, these mechanisms support the notion that RAB5 and its effectors cluster in 
membrane sub-compartments and their spatial segregation in well-defined membrane sub-
domain favors their coordination and interaction in mediating RAB5 functions.  
RAB5 shuttling between a GDP-inactive and a GTP-active form plays a fundamental role 
in the control of this complex network. Previous studies have identified RAB5-specific sets 
of GAPs and GEFs. Example of the latter are: Rabex-5, Rin1 and ALS2/Alsin, whereas the 
GAPs include RabGAP-5, RN-tre and p85α (the regulatory subunit of PI(3)K) (Zerial and 
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McBride 2001).  
The essential role of RAB5 nucleotide state in membrane fusion was confirmed in vitro by 
the expression of mutants with altered GTPase activity. RAB5 Q79L, a mutant with a 
strong reduction in GTPase activity, enhances early endosome fusion and expands their 
size; conversely the GDP-locked RAB5 S34N mutant results in the accumulation of very 
small endocytic vesicles (Li and Stahl 1993; Stenmark, Parton et al. 1994). Furthermore, 
the key role of RAB5 in the assembly of the endosomal machinery has been confirmed by 
in vivo silencing of RAB5A, B and C, in mouse hepatocytes. Interestingly, no alteration in 
the expression of RAB5 effectors such as membrane tethering or fusion proteins was 
observed. Conversely, immunofluorescence and electron microscopy analysis showed a 
dramatic impairment in all the endo-lysosomal system, thus affecting the distribution of 
apical markers. Of note, alterations of all the endocytic compartments were achieved only 
upon loss of RAB5 below a specific threshold (Zeigerer, Gilleron et al. 2012). 
 
 
1.4 The tumor suppressor function of RAB5: lessons from the fly. 
 
 Intracellular trafficking is a key process in cell proliferation control and in the 
establishment of epithelial cell polarity. Evidence in support of this latter contention has 
come from genetic studies in Drosophila, where only one highly conserved RAB5 GTPase 
gene is expressed. Indeed, early studies performed in this model system have shown that 
the genetic disruption of different endocytic stages perturbs both cell polarity and cell 
proliferation control leading to the formation of neoplastic tissues (Vaccari and Bilder 
2005; Rodahl, Haglund et al. 2009). Among the identified endocytic neoplastic tumor 
suppressor genes (nTSG), RAB5 and some of its key effectors have been shown to play an 
essential role in the development of imaginal disc epithelium (Lu and Bilder 2005; 
Morrison, Dionne et al. 2008; Robinson and Moberg 2011). Loss-of-function mutants of 
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RAB5, for example, transform this epithelial tissue into a highly proliferative, invasive 
neoplastic mass that fails to terminally differentiate. At the molecular level, this neoplastic 
phenotype may be caused by alterations in a variety of different signaling pathways, 
affected by blockade of the endosomal function of RAB5. Among the pathways affected, 
loss of function of RAB5 was shown to lead to; i) disruption of polarity, as determined by 
alterations in the distribution of the key polarity determinant, Crumbs: ii) deregulation of 
cell proliferation through hyperactivation of Notch receptor (Lu and Bilder 2005); or iii) 
alterations of Yorkie (yes associated protein-YAP and transcriptional co-activator with 
PDZ-binding motif-TAZ, in vertebrates) and JNK (c-Jun NH(2)-terminal kinase) 
pathways, the latter already known to promote Yorkie (Yki) activity in cells with alteration 
in polarity (Robinson and Moberg 2011). More recent studies expanded these early 
findings and characterized in deeper details the mechanism leading to the RAB5-dependent 
neoplastic growth. It was shown that loss of RAB5 can sustain a non-cell autonomous 
overgrowth of the imaginal disc and surrounding tissues by accumulation of EGFR 
(epidermal growth factor receptor) and TNF (tumor necrosis factor) homolog Eiger, a 
soluble factor that activates JNK and Ras signaling pathways, which both participate 
inactivating the Hippo pathway and thus promoting Yorkie activity. The Hippo pathway is 
indeed, fundamental for the control of the co-transcription factor Yki, whose deregulation 
causes uncontrolled proliferation at the basis of the overgrown phenotype typically 
observed in the Hippo mutants. Notably, the molecular cascade at the basis of the control 
of Yki activity is highly conserved between Drosophila and mammals: and constituted by 
the following set of kinases: i) Warts (Lats1/2, large tumor suppressor kinase 1/2 in 
mammals) and the kinase Hippo (MST1/2, mammalian Ste20-like kinase 1/2 in mammals), 
which are brought into close spatial proximity by the scaffold protein Salvador (SAV1 in 
mammals) thereby promoting Hippo-kinase mediated phosphorylation of Warts. In 
addition, ii) Mats (MOB1A and MOB1B, Mps one binder 1a and 1b in mammals) can 
enhance the kinase activity of Warts that targets directly the transcriptional co-activator 
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Yki, preventing it from entering the nucleus.  Impairment of the Hippo kinase cascade 
liberate Yki, which is no longer phosphorylated and free to translocate to the nucleus 
where it mediates the expression of a number of proliferation genes (Yu and Guan 2013). 
Among them, a key role was shown to be exerted by the growth factor Upd (unpaired), an 
homolog of IL6 (interleukin 6), which can fuel a positive feedback loop contributing to the 
loss of proliferation arrest of the imaginal disk tissue (Takino, Ohsawa et al. 2014).   
Regardless of the mechanisms through which RAB5 interference may promote tissues 
overgrow, the experiments in Drosophila indicate that RAB5 is critical for the regulation 
of a diverse set of key pathways necessary for the maintenance of epithelial features and 
epithelial homeostasis (e.g. cell polarity, oncogene activity, YAP/TAZ-growth regulatory 
activity), and further point to a tumor suppressor function of RAB5 
Notably, the role of RAB5 in controlling sorting and delivery of specific proteins involved 
in polarity establishment has also been confirmed in mouse hepatocytes in vivo.  In this 
tissue, RNAi-mediated depletion of RAB5 causes not only the ablation of all the 
endolysosomal system, but also the alteration of the apical distribution of a subset of 
polarity proteins, such as the dipeptidylpeptidase 4 (DPPIV) (Zeigerer, Gilleron et al. 
2012). Of note, reduction of the number of early and late endosomes, including lysosomes, 
was achieved only upon loss of RAB5 isoforms below a specific threshold. Furthermore, 
the entire endocytic pathway was completely rebuilt upon RAB5 recovery, thus confirming 
that the assembly of the endosomal machinery strictly requires RAB5 also in vivo 
(Zeigerer, Gilleron et al. 2012). 
 
 
1.5 RAB5A promotes tumor progression in mammals. 
 
 In addition to a role in the control of early phases of tumor development, RAB5A is 
also emerging as a key player in tumor progression and metastatic dissemination (Lanzetti, 
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Palamidessi et al. 2004; Zhao, Liu et al. 2010; Torres and Stupack 2011).  
A number of findings reported that the expression of RAB5A is elevated in human tumor 
cells and is sufficient to promote a mesenchymal mode of cell invasion in in vitro and in 
vivo model of cancer cell migration (Yu, Hui-chen et al. 1999; Torres, Mielgo et al. 2010; 
Liu, Chen et al. 2011; Torres and Stupack 2011; Onodera, Nam et al. 2012). Conversely 
individual ablation of the three human RAB5 genes (RAB5A/B/C) has been shown to impair 
invasion and dissemination of different types of cancer cells (Yu, Hui-chen et al. 1999; 
Torres, Mielgo et al. 2010; Liu, Chen et al. 2011; Torres and Stupack 2011; Onodera, Nam 
et al. 2012). In silico meta-analysis of more than 900 breast cancer tumors revealed, for 
example, that among the RAB5 genes, RAB5A is overexpressed in breast cancers and its 
elevated expression positively correlates with poor prognosis. Moreover, the striking 
difference in RAB5A expression levels observed in human breast cancer was predictive of 
increased local and distant relapse in early stage estrogen breast cancer patients (Frittoli, 
Palamidessi et al. 2014). Most notably, immunohistochemical analysis of a panel of 
primary human breast cancers and their matched lymph node metastases showed that 
RAB5A expression is significantly higher in matched lymph node metastases, with respect 
to their primary tumors, consistent with the notion that RAB5A overexpression confers a 
migratory advantage to tumor cells (Frittoli, Palamidessi et al. 2014).  
This latter possibility was experimentally verified combining the manipulation of RAB5 
expression or function with a variety of in vivo and in vitro assays of cell invasion and 
metastatization on different triple negative breast cancer cell lines: MDA-MB-231 and 
MCF-10.DCIS.com cells, a tumorigenic derivative of normal human mammary epithelial 
MCF-10A cells that recapitulate features of the comedo-type ductal carcinoma in situ 
(DCIS) when injected subcutaneously into immunodeficient mice (Miller, Santner et al. 
2000). Ablation of RAB5A, B and C or the expression of a RAB5A dominant negative 
(RAB5AS34N) impaired lymph node and lung dissemination of aggressive MDA-MB-231 
cells injected into mammary fat pad without affecting the cell proliferation or survival 
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potential of the primary tumors. Furthermore, impairment of RAB5 function delayed the 
conversion of DCIS-to-IDC (invasive ductal carcinoma) of MCF10.DCIS.com xenograft 
model (Frittoli, Palamidessi et al. 2014), a process that requires digestion of the basement 
membrane and local invasion into collagenous stromal tissues (Hu, Yao et al. 2008). 
Conversely, the ectopic expression of RAB5A in poorly invasive HeLa cells injected 
heterotopically in the mammary fat pad enhanced distant lung metastatization as well as 
local intra-tumoral cell motility, as monitored by two-photon intravital imaging, thereby 
reinforcing the notion that RAB5A elevated expression may be sufficient to promote tumor 
dissemination.  
The pro-metastatic function of RAB5A was further investigated through in vivo three-
dimensional (3D) invasion assays.  When stimulated with a potent motogenic factor, such 
as Hepatocyte Growth Factor (HGF), RAB5A-expressing cells extensively remodeled the 
collagen fibers to generate physical gaps and channels through which cells could meander 
in a process strictly depended on metalloprotease activity (Frittoli, Palamidessi et al. 2014). 
Furthermore, RAB5A elevation was shown to be sufficient to trigger the onset of 
invadopodia and to endow poorly degradative cells with the ability to digest ECM. On the 
contrary, the impairment of RAB5 expression in invasive squamous cell carcinoma that 
efficiently forms degradative invadopodia in the absence of motogenic factors, had 
negligible effects. These observations suggest that RAB5A is necessary and sufficient for 
the formation of these invasive structures following modulation with growth factors, which 
also promote a polarized migratory phenotype (Frittoli, Palamidessi et al. 2014).  Under 
these conditions, cell signaling and trafficking pathways are activated, and membrane 
bound cargos undergoes polarized endo/exocytic cycles that are key to spatially restrict 
their activity contributing to the execution of polarized functions (Scita and Di Fiore 
2010). Not surprisingly, the formation of degradative invadopodia induced either by HGF 
stimulation or RAB5A expression requires the expression of MT1-MMP (membrane type 
1-matrix metalloproteinase), which is rapidly re-localization from early endosomes to 
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ventrally restricted, F-actin-rich structures in response to HGF stimulation in a RAB4 and 
RAB5-dependent fashion (Frittoli, Palamidessi et al. 2014). 
 A molecular genetic approach based on the interference with the major internalization and 
recycling routes unveiled the essential circuitry for MT1-MMP plasma membrane delivery. 
The interference with RAB4A and RAB4B, or their effector Rabenosyn-5, robustly 
reduced matrix degradation, indicating that the RAB5-Rabenosyn-5-RAB4A circuitry is a 
major route for the fast delivery of MT1-MMP to the PM in response to motogenic 
stimulation (Frittoli, Palamidessi et al. 2014). MT1-MMP and RAB4 were indeed co-
localized on recycling endosomes that transiently and dynamically contact invadopodia 
along the ventral membrane. Consistent with this possibility, HGF in addition to enhance 
matrix degradation also promotes the acute activation of RAB5A, likely favoring the 
subsequent recruitment of the Rabenosyn-5-RAB4 complex onto early endosomal 
microdomains for recycling of MT1-MMP. Notably, the RAB5A-Rabenosyn-5-RAB4A 
pathway may also serve as trafficking route for cell-adhesion molecules that in addition to 
actin and MT1-MMP are required for the formation of fully functional invadopodia. One 
of the major integrins shown to be required for invadopodia formation, integrin αVβ3, 
primarly utilizes the RAB4 trafficking route to recycle efficiently in response to 
stimulation with Platelet Derived Growth Factor (PDGF) (Roberts, Barry et al. 2001; 
Roberts, Woods et al. 2003). Accordingly, it was found an absolute requirement for αVβ3, 
but not β1-containing integrins for the formation of RAB5A and HGF-induced 
invadopodia. Our lab further provided evidence that, as previously shown, αVβ3 utilizes 
RAB4 routes, like MT1-MMP, suggesting that the two proteins may be co-trafficked for 
efficient delivery to invadopodia.  
Collectively, this set of findings and previously published data (Palamidessi, Frittoli et al. 
2008) support a model in which RAB5 couples elongated protrusions with pericellular 
proteolysis by controlling RAB4-dependent fast recycling of MT1-MMP and β3 integrin 
cargos to enable efficient invasion. The relevance of this model was verified in breast 
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cancer lines, whose ability to invade collagen gels was impaired not only by silencing 
RAB5 and MT1-MMP, but also of RAB4 or β3 integrin (Frittoli, Palamidessi et al. 2014). 
Additionally, RAB4 interference, and likewise RAB5 silencing, delayed the conversion of 
MCF10DCIS.com cells from DCIS-to-IDC in in vivo mouse models. The observations that 
RAB4A is amplified in more than 14% of invasive breast cancers and upregulated in breast 
tumors lend further support to the notion that the RAB5/RAB4A circuitry is specifically 
selected in human tumors and may contribute to their invasive metalloprotease-dependent 
phenotype (Fig.4).  
 
Figure 4. RAB5A promotes a proteolytic/mesenchymal invasive program. 
In response to the motogenic stimuli of hepatocyte growth factor (HGF), Met receptor is internalized by 
clathrin- and RAB5-mediated endocytosis. RAB5A promotes the formation of endosomes containing RAC1 
and its GEF, ensuring RAC1 activation and recycling to specific regions of the plasma membrane, where 
actin remodeling occur and migratory protrusion are then formed. The RAB5/RAB4 trafficking circuitry re-
directs αvβ3 integrin and MT1-MMP to invadosomes, leading to the formation of invasive structures and 
matrix remodeling.  
Adapted from (Frittoli, Palamidessi et al. 2014). 
 
 
In keeping with a general role of RAB5 in tumor progression, RAB5A expression was also 
found to be elevated in ovarian cancer (Zhao, Liu et al. 2010), to be associated with the 
metastatic potential of human lung (Yu, Hui-chen et al. 1999) and gastric cancer (Li, Feng 
et al. 1999), as well as with increased migration of hepatocellular carcinomas (Fukui, 
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Tamura et al. 2007) and with lymph nodes metastasis in breast cancer patients (Yang, Yin 
et al. 2011).   
Collectively, these evidences support the notion that RAB5A promotes a mesenchymal 
program of tumor dissemination.  
 
 
2. MCF-10A cells as a model to clarify RAB5A role in tumorigenesis and tumor 
progression. 
  
2.1 Modeling the development of the human mammary gland in vitro. 
 
 The tumor suppressor activity of RAB5 in Drosophila contrasts with its pro-
metastatic function in advanced human cancer. One way to reconcile these apparently 
contradictory observations is to posit that RAB5 may exert a dual, temporally distinct 
function in the process of tumor development: it may act as suppressor of tumor initiation, 
in the early phase of tumor development, but become a promoter of metastatic phenotypes 
in late advance staged of tumor progression. In an attempt to rationalize these functions 
and dissect the underlying molecular pathways, we decided to carry out our investigation 
by either interfering with or overexpressing RAB5A in a normal, mammary epithelial cell 
line that recapitulate a number of features of mammary epithelium, including the ability to 
undergo a morphogenetic processes resembling gland development, in vitro. 
  
MCF-10A, a normal non-transformed human mammary epithelial cell line, was derived 
from spontaneous immortalization of cells obtained from subcutaneous mastectomy of a 37 
year old breast with benign fibrocystic disease (Soule, Maloney et al. 1990). Notably, this 
cell line retains the typical features of a normal breast epithelium: i) their proliferation and 
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survival depend on exogenously added growth factors and hormones; ii) it displays 
anchorage dependent growth properties; and iii) it is unable to form tumor when injected 
into nude mice (Soule, Maloney et al. 1990). iv) Finally, MCF-10A cells can grown in 
three dimensions, where they can give rise to acinar-like spheroids with an hollow lumen, 
apicobasal polarization and basal deposition of basement membrane components (laminin 
V and collagen IV), thus recapitulating the morphogenetic program of mammary gland 
formation (Fig. 5). 
 
 
 
Figure 5. The morphological architecture of in vitro MCF-10A 3D acini resembles the 
structure of human mammary gland lobule in vivo.  
(A) Schematic of the human mammary gland lobule: a hollow lumen is surrounded by an inner monolayer of 
polarized luminal epithelia cells and an outer monolayer composed of basal epithelial and myoepithelial 
cells. (B) Tissue section of acini in vivo, stained with hematoxylin and eosin. The arrow indicates 
accumulation of proteinaceous secretory material (C) Phase-contrast image of a MCF-10A acinar structure 
cultured on reconstituted basement membrane for 14 days, in vitro. The general architecture is similar to that 
observed in vivo. The hollow lumen is surrounded by polarized epithelial cells that deposit basement 
membrane components.  
Adapted from (Debnath, Muthuswamy et al. 2003) 
 
 
 
 
 
2.2 MCF-10A acinar morphogenesis in 3D culture. 
 
 The importance of the extracellular matrix in the regulation of growth and 
differentiation of normal mammary epithelial cells was first shown in rodent models and 
further confirmed in primary human mammary epithelial cells (Petersen, Ronnov-Jessen et 
A B C
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al. 1992). The maturation of in vitro 3D acini is characterized by the alternation of key 
cellular processes that are rigorously temporally regulated. MCF-10A cells cultured on 
reconstituted basement membrane initially proliferate creating a disorganized cluster of 
cells. The subsequent establishment of polarity is accompanied by the deposition of 
basement membrane proteins (laminin V and collagen IV) and the definition of specific 
subpopulation of cells. The inner population of cells loose contact with the extracellular 
matrix and die by anoikis, leading to the clearance of the lumen. Once a luminal hollow 
structure is formed, these structures stop proliferating. Around day 14, a growth-arrested 
and terminally differentiated acinar structure is formed, recapitulating the morphology of 
mammary gland lobule in vivo (Debnath, Mills et al. 2002; Debnath, Muthuswamy et al. 
2003) (Fig. 6). 
 
 
Figure 6. Schematic of biological events during MCF-10A 3D acinar morphogenesis. 
MCF-10A cells follow a reproducible morphogenetic program when cultured on reconstituted basement 
membrane (Matrigel). During the early stages, single cells proliferate to form a cellular cluster, which starts 
to develop an apicobasal polarity. At day 5-8, two distinct populations of cells become evident: an outer layer 
in direct contact with the matrix where Akt (also known as protein kinase B or PKB) signaling pathway 
transduce a survival signal, and an inner subset of cells poorly polarized that loose contact with the matrix 
and lack Akt activation. Starting at day 8, the centrally located cells begin to die by anoikis and contributes to 
the formation of the hollow lumen observed in a terminally differentiated, not-proliferating acini (day 14).  
Adapted from (Debnath and Brugge 2005). 
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Day8 Luminal cell death
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2.3 Three-dimensional culture of MCF-10A cells reveals oncogene-induced 
alteration of mammary architecture. 
 
 A caveat in monolayer cell culture is the artificial and non-physiological two-
dimensional organization of cells. Moreover, traditional assays investigate cellular 
processes associated with tumor initiation and progression without considering critical 
architectural alteration of the mammary gland involved in cancer development. 
Conversely, differently from cells monolayers, the development of three-dimensional 
culture on reconstituted extracellular matrix provides the optimal system to dissect the 
emerging role of the matrix microenvironment in the process of morphogenesis, and 
tumorigenesis and to unmask neoplastic phenotypes, not distinguishable in normal culture 
condition (Li, Aggeler et al. 1987; Petersen, Ronnov-Jessen et al. 1992; Weaver, Howlett 
et al. 1995; Bissell, Rizki et al. 2003).  
Three-dimensional culture of mammary epithelial cells indeed allows us to examine how 
the interplay between cell proliferation, cell death, and differentiation influence the 
structure and function of glandular epithelium, both in the normal state and during 
oncogene-induced early tumor formation (Spancake, Anderson et al. 1999; Herr, Wohrle et 
al. 2011). It has already been shown that oncogene induced transformation may affect 
different signaling pathways that impinge on MCF-10A acinar morphogenesis and 
maturation, and may cause: i) increased acinar size due to a bypass of the proliferation 
arrest typically observed in fully matured hollow acini; ii) block or delay of luminal 
clearance due to defective control over luminal localized cell death (Shaw, Wrobel et al. 
2004). For example, acini expressing human papillomavirus E7 or high level of cyclin D1, 
both of which promote cell cycle progression by inactivation of the retinoblastoma protein 
(Rb), show a normal morphology but increased size caused by scheduled, excessive 
proliferation (Debnath, Mills et al. 2002). However, proliferating cells lacking direct 
contact with the matrix are nearly invariably eliminated by apoptosis and acini retain a 
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hollow lumen. Instead, the activation of ErbB2 oncoprotein leads to the formation of 
multiacinar structures with a filled lumen, a more severe phenotypic alteration 
characterized by the combination of hyper-proliferation, resistance to apoptosis, and a 
striking loss of epithelial polarity (Muthuswamy, Li et al. 2001; Debnath, Muthuswamy et 
al. 2003) (Fig.7).  
 
             
Figure 7. Oncogene expression differently affects MCF-10A acini morphogenesis and 
architecture. 
Normal 3D architecture of acini seeded on Matrigel is shown on the left. The expression of the human 
papillomavirus E7 induces a hyper-proliferative phenotype and the formation of acini 30% bigger in size, 
without any alteration in the general architecture of acinar structures that retain hollow lumen and a correct 
apico-basal polarity (middle panel). Activation of ErbB2 oncoprotein during acinar morphogenesis elicits a 
complex multiacinar structure with filled lumen (on the right).  
Adapted from (Debnath, Muthuswamy et al. 2003) 
 
Three-dimensional culture represents, indeed, a powerful tool to investigate the effects of 
oncogenic stimuli that induces uncontrolled proliferation, resistance to apoptosis, loss of 
cell polarity and the acquisition of invasive properties, typical hallmarks of aggressive 
cancer phenotype.  
 
 
 
 
MCF-10A MCF-10A HPV E7 MCF-10A active ErbB2
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3. Deregulation of the endocytic pathway alters different aspects of acinar 
morphogenesis. 
 
3.1 Alteration of epithelial integrity and architecture synergize with oncogenes 
in promoting invasive phenotype. 
 
 So far, most of the studies on MCF-10A cells have investigated the effect of breast 
cancer-related oncogene expressed in the entire cell population, since the beginning of the 
morphogenetic process. Under these conditions, abnormal acinar growth and development 
is frequently observed reflecting only in part oncogenic alterations seen in human breast 
cancer. However, carcinomas typically derive from single mutated cell in a context of 
differentiated, normal epithelium that exerts a tumor suppressive function (Leung and 
Brugge 2012). This prompted us to focus the attention on the effects of oncogenes in later 
stages of acinar morphogenesis and homeostasis and on the importance of tissue 
architecture and integrity in the control of oncogene driven phenotypes. 
Within this context, for example, it has been shown that concomitant perturbation of cell-
matrix adhesion by MMPs and induction of c-Myc is sufficient to trigger cell translocation 
and luminal expansion in 3D acinar structures (Leung and Brugge 2012). A similar 
phenotype was observed in mature acini interfered for p120-catenin: the destabilization of 
cell-to-cell junctions unleashes oncogene-expressing cells from their suppressive epithelial 
environment and induces clonal expansion (Leung and Brugge 2012; Leung 2013). These 
experimental observations support the notion that epithelial organization, together with 
cell-to-cell and cell-matrix adhesion can modulate cellular responses to oncogenic stimuli 
known to drive hyper-proliferation in un-organized structures (Simpson, Yu et al. 2011). 
 It is relevant to point out that several lines of evidence demonstrate that in 
Drosophila, as well as in mammalian cells, the polarized organization of epithelial cells is 
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an overarching factor in the control not only of tissues architecture, but also of cell 
proliferation; indeed, disruption of proteins involved in polarity establishment causes a 
hyperplastic growth and cooperate with other oncogenes in driving a tumorigenic and 
invasive behavior (Bilder, Li et al. 2000; Wodarz 2000; Brumby and Richardson 2003) 
(Pagliarini and Xu 2003) (Chatterjee, Seifried et al. 2012; Xue, Krishnamurthy et al. 2013). 
For example, it has been shown in MCF-10A cells the correlation between disruption of 
cell polarity and epithelial organization with c-Myc-induced hyper-proliferation.  Albeit 
chronic activation of c-Myc at early stages of acinar morphogenesis, when polarity in not 
well established, results in hyper-proliferation and transformation, acute c-Myc activation 
in mature and polarized structures fails to reinitiate cell cycle and transform 3D acini. 
Further investigation better dissected the underlying tumor promoting mechanism 
highlighting the notion that in order for c-Myc to release its oncogenic potential, disruption 
of polarity through the deregulation of Lkb1 (Par-4, a member of partitioning defective 
protein PAR family, known to regulate cell polarity) must occur. Although loss of the 
tumor suppressor gene Lkb1 alone is not sufficient to drive mammary tumorigenesis, the 
combination of Lkb1 deletion with c-Myc overexpression affects epithelial integrity and 
leads to hyper-proliferation (Partanen, Nieminen et al. 2007; Partanen, Tervonen et al. 
2012).   
 
 
3.2 Alteration of polarity may be induced by deregulation of endocytosis.  
 
 Even more striking and relevant to this work are the findings showing that mutation 
in key essential membrane trafficking factors give rise to a neoplastic over-proliferating 
epithelia that is often caused by altered delivery of key polarity molecules (Vaccari and 
Bilder 2005; Rodahl, Haglund et al. 2009).  Indeed, Drosophila RAB5 null mutants, 
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similarly to syntaxin Avalanche (avl) mutants, cause multilayered, hyper-proliferative 
phenotypes in eye discs and follicle cells: disruption of the endocytic trafficking results in 
the accumulation of specific membrane proteins as Notch receptor and the apical 
determinant Crumbs, leading to epithelial polarity defects and a specific expansion of the 
apical membrane domain (Lu and Bilder 2005) (Robinson and Moberg 2011). Moreover, 
among the Drosophila homolog of RAB5 effectors, novel endocytic neoplastic tumor 
suppressor genes were identified: unlike Rbns-5 mutants (Rabenosyn 5 in mammalian) that 
disrupt the correct localization of protein controlling the planar polarity establishment 
(Mottola, Classen et al. 2010), mutants of Rbpn-5 (Rabaptin-5 in mammalian), the effector 
protein of RAB5 that promotes homotypic early endosome fusion, and Rabex 5, a RAB5 
GEF, showed hyper-proliferation and a disrupted epithelium, but retaining a normal 
polarity (Thomas and Strutt 2014). Thus, ablation of the endocytic pathway in epithelial 
tissues promotes hyper-proliferation through mechanism that are not fully understood, but 
seems not to depend only on altered epithelial polarity. 
 
 
3.3 Alteration of the endocytic machinery drives uncontrolled cell proliferation 
through non-cell autonomous mechanisms. 
 
 Another critical hallmark of cancer cells is the acquisition of growth factor 
independent proliferation, frequently achieved by the autocrine or paracrine production and 
secretion of soluble proliferating signals. Endocytosis, initially studied as the process 
responsible for nutrient internalization for cell survival, has more recently emerged as a 
master organizer of cell signaling. A tight control of ligand-receptor internalization, 
recycling and degradation allows, for example, space and time resolving of different 
stimuli. The integration of such different endocytic routes defines the net biological 
outcome (Scita and Di Fiore 2010).  
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Alteration in the endocytic circuitry has been shown to be associated with human cancer 
(Mosesson, Mills et al. 2008). Moreover, a recent genetic screen performed in Drosophila 
model suggests that dysfunction of RAB5 drives non-autonomous cell proliferation in 
imaginal disc epithelium, inducing the accumulation of both EGFR and Eiger (an homolog 
of TNF) together with a downstream activation of JNK and Ras signaling pathways.  Both 
cascades control and inactivate the Hippo pathway, triggering Upd (an IL6 homolog) 
expression and secretion, thus promoting cell proliferation (Takino, Ohsawa et al. 2014). 
Similar mechanisms has been observed in mammalian: in breast cancer, EGF independent 
growth was shown to be sustained by the increase in the secreted factor Amphiregulin 
(AREG), an EGFR ligand initially identified in the human breast carcinoma cell line MCF-
7 after treatment with PMA (phorbol 12-myristate 13-acetate)(Shoyab, McDonald et al. 
1988). Importantly, evidences collected in MCF-10A, a human normal mammary epithelial 
cell line strongly dependent on EGF to proliferate, support that an Hippo-dependent, non-
cell autonomous mechanism observed in Drosophila might also be operative in 
mammalian system. Of note, the ectopic expression of YAP or TAZ, downstream effectors 
of the Hippo pathway, is sufficient to sustain EGF-independent growth through the 
secretion of a diffusible factor, AREG. Hence, YAP- or TAZ-dependent secretion of 
AREG identifies this EGFR ligand as a direct effector of the Hippo pathway with 
implications on the regulation of both physiological and malignant cell behavior (Zhang, Ji 
et al. 2009; Yang, Morrison et al. 2012). 
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4. The EGF-like growth factor Amphiregulin and its role in physiological and 
pathological conditions. 
  
4.1 The ErbB/HER family of protein-tyrosine kinases. 
 
 Mammary epithelial tissues, as well as the in vitro model MCF-10A cells, strongly 
depend on EGF for their growth and proliferation. The specific binding of EGF with its 
receptor EGFR, activates a signal transduction cascade that modulates cell proliferation, 
survival, migration and differentiation.  
EGFR is a member of the ErbB/HER (human epidermal growth factor receptor) family of 
receptors, originally named ERBB because of their homology with v-erbB, the 
erythroblastoma viral gene. This family comprises four receptor tyrosine kinases: EGFR 
(ErbB-1/HER1), HER2 (ErbB-2), HER3 (ErbB-3), and HER4 (ErbB-4) which are 
activated by ligand-induced dimerization. In human, the receptor homo- or 
heterodimerization together with the identification of more than 30 different ligands, 
generate a complex network of cellular responses (Yarden 2001). Interestingly, ErbB-2 has 
no ligands and ErbB-3 is devoid of kinase activity. Despite the described deficiencies, both 
of these receptors generate cellular signals by heterodimerization with other ligand-
occupied ErbBs. ErbB-2, especially, is the preferred partner in heterodimeric complexes 
with the other family members, and ErbB-3 heterodimers are potent inducers of 
intracellular signals (Yarden and Sliwkowski 2001) (Fig.8). 
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Figure 8. Dimerization and ligand specificity of ErbB/EGFR family members. 
Each receptor is characterized by an extracellular ligand-binding domain, a transmembrane lipophilic domain 
and an intracellular tyrosine kinase domain. Trans-phosphorylation of tyrosine residues relies upon receptor 
dimerization and is induced by ligand binding. Receptor phosphorylation causes activation of downstream 
signaling pathways. Known receptor dimerization and corresponding ligands are shown. No ligand for HER2 
has been identified. The kinase domain of HER3, which is marked with a cross, is kinase-impaired. 
Adapted from (Linardou, Dahabreh et al. 2009) 
 
 
After ligand binding, ErbB/HER family receptors activate a set of canonical biochemical 
cascaded including: the mitogen-activated protein kinase (MAPK), the 
phosphatidylinositol 3-kinase (PI3K)/Akt and the phospholipase Cγ (PLCγ) pathways. 
These signaling pathways invariably lead to the activation of several transcriptional 
regulators that modulate proliferation, apoptosis, migration and adhesion (Scaltriti and 
Baselga 2006).  
The duration, intensity and localization of the activity of these signaling cascades are 
tightly regulated. Endocytosis is one mechanism through which signal attenuation is 
achieved. Indeed, it has been shown, for example, that EGFR in physiological conditions 
(low doses of EGF) is mostly internalized via clathrin-dependent endocytosis and recycled 
back to the plasma membrane, whereas at higher doses of EGF, clathrin-indipendent 
endocytosis targets primarily the receptor to degradation via the lysosomal pathway 
(Sigismund, Woelk et al. 2005) (Sorkin and von Zastrow 2009). 
ErbB/HER receptors family has been also implicated in the acquisition of malignant 
X
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phenotypes like uncontrolled proliferation, resistance to apoptosis, angiogenesis and 
metastasis. Consistently, they have been one of the most extensively studied protein 
families with respect to their bio-physiological properties and use as prognostic and 
predictive markers in various tumor types (Zaczek, Brandt et al. 2005). A case in point is 
represented by ErbB-2. ErbB-2 amplification is a frequent occurrence in breast and ovarian 
cancer malignancies, and it is associated to aggressive diseases, predicting overall survival 
and time to relapse (Slamon, Clark et al. 1987) (Slamon, Godolphin et al. 1989). Similarly, 
in many different cancer types ErbB-1 is constitutively activated as a result of specific 
mutation in the autocrine kinase loop or through events that lead to its upregulation and 
elevated expression (Klijn, Berns et al. 1992; Holbro and Hynes 2004). 
 
 
4.2 The EGF-like growth factor Amphiregulin. 
 
 Mammary gland development is probably the best-studied epithelial organ 
morphogenesis regulated by ErbB signaling. Among the identified ligands involved in this 
process, a fundamental role is played by Amphiregulin (AREG), a well-characterized 
ligand of EGFR (HER1/ErbB-1). AREG protein is firstly synthetized as a transmembrane 
polarized glycoprotein precursor (Pro-AREG), with the mature soluble AREG processed 
by proteolytic cleavage mediated by TACE (TNFα converting enzime or ADAM17 ).   Its 
N-terminus contains six spatially conserved cysteine residues, flanked by a set of semi-
conserved amino acids, the so-called EGF domain, and two potential nuclear targeting 
sequences. Both Pro-AREG and AREG are involved in the activation of specific cell 
response throught a juxtacrine (Pro-AREG) and autocrine/paracrine (AREG) signaling. 
Upon EGFR binding, AREG induces its activation by homo- or heterodimerization and 
engages different signaling pathways, including Ras/MAPK, PI3K/Akt, mTOR 
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(mammalian target of rapamycin), STAT (Signal Transducer and Activator of 
Transcription) and PLCγ (Fig.9).  
                              
Figure 9. Schematic of AREG cell signaling strategies.  
Membrane bound Pro-AREG elicits a juxtacrine signaling with neighboring cells or a paracrine signaling 
when included in exosomes. Alternatively, the cleavage of Pro-AREG by TACE can be stimulated by 
GPCRs (G-protein coupled receptor) and RTKs (receptor tyrosine kinases) ligands: soluble AREG can 
trigger autocrine or paracrine signaling. The interaction of AREG with EGFR induces homo- or 
heterodimerization of the receptor and its activation by cross-phosphorylation. pEGFR triggers the activation 
of downstream intracellular signaling pathways. 
Adapted from (Berasain and Avila 2014). 
 
 
Considering the multiple cellular responses modulated by AREG, it is not surprising that it 
is involved in cell proliferation, apoptosis and migration of different cell types, both in 
physiological and pathological processes (Busser, Sancey et al. 2011; Berasain and Avila 
2014).  
 
 
4.3 Amphiregulin role in physiological mammary gland development.  
 
 Within the physiological context of mammary gland development, AREG has been 
shown to mediate specifically pubertal mammary ductal development, induced both by 
Estrogen (ER) and Progesteron Receptors (PR) activation (McBryan, Howlin et al. 2008). 
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In the former case, it has been shown first in vitro and confirmed in vivo, that AREG 
expression is controlled by estrogen secretion. These findings highlight the notion that 
AREG is a key paracrine mediator of ERα signaling fundamental for epithelial cell 
proliferation during the pubertal ductal elongation, but not for earlier or later stages of 
mammary gland development (Ciarloni, Mallepell et al. 2007). ERα, AREG and EGFR 
knockout mice phenocopy each other, showing a clear deficiency in the morphogenesis of 
mammary gland ducts, supporting the hypothesis that this signaling cascade initiated by 
estrogens is mediated by AREG interaction with EGFR.  
In the latter case, both prior and at puberty, progesterone acting through its specific 
receptor PR, causes the formation and proliferation of the mammary gland end buds, which 
was dependent on a significant increased AREG expression (Aupperlee, Leipprandt et al. 
2013). Furthermore, branching morphogenesis requires a constant crosstalk between the 
developing epithelia and the surrounding stroma. In this process, TACE mediates the 
release of epithelial AREG that binds and actives stromal EGFR, thus orchestrating 
mammary duct morphogenesis (Sternlicht, Sunnarborg et al. 2005).  Taken together, these 
evidences support the notion that AREG is required for normal ductal morphogenesis. 
 
 
4.4 Amphiregulin in breast cancer.     
     
 In pathological conditions, AREG expression is correlated with inflammation and it 
is up-regulated in a wide variety of human cancer. In keeping with these observations, 
AREG overexpression can sustain growth factor independent proliferation of transformed 
cells.  In particular, many studies performed both in vitro and in vivo on breast cancer 
tissues suggest that AREG play a key role in driving the initiation and progression of 
human breast cancer (Busser, Sancey et al. 2011). Accordingly, AREG overexpression in 
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different breast cell lines was shown to confer EGF-independent proliferation ability and to 
promote motility and invasion, typical hallmarks of cancer progression (Willmarth and 
Ethier 2006).  
Converseley, the inhibition of AREG expression by RNA interference has been shown to 
revert the malignant phenotype and suppress the tumorigenicity of human breast epithelial 
cell lines (Ma, Gauville et al. 1999). Additionally, AREG expression in mammary 
epithelial cell lines increases the expression of TGFβ1 (transforming growth factor beta 1), 
which synergizes with AREG in stimulating the production of uPA (urokinase-type 
plasminogen activator), promoting protease production, and consequently breast cancer 
progression (Giusti, Desruisseau et al. 2003).  
 
 
4.5 Amphiregulin transcriptional control. 
 
A variety of regulatory pathways control the production and secretion of this 
growth factor. Studies performed on AREG promoter identified diverse functional 
elements that may explain its modulation by multiple inputs. Among these regulatory 
sequences, an estrogen responsive element (ERE) was identified by ChiP (chromatin 
immunoprecipitation) analysis, thus pointing to a direct ER driven transcriptional 
regulation of AREG expression by binding of ER to AREG gene regulatory sequence 
(Martinez-Lacaci, Saceda et al. 1995; Britton, Hutcheson et al. 2006) (Ciarloni, Mallepell 
et al. 2007). Additionally, in breast cancer under hypoxic conditions, the overexpression of 
HIF-2α (Hypoxia Inducible Factor 2 α, a well known mediator of cell response to local 
tissue hypoxia) promotes the autotrophic AREG/EGFR/ErbB4 pathway that is capable of 
sustaining a cell autonomous growth, thereby overcoming unfavorable microenvironment 
and hostile growth conditions. Although ChiP data showed a physical interaction of HIF-
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2α with AREG promoter region, this gene regulation has been shown to be HRE (hypoxia 
responsive element)-independent, likely suggesting additional so far unrecognized 
regulatory elements that cooperates with HIF-2α to control AREG transcription (Bordoli, 
Stiehl et al. 2011; Stiehl, Bordoli et al. 2012). Finally, YAP and TAZ, emerging co-
transcriptional regulators that are often amplified in tumors and associated with malignant 
transformation, have also been shown to mediate AREG transcription (Zhang, Ji et al. 
2009; Yang, Morrison et al. 2012). Studies performed on MCF-10A cells demonstrated 
that the expression of YAP or TAZ was sufficient to enhance cell proliferation of non-
expressing cells through a non-cell-autonomous mechanism. The EGFR ligand AREG was 
identified as the downstream effector of the Hippo pathway responsible for EGF-
independent growth both in 2D and 3D. The strong correlation between these two 
signaling cascades was confirmed by interfering at different levels of the Hippo pathway: 
abrogation of YAP/TAZ negative regulators LATS1 and 2 induces AREG up-regulation; 
conversely TEAD transcription factor ablation completely abolishes AREG 
overexpression. These evidences, together with ChiP-based assays, identify another 
regulatory pathways controlling the production and secretion of AREG, specifically 
mediated by TEAD in TAZ expressing cells (Zhang, Ji et al. 2009; Yang, Morrison et al. 
2012). 
 
 
4.6 Hypoxia regulation of endocytosis.  
 
One of the typical hallmark of cancer progression is a state of self-sufficiency that 
supports cell autonomy (Hanahan and Weinberg 2000). Cancer cells indeed may acquire 
the capability to express and secrete growth factor in order to sustain their own 
proliferation via either an autocrine or paracrine mechanism. 
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Oxygen deprivation or oncogenic activation of HIF has been correlated with cancer 
progression and poor prognosis. In hypoxic conditions, proliferation and cell survival may 
be supported by a deregulation of RTKs-mediated signaling pathways; or by the 
expression and secretion of specific growth factors. In the former case, increased EGFR 
half-life can result in a prolonged and accentuated EGFR signaling (Wang, Roche et al. 
2009). In this conditions, endocytosis-mediated de-activation of EGFR has been indeed 
shown to be altered through the attenuation of RAB5-mediated early endosome fusion and 
a significantly reduced expression of Rabaptin-5, a key RAB5 effector, was documented to 
occur in hypoxic primary breast and kidney tumors (Wang, Roche et al. 2009). In the latter 
case, hypoxia is one of the pathways that control the expression of the EGFR ligand AREG 
and the up-regulation of this secreted factor has been shown to allow growth factor 
independent proliferation of transformed cells (Bordoli, Stiehl et al. 2011; Stiehl, Bordoli 
et al. 2012). 
Given these evidences, further investigations will elucidate if, in hypoxic conditions, the 
alteration of vesicles trafficking and endocytic regulators, RAB5A in particular, may 
represent the common hub triggering both a prolonged half-life of EGFR and the up-
regulation and secretion of the EGFR ligand AREG, thus sustaining a state of self-
sufficiency.  
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5. Cell migration. 
 
5.1 The diverse strategy of cell motility. 
 
Cell migration is a complex process involved both in physiological and 
pathological conditions. Indeed, proper embryogenesis, immune surveillance and tissue 
homeostasis all relies on the tight regulation of cell locomotion, which is often hijacked 
during pathologies such as chronic inflammation or cancer progression.  
The balance of different extracellular and intracellular structural and molecular 
determinants defines the multiple and diverse motility strategies that a cell can adopt in 
order to cope with micro-environmental cues (Friedl and Wolf 2010) (Fig.10).   
 
   
Figure 10. The migratory mode is influenced by micro-environmental and cellular 
parameters. 
The combination of ECM architecture properties together with cellular determinants defines the migratory 
strategy adopted by motile cells. Each colored line represent the diverse strategies adopted depending on the 
intensity (dashed vertical lines) of each parameter. 
Adapted from (Friedl and Wolf 2010) 
 
Each of these modes is driven and regulated by distinct molecular pathways. To exemplify 
this notion, it is evident that cell can move either collectively or as single cells (amoeboid 
and mesenchymal modes). Within single cell locomotion, ameoboid migration is thought 
to resemble motility strategy and morphology typically ascribed to the amoeba 
Dictyostelium discoideum. Amoeboid Dictyostelium motility involves Rho-Rock (Rho-
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associated protein kinase)-dependent actomyosin contractility, that drives blebbing-like 
movements of rounded and loosely adherent cells. Cells displace matrix fibrils and squeeze 
across the narrow spaces without requiring extensive remodeling of the extracellular 
matrix (ECM) or its degradation mediated by protease activity (Friedl 2004; Lammermann 
and Sixt 2009; Madsen and Sahai 2010).  Conversely, in the mesenchymal motility mode 
cells adopt an elongated, fibroblast-like morphology, more akin to the prototypical 2D 
motility classically described by Abercrombie back in the sixty (Abercrombie 1961). 
Locomotion relies on a dynamic integrin-mediated attachment to the extracellular matrix 
and on the formation of RAC-dependent, F-actin rich protrusions that drive directional 
motility coupled with pericellular proteolysis and high MMP activity (Wolf, Mazo et al. 
2003; Palamidessi, Frittoli et al. 2008; Sanz-Moreno, Gadea et al. 2008; Egeblad, 
Nakasone et al. 2010; Kessenbrock, Plaks et al. 2010).  Likewise, the described single cell 
migratory mode sustains the normal morphogenetic process but also cancer dissemination, 
where single cells detach from the mass and migrate in a secondary tissue to initiate 
metastatic growth (Fig. 11, top panels).  
Otherwise, the maintenance of stable cell-to-cell adhesions among migrating cells allows 
cells to move as clusters (typical of primary cancer lesions) or as a multicellular connected 
sheet (frequently observed in epithelia) in the so-called collective locomotion. Among cell-
cell contacts, adherens junctions (AJs) are common structures observed in epithelial 
collective migration and are mainly composed of cadherins, in particular E-cadherin in 
epithelial cells (Friedl and Gilmour 2009). Also collective locomotion relies on adhesion to 
the substrate and protease activity in order to allow migration across the extracellular 
matrix, but with additional cell-to-cell adhesions. Finally, other locomotory strategy has 
been identified, including: i) mesenchymal chains, when elongated cells move in a loose 
chain-like fashion; ii) collective branching, typical of mammary gland morphogenesis; and 
iii) collective vascular sprouts of endothelial cells from new blood vessel that mature into a 
growing strand containing a lumen (Fig.11, bottom panels) (Friedl 2004).  
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Figure 11. Cell migration strategies differently rely on adhesion, proteolytic activity and cell-
to-cell adhesions. 
Different migratory modes are shown, divided in the two main categories: single vs collective cell 
locomotion. Integrins, proteases and cadherins dependency is shown. For details refer to the text. 
Adapted from (Friedl 2004) 
 
 
As already anticipated, collective locomotion of cohesive group of cells is a typical 
physiological mechanism involved in embryogenesis and tissues or organs formation. 
Remarkably, however, a similar collective behavior is also displayed by cancer cells 
during tumor progression and invasion, particularly in those of epithelial origin.  
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5.2 The plasticity of cell motility. 
 
In tumor progression, neoplastic cells invade through the basement membrane and 
diverse types of stromal ECM that provide on one hand a substrate for adhesion and 
traction, but on the other hand impose biomechanical resistance (Friedl and Alexander 
2011). Tumor cells flexibly employ the described diverse modes of migration and switch 
between them depending on both intrinsic as well as microenvironmental factors (Wolf 
and Friedl 2006). This adaptive capability is termed plasticity. Within this context, the 
transition from cells migrating as a group to single motile cells is called epithelial to 
mesenchymal transion (EMT) and it usually occurs when cell-to-cell adhesions are lost and 
epithelial cancer undergo to progressive de-differentiation (Thiery, Acloque et al. 2009) 
(Giampieri, Manning et al. 2009). Conversely, when cell-to-cell or cell-ECM adhesions 
and pericellular proteolysis are weakened, single cells detach from the tumor mass and 
adopt an amoeboid motility mode, in a collective to amoeboid transition (CAT) 
(Hegerfeldt, Tusch et al. 2002). Interestingly, it has been shown that a reverse transition 
from amoeboid to mesenchymal locomotion (AMT) can also take place, at least in vitro. 
For instance, treatments with ROCK inhibitors or RAC hyper-activation induce AMT; 
conversely, protease inhibitors or integrin antagonists can cause mesenchymal to amoeboid 
transition (MAT) (Sahai and Marshall 2003; Wolf, Mazo et al. 2003) (Fig.12).   
 
 
 53 
             
Figure 12. Neoplastic cells can adapt to different microenvironment by switching motility 
strategy. 
Loss of cell-to-cell interactions induces single cell detachment from the primary tumor mass and migration in 
a protease and integrin dependent (EMT) or independent (CAT) motility mode. In individual cells, the 
weakening of cell to ECM interaction and the inhibition of proteolysis results in MAT. 
Adapted from (Friedl 2004) 
 
 
 
 
While these two single motility modes are often defined as distinct behavior, it is more 
accurate to define them as a continuous spectrum with intermediate phenotype. Cancer 
cells can, indeed, exploit a wide spectrum of migratory modes, ranging from single to 
collective, from proteolytic to protease independent and from adhesive to non-adhesive 
strategies, easily adapting to the surrounding microenvironment. This plasticity represents 
also a mechanism that provides migratory-based escape strategies after specific 
pharmacotherapeutic treatment, thus prompting an alternative method of cancer 
dissemination and resistance to single metastatic inhibitory agents. 
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5.3 Epithelial collective locomotion. 
 
Collective locomotion of cohesive groups of cells is a typical hallmark of 
remodeling events involved in processes of embryogenesis, tissue repair and cancer 
invasion.  
Some specific features define collective migration and ensure cells to move as a unique 
unit: i) cell-to-cell junctions are conserved during cell movement and cells within the 
group remain physically but also functionally connected; ii) actin cytoskeleton 
organization generates traction and lamellipodia protrusion forces, transmitting migratory 
cues along the moving cell group; iii) a tightly regulated focal adhesions turnover ensures 
coordinated monolayer to move across a two-dimensional extracellular matrix substrate 
(Theveneau and Mayor 2013). 
Epithelial locomotion is a widely investigated kind of collective migration, sustained by 
different mechanism that involves cell-cell cohesion, cell-ECM adhesion, migratory 
protrusions and actomyosin contractily.  
A typical approach for in vitro studies of epithelial collective locomotion is the wound 
healing assay: when epithelial cells are presented with a cell free area created by a scratch 
in the monolayer, they move collectively toward the artificial gap to heal the wound, until 
the monolayer is established again. Cells within the sheet maintain cell-to-cell junctions 
and show typical mechanism occurring in vivo (Liang, Park et al. 2007). 
Intriguingly, as well as in wound healing, it has been shown that collectively migrating 
cells form specific patterns, similar to ordered motions seen in natural systems such as fish 
schools, bird flocks and fluids (Li and Sun 2014). This similarity led to a new approach in 
the quantification of wound healing and cell streaming processes, applying typical 
software and methods firstly designed to model natural systems. Cell Image Velocimetry 
(CIV) represents an example of this kind of approach (Milde, Franco et al. 2012). 
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5.4 RAB5A modulation of RAC1 driven migratory protrusions. 
 
The cell free space of a wounded monolayer is a potent motility signal that 
stimulates cells in the first rows to migrate to heal the wound. Cells at the leading front 
sense a directional cue and extend persistent, and dynamics lamellipodia that drive the full 
sheet forward. Lamellipodia are flat, plasma membrane protrusions, anchored to the 
underlying surfaces during forward protrusion of motile cells (Small, Stradal et al. 2002).  
A specific role of RAC1, a member of the Rho-GTPases family, has been well 
characterized in promoting lamellipodia formation. RAC1 activation, mediated by its 
GEFs, induces a dramatic increase in actin polymerization and the formation of a branched 
network of actin filaments that pushes the plasma membrane and sustains the formation of 
broad migratory protrusions (Nobes and Hall 1995; Nobes and Hall 1999). Lamellipodia 
are than stabilized by adhesion with the ECM, thus allowing the conversion of propelling 
actin-based forces into traction forces that sustain cell locomotion; conversely its depletion 
has been shown to impair lamellipodia formation and cell migration (Ridley, Paterson et al. 
1992; Ridley, Schwartz et al. 2003).  
Activated RAC1, the key coordinator of actin dynamic, mediates the formation of 
migratory protrusion in response to the internalization of activated growth factor receptor 
tyrosine kinases, thus representing a downstream target of RTKs. Re-localization of 
activated RAC1 to specific area of the plasma membrane, where actin remodeling induces 
the formation of migratory protrusions has been proposed to be mediated by polarized 
vesicular transport. Within this context, the endosomal-recycling pathway, dependent on 
the small GTPase RAB5A, has been shown to play an essential role in spatial restriction of 
RAC1 activation and hence directional cell locomotion. Concordantly, different studies 
support the fundamental role of RAB5A in promoting mesenchymal locomotion. It has 
been shown, for example, that the expression of RAB5A in poorly motile, amoeboid HeLa 
cells is necessary and sufficient to induce the formation of elongated, polarized cell 
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protrusions, promoting cell locomotion. In particular, the formation of migratory 
protrusion, such as lamellipodia and dorsal ruffles, is mediated by RAB5A regulation of 
endocytosis and spatially restriction of RAC1-mediated actin dynamics to specific region 
of the plasma membrane (Lanzetti, Palamidessi et al. 2004; Palamidessi, Frittoli et al. 
2008) (Fig. 13). 
 
                                    
 
Figure 13. Schematic of the RAB5-dependent control of RAC1 activation relocalization to the 
plasma membrane. 
Clathrin- and RAB5-mediated endocytosis control RAC activation induced by motogenic stimuli: RAC and 
its GEF Tiam1 are simultaneously recruited onto endosomal membranes and activated RAC is recycled to 
specific regions of the plasma membrane to promote actin remodeling and migratory protrusion formation. 
Adapted from (Palamidessi, Frittoli et al. 2008) 
 
 
 
 
5.5 RAB5A is involved in the dynamic turnover of focal adhesions.  
 
As already mentioned in sections before, the interaction of the cell with the 
extracellular matrix is essential to sustain migration. Cell-matrix adhesions represent sites 
where actin cytoskeleton converges with fibers of the ECM, creating a mechanical link 
between the cell and the substrate (Nobes and Hall 1995). Among the diverse kind of 
adhesion, focal adhesions (FAs) are highly dynamic structures usually linked to 
actomyosin stress fibers that undergo to a spatiotemporally regulated turnover, particularly 
during cell migration (Ridley, Schwartz et al. 2003). In motile cells, FAs form at the 
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leading edge and establish transient attachment of the cell to the substrate. Subsequently, 
these dynamic structures must be disassembled to allow the detachment of cell rear and 
cell to move. In agreement with this observation, the impairment of FAs disassembly 
inversely correlates with cell motility. 
Together with activation and spatial restriction of RAC1 in protrusion formation, RAB5 
has also emerged as an important regulator of FAs turnover, directly influencing several 
aspects of cell migration. The depletion of RN-tre, a GAP of RAB5, was indeed increasing 
FAs turnover and cell migration, by enhancing the endocytosis of β1 integrin, one of the 
components of FAs, already shown to be required in traction forces generation at the 
leading front and in maintaining migration speed (Hegerfeldt, Tusch et al. 2002; 
Palamidessi, Frittoli et al. 2013) (Maruthamuthu, Aratyn-Schaus et al. 2010). The 
localization of RN-tre both at the level of FAs and in RAB5-positive vesicles close to the 
ventral plasma membrane further confirmed the involvement of RAB5 in FAs assembly 
and disassembly circuitry. More in detail, turning off RAB5, RN-tre acts as a ‘‘brake’’ in 
cell motility and stabilizes FAs by the inhibition of RAB5-mediated β1 integrin 
endocytosis. This FAs stabilization strongly impairs cell motility (Palamidessi, Frittoli et 
al. 2013).  
Additional confirmation of the role of RAB5 in FAs dynamics comes from recent data 
showing the interaction of RAB5 with FAs components and its involvement in the control 
of Focal Adhesion Kinase (FAK) phosphorylation/dephosphorylation rate, thus controlling 
FAs disassembly (Mendoza, Ortiz et al. 2013). 
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5.6 Cell-to-cell adhesions mediate cell cohesion and coupling within the 
migrating epithelial sheet. 
 
A typical hallmark of collective migration is the maintenance of stable cell-to-cell 
adhesions, a class of cell-cell contact including adherens junctions (AJs), tight junctions 
(TJs) and desmosomes (Niessen 2007). The common structures observed in epithelial 
collective migration are AJs, which are mainly composed of cadherins, in particular E-
cadherin in epithelial cells (Friedl and Gilmour 2009). As opposed to individual cell, in 
collective epithelial cell locomotion cells at the leading front retain intact cell-to-cell 
adhesions with cells in the rows behind, thus mechanically holding the epithelial sheet 
together and promoting multicellular coordination. Moreover, strength and stability of cell-
cell junctions affect collective migration output and efficiency. Indeed, intermittent and 
transient cell-to-cell adhesions result in a coordinated but individual cell motility with 
short-lived contacts between cells within the monolayer, as it has been shown in cranial 
neural crest cells (Teddy and Kulesa 2004). Whereas, total depletion of cell-to-cell 
contacts lead to disaggregation of the migrating sheet and single cell independent 
migration both in speed and direction (Simpson, Selfors et al. 2008).  
Cadherin-based junctions interact with different cytoplasmic proteins that link them to 
actin cytoskeleton, thus transmitting forces generated by actomyosin contractility from one 
cell to the neighboring ones (Maruthamuthu, Aratyn-Schaus et al. 2010). Thus, in 
homophilic adherens junctions, the cytoplasmic tail of E-cadherin binds to p120 catenin 
and β−catenin.  β−catenin in turn binds α−catenin, which interact with actin and modulate 
actin filaments organization. Additionally, the transcriptional co-activator β−catenin 
transduced mechanical signals from the adherens junction to the nucleus, thus identifying 
AJs as mechanosensory structure that can detect not only changes in cell-to-cell contacts 
but also mechanical stress (Yonemura 2011) (Baum and Georgiou 2011). 
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6. Cell invasion 
 
6.1 MCF10.DCIS.com cells as a model of the transition from in situ to invasive 
breast carcinoma. 
 
 MCF-10.DCIS.com cell line represents a nearly ideal system to study cancer 
progression due to fact that once injected into recipient mice, these cells faithfully 
recapitulate all the prototypical features of human DCIS (Ductal carcinoma in situ) 
comedo-like lesion (a more aggressive type of DCIS with central necrosis), including their 
spontaneously propensity to progress toward an invasive breast cancer phenotype (Hu, Yao 
et al. 2008; Behbod, Kittrell et al. 2009). To generate this cell line, MCF-10A cells were 
stably transfected with the mutated human T-24 oncogene H-Ras and MCF-10.DCIS.com 
cell line was derived from xenograft lesions obtained after sequential trocar passages of a 
lesion generated from H-Ras-mutated MCF-10A cell line (Basolo, Elliott et al. 1991; 
Russo, Tait et al. 1991; Miller, Soule et al. 1993; Miller, Santner et al. 2000).  
 
Studies performed on a cohort of invasive ductal carcinoma (IDC), the invasive 
evolution of DCIS lesion, reported a specific hepatocyte growth factor (HGF)/c-Met (also 
called HGFR, hepatocyte growth factor receptor) pattern of expression: although HGF was 
homogenously expressed in cancer cells, c-Met staining was accentuated at the cancer 
front. Additionally, this specific co-expression pattern was associated to a paracrine 
pathway and correlated with histologic grade, lymph node involvement and decreased 
disease-free survival (Edakuni, Sasatomi et al. 2001). The paracrine role of HGF/c-Met 
signaling in the regulation of tumor cell migration and invasion has also been confirmed in 
MCF-10.DCIS.com cells. Indeed, the stimulation with HGF of MCF-10.DCIS.com acini 
grown into matrigel/collagen 3D matrices was sufficient to convert them into aberrantly, 
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multiprotrusive and invasive structures resembling the DCIS to IC transformation 
(Jedeszko, Victor et al. 2009) (Fig.14). Importantly, this model represents a useful strategy 
to investigate invasive progression in a controlled, and genetically tractable manner in in 
vitro culture. 
 
             
Figure 14. Recombinant HGF stimulates invasive outgrowths in MCF-10.DCIS.com cells. 
MCF10.DCIS cells were grown in three-dimensional reconstituted basement membrane in absence 
(CONTROL) or presence of 100 ng/ml HGF (rHGF). Arrows indicate invasive outhgrowths. 
Adapted from (Jedeszko, Victor et al. 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
CONTROL rHGF
M
CF
-1
0.
D
CI
S.
co
m
 61 
Aim of the project 
 
Based on the outlined background the aim of the present PhD project was two fold: 
 
1) To dissect the role of RAB5A in the morphogenetic process of mammary epithelial 
development. To this end, we combined inducible expression systems, in which oncogene 
expression can be switched on and off at will, with 3D culture on reconstituted basement 
membrane to mimic normal or oncogene-altered mammary gland development at different 
stages. RAB5A WT or its dominant negative form RAB5AS34N (an inactive GDP-locked 
form of RAB5A) were expressed in MCF-10A cells exploiting a doxycycline inducible 
system that allows the controlled and conditional expression of the gene of interest. This 
strategy provided us a flexible tool to modulate RAB5A mediated endocytosis and to 
investigate the effects of deregulation of this key endocytic protein on MCF-10A acinar 
morphogenesis, integrity and growth factor dependent proliferation. 
 
2) To delineate the mechanisms through which RAB5A altered function or expression 
impact not only on mammary gland morphology, but also on the mode of migration that 
may be harnessed during cancer progression. To this end, we focused specifically on the 
role of RAB5A in collective cell locomotion, a typical motility mode frequently seen in 
invasive solid tumors of epithelial origins, such as breast carcinoma. We initially utilized 
normal mammary epithelial cells as a model system in order to reveal fundamental 
processes that may be affected by deregulation of RAB5A, an event that is frequently 
observed in breast cancer and may therefore be relevant for breast cancer pathogenesis.  
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MATERIALS AND METHODS 
 
 
Plasmids, antibodies and reagents 
Doxycycline-inducible pSLIK-neomycin (neo) lentiviral vectors carrying RAB5A WT or 
RAB5AS34N sequences were obtained by Gataway Technology (Invitrogen), following 
the manufacturer’s protocol. The plasmid pBABE-puromycin (puro)-GFP was purchased 
from Addgene. 
Total ERK1-2 (p44/42 MAPK), phospho-ERK1/2 (Tyr202-Tyr204), phospho-EGFR 
(Tyr1068), total AKT, phospho-AKT (Ser473) and cleaved caspase 3 antibodies were 
purchased from Cell Signaling; mouse monoclonal antibodies raised against actin, 
α−tubulin and vinculin were from Sigma-Aldrich; RAB5A (S-19) and EEA-1 (N-19) 
antibodies from Santa Cruz Biotechnology; anti-paxillin was from Zymed; anti-Ki67 from 
Dako; anti-Laminin V from Millipore and anti-Giantin from Covenance; total EGFR 
antibody was raised against amino acids 1172-1186. Anti-E-cadherin was from BD 
transduction Laboratories. hAREG (1 µg/ml) neutralizing antibody was from R&D 
Systems and control IgG (1 µg/ml) from Jackson ImmunoResearch. AlexaFluor 488 
transferrin was purchased from Abcam. Secondary antibodies conjugated to horseradish 
peroxidase were from Bio-Rad; FITC- and Cy3-secondary antibodies from Jackson 
ImmunoResearch, AlexaFluor 488 was from Molecular Probes. TRITC- and FITC-
conjugated phalloidin were from Sigma Aldrich.  
Recombinant human Amphiregulin was purchased from R&D Systems. MEK1 inhibitor 
PD325901 was purchased from Millipore, Mitomycin C from Sigma Aldrich and EGFR 
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inhibitor Cetuximab was kindly provided by Dr. Maria Rescigno (IEO-Milan). Growth 
Factor Reduced BD MatrigelTM Matrix Basement Membrane was from BD Biosciences, 
purified bovine atelo-collagen (PureCol) was from Advanced Biomatrix. Recombinant 
Human HGF was from R&D Systems. 
 
Cell cultures and transfection 
MCF-10A cells were maintained in DMEM/F12 medium (Invitrogen) supplemented with 
5% horse serum, 0.5 mg/ml hydrocortisone, 100 ng/ml cholera toxin, 10 µg/ml insulin and 
20 ng/ml EGF (Soule, Maloney et al. 1990). MCF-10.DCIS.com cells were kindly 
provided by Dr. John F. Marshall (Barts Cancer Institute, Queen Mary University of 
London) and maintained in the same media of MCF-10A without cholera toxin. Cells were 
grown at 37 °C in humidified atmosphere with 5% CO2.  
MCF-10A and MCF-10.DCIS.com cells were infected with pSLIK-neo-EV (empty vector 
control), pSLIK-neo-RAB5A WT and pSLIK-neo-RAB5AS34N lentiviruses and selected 
with the appropriate antibiotic to obtain stable inducible cell lines. Constitutive expression 
of GFP was achieved by retroviral infection of MCF-10A EV cells with pBABE-puro-GFP 
vector.  
 
Generation of lentiviruses and retroviruses particles 
Packaging of lentiviruses or retroviruses was performed following standard protocols. Four 
batches of viral supernatant were collected and filtered through 0.45 µm filters. Cells were 
subjected to four cycles of infection and selected using the appropriate antibiotic: 
neomycin for pSLIK vector (150 µg/ml) or puromycin for pBABE vector (2 µg/ml). After 
several passages, stable bulk populations were selected and tested for i) the homogeneity 
of the cell pool by immunofluorescence staining, and ii) induction efficiency by Western 
Blotting and quantitative RT-PCR (qRT-PCR).  
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RNA interference 
MCF-10A EV cells were seeded the day before to be 60-80% confluent at the time of 
transfection. siRNAs (small interfering RNAs) delivery was achieved by mixing 1 nM of 
specific siRNAs with Optimem and Lipofectamine RNAiMAX Transfection Reagent (Life 
Technologies). The sets of oligos used for knocking down specific genes are listed in the 
table below. All siRNAs were purchased from Life Technologies. For each RNA 
interference experiment, negative control was performed with the same amount of 
scrambled siRNAs. Knocking down efficiency was controlled by qRT-PCR. 
 
 
 
 
 
 
 
 
 
Table 1. List of oligos and corresponding 5’ to 3’ sequences, utilized in the RNA interference 
experiments. 
 
Total RNA extraction and reverse transcription 
2D monolayers and 3D acini were lysed by Trizol Reagent (Invitrogen). Total RNA was 
extracted using RNeasy Mini kit (Qiagen) and quantified by NanoDrop to assess both 
concentration and quality of the samples. Reverse transcription was performed using 
SuperScript VILO cDNA Synthesis kit from Invitrogen. 
 
Gene target Sequence 5’ to 3’ 
RAB5A oligo 1 CAAGCCTAGTGCTTCGTTT 
RAB5A oligo 2 GCCAGAGGAAGAGGAGTAGACCTTA 
RAB5B oligo 1 CGACATTACTAATCAGGAA   
RAB5B oligo 2 GCAGATGACAACAGCTTATTGTTCA 
RAB5C oligo 1 GGACAGGAGCGGTATCACA   
RAB5C oligo 2 TCCGCTTTGTCAAGGGACAGTTTCA 
RAB21  GGGTCCAATTTACTACAGA 
RAB22A  TGAGCTACATAAATTCCTA 
RAB31 GGAATACGCTGAATCCATA 
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Affymetrix analysis 
MCF-10A cells were seeded in complete media and doxycycline-induced for 72 hours.  
Total RNA extraction and reverse transcription were performed as described in the section 
before. The experiment has been performed three times with two technical replicates. Gene 
lists were ranked according to the log2 ratio and a p value ≤ 0.05.  
 
Quantitative RT-PCR detection of mRNAs 
Gene expression was analysed using TaqMan Gene expression Assay (Applied 
Biosystems). More in details, 0.1 ng cDNA was amplified, in triplicate, in a reaction 
volume of 25 µl with 10 pMol of each gene-specific primer and the SYBR-green PCR 
MasterMix (Applied Biosystems). Real-time PCR was performed on the 14 ABI/Prism 
7700 Sequence Detector System (PerkinElmer/Applied Biosystems), using a pre-PCR step 
of 10 min at 95°C, followed by 40 cycles of 15 s at 95°C and 60 s at 60°C. Specificity of 
the amplified products was confirmed by melting curve analysis (Dissociation Curve TM; 
PerkinElmer/Applied Biosystems) and by 6% PAGE. Samples were amplified with 
primers for each gene (listed in the table below) The Ct values were normalized to the 
GAPDH curve. Results were quantified using the 2−ΔΔCT method. PCR experiments were 
performed in triplicate.  
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Table 2. List of primer assay IDs and corresponding target genes, utilized for qRT-PCR 
analysis. 
 
 
MTT proliferation assay 
Cell proliferation was assessed by MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay following the standard protocol. Briefly, cells were 
seeded at 2*103 cells/well in 96-well plates and maintained in complete medium.  Cell 
proliferation was assessed at different timepoints, with a 24 hours interval. 500 µg/ml 
MTT (Sigma-Adrich) was added to each well. After 2 hours of incubation at 37°C, the 
MTT solution was carefully removed and 100 µl of DMSO was added to each well. Plates 
were incubated 15 minutes at room temperature in agitation. Absorbance was measured at 
570 nm using a VICTOR3 V Multilabel Counter (PerkinElmer model 1420). Each 
condition was performed with quadruple technical replicates.  
 
Gene name Primer assay ID 
GAPDH Hs99999905_m1 
RAB5A Hs00702360_s1 
RAB5B Hs00161184_m1 
RAB5C Hs00428044_m1 
AREG Hs00950669_m1 
RAB21 Hs00209226_m1 
RAB22A Hs00221082_m1 
RAB31 Hs00199313_m1 
CTGF Hs00170014_m1 
Progesteron Receptor (PGR) Hs00172183_m1 
Estrogen Receptor (ESR1) Hs00174860_m1 
HIF2a (EPAS1) Hs01026149_m1 
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Quantification of cell proliferation rates 
For conditioned media experiments, doxycycline-induced MCF-10A EV and RAB5AS34N 
cells were plated in fresh media without EGF.  Conditioned media from similar number of 
cells were collected after 4 days and filtered through 0.45 µm filters to eliminate any 
debrides or floating cell. Cleared conditioned media were applied onto parental MCF-10A 
cells seeded in 96-well plate (2*103 cells/well) and cell proliferation was monitored taking 
images every 2-3 days by differential interference contrast (DIC) imaging, using a 10x 
objective. The number of cells/field was manually counted at each time-point by Cell 
Counter ImageJ software plugin.  
In neutralizing antibody experiment, rAREG (20 ng/ml), normal goat IgG (1 µg/ml, 
negative control) and anti-hAREG antibody (1 µg/ml) were added to the media at the 
moment of seeding of induced-cells. 
The same procedure was applied for Cetuximab treatment (10 µg/ml or 20 µg/ml) in 
EGFR inhibition experiment. 
 
Analysis of apoptosis rate by FITC-Annexin V/PI staining 
FITC-Annexin V/propidium iodide (PI) staining was performed using flow cytometry. 
Doxycycline-induced MCF-10A cells were seeded in complete media 72 hours in sub-
confluency conditions. 5*105 cells were collected together with the supernatant and 
precipitated by centrifugation at 2,000 rpm 7 minutes. Cells pellets were washed one time 
in annexin buffer (1 M HEPES, 5 M NaCl, 1 M MgCl2, 1 M CaCl2, 50 mM KCl and H2O). 
Samples were resuspended in 50 µl of 1.5 µg/ml annexin V-fluorescein isothiocynate 
diluted in annexin buffer and incubated 1 hour at room temperature, protected from light. 
Cells were washed again in annexin buffer and resuspended in 500 µl of 10 µg/ml 
propidium iodide diluted in PBS. Flow cytometric analysis was immediately performed 
using a FACS CantoII Instrument (Becton Dickinson). 30,000 events were acquired for 
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each cell line. Data analysis was performed by FACS Diva 6.1.1 software. An example of 
a scatter plot obtained after FITC-Annexin V/PI staining and relative identified 
subpopulations of cells are shown in figure 15.     
 
                     
Figure 15. Scatter plot obtained through Annexin V-FITC/PI staining. 
One of the earliest features of apoptosis is the loss of plasma membrane asymmetry. In apoptotic cells, the 
membrane phospholipid phosphatidylserine (PS) is translocated from the inner to the outer leaflet of the 
plasma membrane, becoming available for binding of Annexin V-FITC, a Ca2+-dependent phospholipid-
binding protein showing high affinity for PS. Viable cells with intact membranes exclude PI, whereas the 
membranes of dead and damaged cells are permeable to PI. Cells that are viable are both Annexin V-FITC 
and PI negative. While cells that are in early apoptosis are Annexin V-FITC positive and PI negative and 
cells that are in late apoptosis or necrotic are both Annexin V-FITC and PI positive. 
 
Cell cycle profiling 
Cell cycle profiling was performed exploiting two different strategies to synchronize cells. 
Doxycycline-induced MCF-10A cells were plated 48 hours in complete medium without 
EGF, to arrest cell growth and synchronize them in G0 phase. Cell cycle was released by 
replacing the starvation medium with fresh complete medium supplemented with EGF. All 
experimental steps were performed in doxycycline-induced conditions.  
Alternatively, cell cycle progression was investigated by Double Thymidine Block assay. 
Briefly, MCF-10A cells were seeded at 30% confluency in complete medium in the 
presence of EGF and doxycycline. Then, cells were treated with 2 mM thymidine blocking 
solution and after 15 hours, thymidine was removed by washing with 1X PBS. Cells were 
released adding fresh complete medium (+EGF and doxycycline) for 9 hours. A second 2 
Viable cells
Late apoptotic/Necrotic cells
Early apoptotic cells
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mM thymidine pulse was performed and to better synchronize the cell cycle, EGF was not 
added in this latter thymidine pulse. After 15 hours, cells were washed with 1X PBS and 
fresh complete medium, supplemented with EGF and doxycycline, was added to cells to 
induce cell cycle re-initiation.  
For both the described strategies, samples were collected at different timepoints to monitor 
cell cycle progression. 1*106 cells were collected together with the supernatant, washed 
two times with 1X PBS and centrifuged at 3,000 rpm 5 minutes. Pellets were re-suspended 
in 250 µl of 1X PBS and fixed by adding drop-wise 750 µl of pure ethanol while 
vortexing. After 1 hour incubation on ice, samples were washed in 1 ml of PBS+1% BSA 
(bovine serum albumin) and re-suspended in 1 ml of assay buffer containing 50 µg/ml PI 
and 250 µg/ml of RNase A. PI staining was carried out overnight at 4°C. Flow cytometric 
analysis was performed using a FACS CantoII Instrument (Becton Dickinson). 20,000 
events were acquired for each condition and data were analysed by ModFit LT3.0 
software. A typical cell cycle profiling is shown in figure 16. 
 
         
Figure 16. Flow cytometric analysis of cellular DNA content. 
The propidium iodide fluorescence detected by FACS is proportional to the amount of DNA present in cells 
and it allows the identification of the proportion of cells that are in the different cell cycle phases. 
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Immunoblotting 
For protein extraction, cells were lysed in JS buffer containing proteases inhibitors and cell 
lysates were cleared by centrifugation at 13,000 rpm for 30 min at 4°C. Protein 
concentration was quantified by Bradford colorimetric protein assay. The same amount of 
protein lysates was loaded onto polyacrylamide gel in 5X SDS sample buffer. Proteins 
were transferred onto Protran Nitrocellulose Transfer membrane (Whatman), probed with 
the appropriate antibodies and visualized with ECL Plus western blotting detection 
reagents (GE Healthcare). Membrane blocking and incubation in primary or secondary 
antibodies were performed for 1h in TBS/0.1% Tween/5% BSA for antibodies recognizing 
phosphorylated proteins or in TBS/0.1% Tween/5% milk for antibodies recognizing the 
total proteins. Primary antibodies were diluted 1:1,000 and secondary antibodies 1:10,000 
as suggested by the manufacturer. Where specified, cells were EGF-starved for 9 hours and 
treated with 100 ng/ml EGF for different time-points. 
 
Microscopes equipment 
Wide-field fluorescence images were taken by an AX70 (Olympus) microscope equipped 
with a 12 bit b/w camera (FviewII, Olympus). Confocal images were taken with a Leica 
TSC SP2 AOBS confocal microscope controlled by Leica Confocal Software and equipped 
with violet (405 nm laser diode), blue (argon, 488 nm), yellow (561 nm Solid State Laser), 
and red (633 nm HeNe Laser) excitation laser lines. A 63x oil-immersion objective lens 
(HCX Plan-Apochromat 63x NA 1.4 Lbd Bl; Leica) was used for image acquisition. Time-
lapses were performed by motorized Olympus IX81 Inverted microscope, driven by an 
"Olympus Scan^R" software and equipped with a "Hamamatsu Orca-AG" CCD camera 12 
bit (pixel size = 6.45 µm), and 10x or 20x (and an additional 1.6x magnification lens where 
indicated) objectives. Wound healing, cell protrusions and cell streaming assays were 
performed using an environmental microscope incubator set to 37°C and 5% CO2 
perfusion.  
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Immunofluorescence  
Cells (1*105) were seeded in a 6-well plate containing glass coverslips and treated as 
indicated in the text and in figure legends. Coverslips were fixed in 4% paraformaldehyde 
(PFA) and permeabilized with 0.1% Triton X-100 and 1% BSA 10 minutes. After 1X PBS 
washes, primary antibodies were added for 1 hour at room temperature. Coverslips were 
washed in 1X PBS before secondary antibody incubation 1 hour at room temperature, 
protected from light. FITC- or TRITC-phalloidin was added in the secondary antibody 
step, where applicable. After removal of not specifically bound antibodies by 1X PBS 
washing, nuclei were stained with 0.5 ng/ml DAPI. Coverslips were post-fixed and 
mounted on glass slides in anti-fade mounting medium (Mowiol). Antibodies were diluted 
in 1X PBS and 1% BSA. Images were acquired by wide-field fluorescence microscope or 
confocal microscope, as indicated in figure legends.  
E-cadherin staining was analyzed by confocal microscopy and images were processed to 
obtain the straightness index of the junction. “Junction length” was measured by tracking a 
straight line and “junction tracking” was obtained tracking manually the same junction 
following its profile. The straightness index of the junction has been quantified as the ratio 
of the junction length and the junction tracking of the junction. Value close to one 
indicates straight junction (Fig. 17). 
       
Figure 17. Quantification of the straightness index of the junction. 
For more details refer to the text. 
 
 
Straightness index of the junction = 
Junction length 
Junction tracking 
Straightness index of the junction = 1 ---> Straight junction
  
Straightness index of the junction = 0 ---> Non straight junction  
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Transferrin internalization assay 
Cells were grown on glass coverslips 48 hours in the presence or absence of doxycycline. 
Cells were starved in DMEM supplemented with 2 mM L-glutammine, 20 mM HEPES 
and 0.2% BSA for 4 hours before experiments. Media was replaced by fresh L15 media 
(Gibco) containing 5 µg/ml AlexaFluor 488 transferrin (Abcam) and incubated 30 minutes 
at 4°C. To induce transferrin internalization, samples were transferred to 37°C for 15 
minutes. The residual surface-bound transferrin was removed by cold mild acid washing 
(150 mM NaCl, 1 mM CaCl2, 20 mM CH3COONa). Cells were washed with cold 1X PBS 
before fixation with 4% paraformaldehyde. Indirect immunofluorescence staining was 
performed on permeabilized cells by incubation with RAB5A antibody and Cy3-
conjugated secondary antibody. Images were acquired by wide-field fluorescence 
microscope. 
 
Overlay three-dimensional culture of MCF-10A cells on reconstituted 
basement membrane 
Three-dimensional cultures were performed as described previously, adding some 
modification to the original protocol. Of note, the already described overlay method has 
been exploited for some beneficial features: i) compared with the total embedding 
procedure, overlayed acini are larger, making easier the identification of the hollow lumen 
and anoikis occurring in lumen formation stage; ii) proteins are easier to be extracted for 
immunoblotting analysis; iii) acini staining in situ allows confocal analysis of the 
localization of typical subcellular markers. Schematic of the experimental procedure is 
shown below, in figure 18. 
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Figure 18. Schematic of the overlay method for culturing MCF-10A in 3D. 
For more details, refer to the text.  
Adapted from (Debnath, Muthuswamy et al. 2003). 
 
Nunc Lab-Tek II 8-wells Chamber Slide (Thermo Scientific) was coated with 40 µl of 12 
mg/ml Growth Factor Reduced BD MatrigelTM Matrix Basement Membrane (BD 
Biosciences) and allowed to solidify 30 minutes at 37°C. To avoid cell clumps and make 
sure each acinar spheroid was deriving from one single cell, doxycycline-induced cells 
were carefully re-suspended and seeded as a single cell suspension at 2.5*103 cells/well in 
growing media containing 2% matrigel and 5 ng/ml EGF (were specified). Each condition 
was performed with technical duplicate. Cells were grown at 37°C with 5% CO2 and 
growing media was replaced every 4 days. Acini morphogenesis was monitored from 
seeding (day 0) to longer timepoints (day 28), taking images every 3 days by differential 
interference contrast (DIC) imaging using a 10x objective.  
In growth arrested acini experiments, MEK1 inhibitor PD325901 was added together with 
doxycycline.  
In the mixed culture experiment, not-labeled MCF-10A RAB5AS34N cells were co-
cultured with GFP-labeled control MCF-10A EV at a ratio of 1:1. Growing media 
MCF-10A cells as single 
       cell suspension
Overlay of growing media 
        with 2% Matrigel
Chamber slide
Replace growing media with 2% 
         Matrigel every 4 days
Bed made of 100% 
  gelled Matrigel
DAY 0
DAY 10+
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containing 2% Matrigel was supplemented with EGF and doxycycline where indicated. 
Both DIC and fluorescence images were acquired.  
 
Analysis of morphogenetic parameters within 3D cultures 
Acini staining was performed optimizing the protocol previously described (Debnath, 
Muthuswamy et al. 2003). Acini were fixed in 2% paraformaldehyde 5 minutes in 
agitation. To remove PFA, samples were washed three times with 1% glycine diluted in 
1X PBS, 5 minute/wash with gentle agitation. After permeabilization in 1X PBS 
containing 0.5 % Triton X-100 for 10 minutes at 4°C, acini were washed again three times 
with 1% glycine diluted in 1X PBS, 5 minute/wash with gentle shaking. Primary 
antibodies were diluted in IF Buffer (130 mM NaCl, 7 mM Na2HPO4, 3.5 mM NaH2PO4, 
7.7 mM NaN3, 0.1% bovine serum albumin, 0.2% Triton X-100, 0.05% Tween-20) and 
incubated overnight at 4°C, with gentle agitation. Samples were rinsed three times (5 
minutes each) with 1X PBS and incubated 1 hour with AlexaFluor-secondary antibodies 
diluted in IF Buffer at room temperature. Un-bound antibodies were removed by three 
washes in 1X PBS, 5 minute/wash with gentle shaking. Lastly, nuclei were stainined with 
0.5 ng/ml DAPI. Acini were washed in 1X PBS and post-fixed in 2% PFA before 
mounting with fresh antifade mounting medium. Different combinations of antibodies 
were used: acini were stained with Ki-67 and cleaved caspase 3 antibodies to assess 
proliferation and apoptosis rates; DAPI, Laminin V and Giantin antibodies were used to 
study acinar architecture and development. Images were acquired with a Leica TSC SP2 
AOBS confocal microscope and a 63x oil-immersion objective lens. ImageJ software was 
used for image analysis. 
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Secreted Amphiregulin detection 
Doxycycline-induced MCF-10A cells were grown in 2D 4 days in the absence of EGF. 
Conditioned media, deriving from a similar number or cells, were collected and filtered to 
eliminate any debrides. Cleared media were applied onto RayBio Human Amphiregulin 
ELISA kit (RayBiotech) and assayed following the manufacturer’s protocol. Briefly, 
Amphiregulin standard was serially diluted in Assay Diluent B, in a range from zero to 
4,000 pg/ml. Samples were tested either pure or diluted 5 times in Assay Diluent B. 100 µl 
of standard or samples were added to each well and incubated 2.5 hours at room 
temperature with gentle shaking. The plate was washed 4 times with wash solution using a 
muti-channel pipette and carefully removing the liquid at each step. After the last wash, 
100 µl of biotin antibody was added to each well and incubated 1 hour. The plate was 
washed as described before and incubated 45 minutes with 100 µl of Streptavidin Solution. 
The solution was discarded and after washing steps, 100 µl of TMB One-Step Substrate 
Reagent was added to each well and incubated 30 minutes in the dark. The colorimetric 
reaction was stopped adding 50 µl of Stop Solution/well and the plate was read 
immediately at 450 nm by VICTOR3 V Multilabel Counter (PerkinElmer model 1420). All 
incubation steps were performed at room temperature with gentle shaking. Amphiregulin 
concentration was calculated plotting the standard curve on a log-log plot with standard 
concentration on the x-axis and absorbance on the y-axis and drawing the best-fit straight 
line (as indicated in the manufacturer’s protocol). Samples concentrations were calculated 
considering dilution factors. 
 
Wound healing assay 
Cells were seeded in 6-well plate (1.5*106 cells/well) in complete medium and cultured 
until a uniform monolayer had formed. RAB5A expression was induced, were indicated, 
16 hours before performing the experiment by adding fresh complete media supplemented 
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with 2.5 µg/ml doxycycline to cells. Cells monolayer was scratched with a pipette tip and 
carefully washed with 1X PBS to remove floating cells and create a cell-free wound area. 
The closure of the wound was monitored by time-lapse recording picture of 10 
positions/condition. Olympus ScanR inverted microscope with 10x objective was used to 
take pictures every 5 minutes over a 24 hours period. The assay was performed using an 
environmental microscope incubator set to 37°C and 5% CO2 perfusion. After cell 
induction, doxycycline was maintained in the media for the total duration of the time-lapse 
experiment. The percentage of area covered by cells (area coverage %) overtime and 
wound front speed were calculated by MatLab software. In Mitomycin C experiment, 1 
µg/ml inhibitor was added together with doxycycline in fresh media 16 hours before 
scratching the monolayer. 
For wound healing assay performed on interfered cells, 2.5*105 cells/well were plated in a 
6 well plate and interfered the day after with 1 nM of siRNAs, following the same 
conditions already described in “RNA interference” section. Confluent and stable 
monolayers were scratched and cell migration was recorded by time-lapse microscopy. 
 
Kymograph analysis of cell protrusions  
Wound healing assay was performed by Ibidi Culture Inserts (Ibidi) to avoid debrides 
affecting the quality of the kymograph analysis. Inserts were placed in a 12-well plates and 
MCF-10A cells were plated in each chamber, 5*104 cells/chamber. 16 hours before 
starting the experiment, growing media was replaced with fresh complete media containing 
2.5 µg/ml of doxycycline to induce RAB5A expression. Cell-free, wound area was created 
by removal of the insert. Cell migration was monitored by Olympus Scan^R inverted 
microscope with 20x objective (with an addictional 1.6x magnification lens). Pictures were 
taken with shorter time frame to better evaluate protrusion dynamics. Images from 10 
positions/condition were recorded every 30 seconds over 1 hour period. To measure the 
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dynamic of protrusive structures Kymograph plugin of ImageJ software was used. More in 
detail, a linear ROI (region of interest) was drawn on the protrusion of the migrating cell 
(Fig.19A). The software recorded changes of certain intensity and contrast in grey value of 
the moving structure. A new image (the kymograph) was assembled: the y axis 
representing a time axis (t) and the unit was the time interval set up in the time-lapse 
experiment (seconds); and the x axis representing the distance (s) and the unit was the 
pixel size of the camera. 
                 
Figure 19. ROI tracking on the migratory protrusion and schematic of a typical kymograph 
analysis. 
(A) Example of ROI tracking on the protrusion of cells at the leading front of the migrating sheet. (B) 
Example of kymograph and relative formulas to calculate protrusion dynamic parameters. 
 
Dynamic parameters were measured on kymograph images: persistence (Δt), protrusion 
rate (Δs1/Δt1) and retraction rate (Δs2/Δt2) (Fig.19B). The same time interval and ROI 
length were set in the analysis of each condition.  
 
Quantification of focal adhesions 
Focal adhesions were analyzed in wound healing conditions, focusing on cells at the 
leading front. MCF-10A cells were seeded 7*105 cells in ibiTreat µ-Dish 35 mm, high (Ibidi) 
and maintained in complete growing medium supplemented with EGF till reaching the 
complete confluency. The monolayer was induced by doxycycline and 16 hours later, the 
wound was made by scratching it through a pipette tip. Floating cells were removed by 
sequential washing and fresh media with EGF and doxycycline was replaced. Migrating 
epithelial sheets were fixed in 4% paraformaldehyde, before the complete closure of the 
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wound.  Samples were permeabilized with 0.1% Triton X-100 and 2% BSA 10 minutes 
and blocked 1 hour in 1X PBS containing 2% BSA. Anti-Paxillin or anti-Vinculin primary 
antibodies were incubated overnight at 4°C, with gentle shaking. Culture dishes were 
washed in 1X PBS and secondary AlexaFluor-antibodies were incubated 1 hour at room 
temperature, protected from light. FITC- or TRITC-phalloidin was added in the secondary 
antibody step, where applicable. Cells were washed and nuclei were stained with 0.5 ng/ml 
DAPI. Last, samples were post-fixed and stored in 1X PBS at 4°C. Images were taken with 
a Leica TSC SP2 AOBS confocal microscope and analyzed by ImageJ software: pictures 
were transformed in binary images using the automatic threshold function and analyzed 
with Analyze Particle plugin of ImageJ software. Focal adhesions quantification is shown 
as relative focal adhesion size referred to control cells. 
 
Cell Image Velocimetry 
Quantitative analysis of movies obtained from wound healing assay was performed using 
the Cell Image Velocimetry (CIV) MatLab toolbox. This approach is based on the 
combination of cell layer segmentation together with image velocimetry algorithm. Among 
the important features related to this strategy, CIV analysis allows to automatically 
quantify the advancing front as well as the velocity and directionality of cells inside the 
migrating monolayer. 
First, images are processed enhancing intensity and contrast to clearly discern between cell 
layers and the background. Based on this, a cell layer segmentation algorithm detects the 
progression of migrating fronts in consecutive frames and designs a mask for each layer at 
each frame. Second, a Particle Image Velocimetry (PIV) based algorithm detects the 
movement of cells within the layers. Last, a quantification step combines mask and PIV 
data to calculate wound orientation, front speed and mean angular correlation, assigning a 
specific color code depending on the direction of migration. Coordinated cell migration is 
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quantified considering mean angular correlation values (with correlation bin size of 100 
µm or 80 µm, corresponding to about 4-6 or 2-4 cell rows respectively, depending on the 
dimension of the wound and cells rows/migrating front in the field available for the 
analysis) (Milde, Franco et al. 2012). 
 
Cell streaming assay 
MCF-10A cells were seeded in 6-well plate (1.5*106 cells/well) and maintained in 
complete medium until a uniform and stable monolayer had formed. RAB5A expression 
was induced 16 hours before performing the experiment. Comparable cell confluence were 
tested by taking pictures by differential interference contrast (DIC) imaging using a 10x 
objective and counting the number of nuclei/field. Cell streaming was monitored by time-
lapse Olympus Scan^R inverted microscope with 10x objective, taking images every 5 
minutes over a 12 hours period. Single cells within the monolayer were manually tracked 
for 12 hours by “Manual Tracking” plugin of ImageJ software. Migration parameters were 
obtained by Chemotaxis and Migration Tool ImageJ software plugin. 
 
Single cell random motility assay 
Single cells migration was monitored in normal growing conditions. Briefly, cells were 
seeded sparsely in a 6-well plate (2*104 cells/well) in complete media supplemented with 
20 ng/ml EGF. Doxycycline (2.5 µg/ml) was added to the media 16 hours before starting 
the experiment. Random cell motility was monitored over a 24 hours period. Pictures were 
taken every 5 minutes from 10 positions/condition, using a motorized Olympus Scan^R 
inverted microscope with 10x objective. All the experiments were performed using an 
environmental microscope incubator set to 37°C and 5% CO2 perfusion. Single cells were 
manually tracked using Manual Tracking Tool ImageJ software plugin. Migration plot and 
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relative parameters were obtained by Chemotaxis and Migration Tool ImageJ software 
plugin. 
In random migration assay performed on RNA interfered cells, MCF-10A cells were 
seeded the day before (2.5*105) and interfered with 1 nM of oligos with the same 
procedure already described in “RNA interference” section. One day after transfection 
cells were detached and plated to perform the random migration assay. Cells were 
doxycycline-induced 16 hours before starting the experiment. 
 
MCF-10.DCIS.com cells 3D invasion assay 
Invasion phenotype of MCF-10.DCIS.com cells grown in 3D was performed as previously 
described (Xiang and Muthuswamy 2006).  All the coating steps to prepare the chumber 
slide were performed on ice to avoid a fast and not regular polymerization of the basement 
membrane substrate. First, 500 µl of atelo-collagen type I (Purecoll, 3.2 mg/ml) was mixed 
with 62.5 µl of sterile 1X PBS 10x, 62.5 µl of sterile 0.1 M NaOH and 10 µl of 0.1 N HCl 
to bring the final pH close to 7.5. On ice, we mixed collagen and Matrigel in equal amount 
such that the final concentration of collagen was 1.6 mg/ml. Nunc Lab-Tek II 8-wells 
Chamber Slide were coated with 40 µl of mix collagen/Matrigel and allowed to solidify for 
1 hour at 37°C. Meanwhile, cells were collected, counted and seeded as single cell 
suspension at 2.5*103 cells/well in growing media containing 2% Matrigel and 5 ng/ml 
EGF. RAB5A expression was induced 4 days after seeding and invasive outgrowth was 
stimulated by 100 ng/ml HGF treatment. Images were taken every 3 days by differential 
interference contrast (DIC) imaging. Invasive outgrowths were defined as consisting of 
two or more cells migrating away from their structure of origin. A minimum of 20 images 
was analyzed for each experimental condition. 
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Statistical analysis 
Student's unpaired t test was used for determining the statistical significance. Significance 
was defined as ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001 and ∗∗∗∗p < 0.0001. Statistic calculations 
were performed with GraphPad Prism Software. Data are expressed as mean±SEM. 
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RESULTS 
 
Generation and characterization of stable inducible MCF-10A cell lines 
expressing RAB5A WT or RAB5AS34N. 
 
To investigate the impact of deregulation of RAB5A expression or function in 
normal epithelial mammary cells, we chose a human non-transformed mammary epithelial 
cell line, MCF-10A. MCF-10A cells were infected with a doxycycline inducible lentiviral 
pSLIK vector carrying RAB5A WT or RAB5AS34N, a useful strategy to time-control the 
expression of our gene of interest.  
After neomycin selection, stable inducible bulk populations were analyzed for the level of 
expression of RAB5A both by Western Blotting (Fig. 20A) and Immunofluorescence (Fig. 
20B). Once confirmed the efficiency of the inducible system and the homogeneity of the 
bulk population, we proceeded with the functional characterization of the cell lines.  
To determine whether genetic manipulation of RAB5A directly impact on its function in 
endosomal biogenesis and receptor internalization, we stained cells to detect endosomal 
compartment and performed internalization assays. Doxycycline-induced cells were seeded 
on coverslip and immunostained for EEA-1 (the early endosomal antigen 1), whose 
association with endosomal membranes has been demonstrated to be dependent on the 
activation state of RAB5A (Simonsen, Lippe et al. 1998; Christoforidis, McBride et al. 
1999). As expected, the expression of RAB5A WT induced the formation of enlarged, 
EEA1-positive endosomes. Conversely, in MCF-10A cells expressing RAB5AS34N, a 
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dominant negative RAB5A mutant (Stenmark, Parton et al. 1994), EEA-1 staining was lost 
from the endosome and homogeneously distributed into the cytoplasm, demonstrating that 
RAB5A activation is essential for EEA-1 association with endosomal membranes (Fig. 
20B).  
A well-accepted assay to monitor the efficiency of endocytosis is transferrin 
internalization. This ligand by binding to its cognate receptor is constitutively internalized 
through clathrin-dependent endocytosis. Transferrin internalization was assessed on un-
induced control and doxycycline-induced MCF-10A RAB5AS34N cells. In this assay, 
cells were incubated with AlexaFluor488-conjugated transferrin, and then washed with a 
mild acid solution to remove all the transferrin that had not been internalized. Compared 
with control cells, RAB5AS34N-expressing cells showed a reduced number of vesicles 
containing the fluorescently labeled transferrin (Fig. 20C, D).  
As expected, genetic manipulation of RAB5A by the expression of its dominant negative 
form RAB5AS34N, alters its function both in endosomal biogenesis (Fig. 20B) and 
receptor internalization (Fig. 20C,D).  
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Figure 20. The expression of RAB5A WT or RAB5AS34N alters the endosomal 
compartment.  
(A) 30 µg of lysates of the indicated cell lines were loaded on a 15% polyacrylamide gel. Nitrocellulose 
membrane was blot by mouse monoclonal anti-human vinculin antibody or rabbit polyclonal anti-human 
RAB5A antibody. Vinculin was used as loading control. (B) Cells were seeded on coverslips and induced 72 
hours by 2.5 µg/ml doxycycline, fixed in 4% paraformaldehyde and stained with anti-human RAB5A or anti-
human EEA-1 antibody, to be analyzed by wide field microscopy. Representative images are shown (Scale 
bar, 20 µm). (C) Cells in un-induced or doxycycline-induced conditions were treated 15 minutes with 
fluorescent transferrin. Not-internalized transferrin was removed by mild acid wash. Coverslips were fixed 
and stained to detect RAB5AS34N expression and internalized fluorescent transferrin. Representative 
fluorescence images and relative insets are shown (Scale bar, 40 µm). (D) Quantification of the percentage of 
cells showing internalized transferrin is shown, counting 100 cells/condition. Error bars represent the 
standard deviation. 
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RAB5A expression alters MCF-10A cells proliferation rate and EGF-
dependency, without affecting apoptosis. 
 
To test whether the ectopic expression of RAB5A WT or S34N would affect the 
proliferation rate and EGF-dependency of MCF-10A cells, equal number of cells was 
plated in a 96-wells plate. Growth rates of un-induced and induced cells were monitored 
every 24 hours by MTT cell proliferation assay, a widely accepted protocol to assess cell 
viability and proliferation relying on the capability of the cell to metabolize and transform 
tetrazolium salts in purple formazane, detected by spectrophotometer (Mosmann 1983).  
In control, un-induced conditions, all cell lines display the expected EGF-dependent 
growth profile and a similar proliferation rate (Fig. 21A). Interestingly, the expression of 
RAB5A WT by doxycycline treatement impaired cell growth even in EGF supplemented 
media (Fig. 21B, green line); on the contrary, MCF-10A RAB5AS34N cells acquired an 
EGF-independent growth phenotype (Fig. 21C, pink line). 
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Figure 21. Cell proliferation is altered by the expression of RAB5A WT or RAB5AS34N.  
(A) Cell growth depends on EGF in un-induced conditions (cell lines grown in media without EGF are 
represented with dotted lines). (B) MCF-10A cells expressing RAB5A WT do not grow even in the presence 
of EGF (green line). (C) The expression of RAB5AS34N allows EGF-independent growth of MCF-10A cells 
(pink line). The experiment was repeated 3 times with quadruplicate technical replicates. Error bars represent 
standard deviation for each time-point. 
 
 
To better understand if the alteration in growth rate was also related to a deregulation of 
cell death, an AnnexinV-FITC/PI staining was performed. Through this approach, we 
could discriminate between viable (AnnexinV-FITC-/PI-), early apoptotic (AnnexinV-
FITC+/PI-) or late apoptotic/necrotic cells (AnnexinV-FITC+/PI+). Compared with control 
MCF-10A EV cell line, FACS analysis showed no significant differences in the number of 
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apoptotic cells, considered as the sum of early and late apoptotic cells, ruling out that 
alteration in RAB5A levels and function causes programmed cell death (Fig. 22). 
 
 
Figure 22. Cell death is not affected by RAB5A WT or RAB5AS34N expression. 
Doxycycline-induced MCF-10A cells were collected in growing conditions and stained with 
AnnexinV-FITC and PI. FACS analysis plots revealed no significant differences between 
subpopulations of cells: viable (AnnexinV-FITC-/PI-), early apoptotic (AnnexinV-FITC+/PI-) and 
late apoptotic/necrotic (AnnexinV-FITC+/PI+) cells.  30,000 events were acquired for each cell line. 
Data analysis was performed by FACS Diva 6.1.1 software. The experiment was repeated 3 times. 
 
 
 
 
RAB5A WT expression induces a delay in S-phase entry. 
 
The expression of RAB5A WT causes impairment of MCF-10A cells proliferation; 
we thus explored this defect in further detail by analyzing by FACS the DNA content as a 
measure of the cell cycle profile. Doxycycline-treated MCF-10A EV and MCF-10A 
RAB5A WT cells were first grown for 48 hours in complete media without EGF to induce 
growth arrest in G0 by EGF-starvation. Afterwards, cell cycle re-entry was induced by an 
acute stimulation with EGF. Every 3 hours we evaluated cell cycle progression by FACS 
analysis of PI stained cells. Control MCF-10A EV cells entered into the cell cycle 12 hours 
after the release (Fig. 23, top panels). RAB5A WT expressing cells, instead, entered the S-
phase with a nearly 3 hours delay (Fig. 23, bottom panels).  
 
MCF-10A EV MCF-10A RAB5A WT MCF-10A RAB5AS34N
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Figure 23. MCF-10A cells expressing RAB5A WT show a delay in entering in S-phase. 
Doxycycline-induced MCF-10A cells were synchronized in G0 by 48 hours of EGF-starvation, and acutely 
stimulated with 20 ng/ml EGF to induce cell cycle re-initiation. Cells were fixed and stained with PI at 
different time-points to be analyzed by FACS. Graphs show cell cycle progression and relative percentages 
of cells throughout the different phases of the cell cycle. Top: MCF-10A EV cells clearly enter into the S-
phase after 12 hours. Bottom: the expression of RAB5A WT delays the S-phase entry, cells start to cycle 15 
hours after the release. 20,000 events were acquired for each time-point. Data analysis was performed by 
ModFit software. The experiment was repeated 3 times. 
 
 
The delayed onset of S-phase was also confirmed by double thymidine block experiments. 
Doxycycline-induced cells were treated with a double thymidine pulse for synchronizing 
them at the G1/S border. Cell were then released by addition of fresh complete media and 
collected at different time-points to monitor DNA content and cell cycle progression by PI-
staining and FACS analysis. As it is shown, cell cycle progression through S-phase and 
G2/M was delayed in RAB5A WT expressing cells, compared with control (Fig.24). 
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Figure 24. MCF-10A cells expressing RAB5A WT show a delay in cell cycle progression. 
Doxycycline-induced MCF-10A cells were synchronized at G1/S border by double thymidine treatment. 
Fresh media supplemented with 20 ng/ml EGF was added to induce cell cycle re-initiation. Cells were fixed 
and stained with PI at different time-points to be analyzed by FACS. Cell cycle progression and relative 
percentages of cells in the different cell cycle phases are shown. Top: MCF-10A EV cells cycles after 5 
hours. Bottom: the expression of RAB5A WT delays cell cycle progression. 20,000 events were acquired for 
each time-point. Data analysis was performed by ModFit software. The experiment was repeated 3 times. 
 
 
MCF-10A cells expressing RAB5A WT form a reduced number of acini that 
display a significantly larger size in 3D culture. 
 
To test whether the expression of RAB5A WT affects MCF-10A cells ability to 
proliferate and to undergo a morphogenetic program in 3D culture on reconstituted 
basement membrane, we exploited the 3D matrix overlay assays. Cells were seeded on top 
of Matrigel in the presence or absence of EGF and overlaid with low concentration of 
soluble matrigel under conditions in which hollow acini, recapitulating mammary gland 
morphology, are formed (Debnath, Muthuswamy et al. 2003). As expected, both MCF-
10A EV and RAB5A WT cells were not proliferating in the absence of EGF (Fig. 25, on 
the left), corroborating the observation obtained in 2D culture. However, RAB5A WT-
expressing cells formed a significantly reduced number of acini, but unexpectedly, the few 
that grew had a dramatic increased size, suggesting that in those cells overcoming cell 
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cycle delay, RAB5A expression promotes hyper-proliferation (Fig. 25). Indeed, normal 
spheroids stop proliferating at day 14 from seeding, once the morphogenetic program is 
completed (Debnath, Muthuswamy et al. 2003). RAB5A WT acini, instead, kept on 
proliferating even at later time-points. The mechanisms enabling to overcome the intial 
RAB5A-dependent proliferation delays and the cell cycle arrest typically seen in mature 
and differentiated hollow acini remain unclear and would require further investigation. 
 
 
 
Figure 25. MCF-10A cells expressing RAB5A WT form a reduced number of 3D acini that 
display a significant increased size. 
(A) Equal number of cells was cultured on Matrigel in the absence or presence of EGF. Top panels: both cell 
lines were not able to proliferate in the absence of EGF (no EGF). In growing condition (EGF), after 7 days 
of 3D culture RAB5A WT expressing acini (bottom panels) were fewer but bigger then control cell line (top 
panels). At longer time-points RAB5A WT acini, but not the control one, continue to grow. Images were 
collected every 2-3 days. Representative phase contrast images are shown (Scale bar, 400 µm). The 
experiment was repeated 5 times with 2 technical replicates. (B) RAB5A expression levels on induced-MCF-
10A cells quantified by qRT-PCR at different time-points are shown. GAPDH was used as normalizer and 
EV cells relative to each time-point as calibrator. Error bars represent standard deviation.  
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MCF-10A cells expressing RAB5A WT show increased ERK1-2 
phosphorylation both in 2D and 3D.  
 
RAB5A WT expressing cells showed an altered EGF-dependent growth both in 2D 
and 3D. To characterize the involvement of EGFR signaling cascade in the process, cells 
were cultured either in un-induced or doxycycline-induced conditions for 72 hours and 
EGF-starved 9 hours. Protein lysates were collected after 5 minutes of acute stimulation 
with 100 ng/ml of EGF; the activation of the main signaling pathways was monitored by 
Western Blotting (Fig. 26A). EGFR and PI3K/Akt cascades were not affected. Conversely, 
RAB5A WT expressing cells showed a marked increase in the level of pERK1-2. 
Importantly, MAPK/ERK1-2 up-regulation was also confirmed by Western Blotting on 
protein lysates obtained from acini after 21 days of 3D culture, when RAB5A WT 
expressing acini continue to grow (Fig. 26B, C).  
 
Figure 26. MCF-10A cells expressing RAB5A WT show increased activation of 
MAPK/ERK1-2 pathway. 
(A) The indicated cell lines were cultured un-induced (no DOX) or induced (+DOX) 3 days, starved 9 hours 
and treated with an acute dose of EGF (100 ng/ml) to detect EGFR signaling pathway modulation. 30 µg of 
lysate were loaded on 8% (high molecular weight proteins) or 15% (low molecular weight proteins) 
polyacrylamide gels. Nitrocellulose membrane was immunoblotted as indicated and vinculin was used as 
loading control.  (B) Protein lysates obtained from 3D acini cultured 21 days on Matrigel were loaded on a 
8% or 15% polyacrylamide gel. Nitrocellulose membrane was immunoblotted as shown. Vinculin was used 
as loading control.  (C) Induced RAB5A mRNA in 21 days MCF-10A EV or RAB5A WT acini, as detected 
by qRT-PCR, is shown. GAPDH was used as normalizer and EV cells as calibrator. Error bars represent 
standard deviation. The experiment was performed 3 times.  
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The results suggest that RAB5A may exert an apparently different and distinct dual 
function in 2D culture as compared with 3D long-term culture. On the one hand, MCF-
10A expressing RAB5A WT clearly showed an impairment of 2D proliferation, caused by 
a delay in S-phase entry. On the other hand, when cultured in 3D, these cells develop few 
but giant acini. This apparently controversial data may be possibly rationalized considering 
that the expression of some oncogenes in normal cells cause aberrant proliferation which 
can trigger a stress response leading to accumulation of DNA damage responsible for the 
induction of either apoptosis or senescence-like growth arrest (Hills and Diffley 2014). 
Within this framework, RAB5A elevated expression may induce an oncogenic-like type of 
stress response: on one hand, the accumulation of severe DNA damages may lead to the 
elimination of damaged cells thus explaining first the blockade in S-phase and secondly the 
reduced number of acini. On the other hand, the formation of over-proliferative acini may 
be related to the acquisition and selection of a second mutation induced by accumulation of 
cell stress, enabling to overcome the cell cycle defect and sustaining an uncontrolled 
proliferation.  
 
 
Acini derived from MCF-10A RAB5A WT cells show an increased 
proliferation, without any alteration in morphological architecture and 
polarity. 
 
To assess whether RAB5A-dependent phenotypes could be related to an over-
proliferation effect or a defect in apoptosis, a single cell suspension was seeded on 3D 
reconstituted basement membrane and cultured in the presence of doxycycline and EGF in 
order to induce the formation of 3D acinar-like structures. Acini were fixed and stained at 
different time-points to monitor their maturation. First, proliferation potential was assessed 
by Ki-67 staining, a protein easily detectable in the active S-phases of the cell cycle, but 
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not in G0 (Scholzen and Gerdes 2000). As previously reported, normal acini stop 
proliferating after 14-16 days. Accordingly, after 21 days of culture no Ki-67 positive cells 
were detectable in control MCF-10A EV acini. Conversely, RAB5A WT-expressing acini 
retained a sizable number of Ki-67 positive cells even after 21 days of culture (Fig. 27A, 
B). 
Next we assessed whether RAB5A would affect survival under these 3D culture 
conditions. To this end, we measured the rate of apoptotic cell by staining for cleaved 
caspase 3, a prototypical marker of this cellular process. RAB5A WT expression did not 
significantly alter cell survival (Fig. 27A), confirming previous data obtained by Annexin 
V-PI staining and FACS analysis in 2D culture (Fig. 22). 
Frequently, altered cell growth in 3D culture is the result of an altered epithelial cells 
polarity (Bilder 2004; (Partanen, Nieminen et al. 2007; Partanen, Tervonen et al. 2012). 
Thus, we immunostained day-14-acini with DAPI to assess the overall morphology and 
with antibodies against the Golgi protein Giantin (red) that in polarized epithelia displays 
an apical orientation toward the lumen, and Laminin V (green), a basal marker that 
delineate the secretion of the basement membrane components. 
Neither the morphological architecture nor deposition of basement membrane and Golgi 
polarity were, however, altered by the expression of RAB5A WT (Fig. 27C). 
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Figure 27. Acini derived from MCF-10A RAB5A WT cells show increased proliferation but 
no alteration in the morphological architecture or polarity establishment. 
(A) MCF-10A cells were seeded on Matrigel as a single cell suspension and fed with Assay Media 
containing EGF and doxycycline. Acini were fixed in paraformaldehyde and stained at the indicated time-
points to assess proliferation and apoptosis overtime. Samples were stained as follows: DAPI (blue), Ki-67 
(green) and cleaved caspase 3 (red) and analyzed by confocal microscopy. Representative fluorescence z-
stack images of Ki-67 alone or merged channels are shown (Scale bar, 50 µm). (B) Quantification of the 
percentage of acini showing at least 2 Ki-67+ cells is shown. Error bars represent standard deviation. (C) 
Acinar morphology and architecture are conserved despite the expression of RAB5A WT. Doxycycline-
induced acini at day 14 were immunostained with antibodies against the Golgi protein Giantin (red), Laminin 
V (green) and DAPI (blue). Representative fluorescence images acquired by confocal microscopy are shown, 
equatorial cross sections were chosen to show the overall acinar architecture (Scale bar, 50 µm). The 
experiment was repeated 3 times. 
 
 96 
The expression of RAB5A WT in MCF-10A cells alters signaling pathways 
involved in cell cycle control and DNA repair. 
 
To gain some clues to signaling cascades that might be affected by RAB5A WT 
expression and may lead to derailed cell proliferation, we performed an Affymetrix 
analysis comparing MCF-10A EV and MCF-10A RAB5A WT gene profiling. 
Doxycycline-induced MCF-10A cells were grown in 2D in EGF-supplemented complete 
media for 72 hours and total RNA was extracted to compare genes expressed in control 
and RAB5A WT expressing cells. Genes were ranked according to the log2 ratio values 
and we initially focused our attention on the most up- or down-regulated genes (Tables 3-
4). Gene enrichment analysis performed on these selected gene lists by DAVID 
Bioinformatics Resources software, revealed that a number of genes involved in cell cycle 
and DNA repair pathways (such as APOBEC3B and HIST1H3F) were down-regulated in 
RAB5A WT expressing MCF-10A cells. 
 
      
 
Table 3. log2 ratio gene ranking. 
Gene lists, obtained by Affymetrix gene profiling, were ranked according to the log2 ratio. Three 
different thresholds and relative number of genes up- or down-regulated in RAB5A WT expressing 
cells are shown. 
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  TOP 10 UP-REGULATED GENES 
A_log2ratio Gene Symbol Short description 
4.3607 FAM113A 
Family with sequence 
similarity 113, member A 
It is a member of the GDSL/SGNH superfamily. 
Members of this family are hydrolytic enzymes with 
esterase and lipase activity and broad substrate 
specificity. 
4.2221 ASMTL 
N-acetylserotonin O-
methyltransferase-like 
protein 
The function  is unknown. The presence of the 
putative catalytic domain of S-adenosyl-L 
methionine binding argues for a methyltransferase 
activity. It is widely expressed. 
3.6408 GPD1 
Glycerol-3-phosphate 
dehydrogenase [NAD(+)] 
It promotes the reaction sn-glycerol 3-phosphate + 
NAD+ = glycerone phosphate + NADH. 
Involved in the hypertriglyceridemia, transient 
infantile (HTGTI) 
3.5448 CRISP3 
Cysteine-rich secretory 
protein 3 
It is involved in the innate immune response and in 
neutrophils is localized in specific granules. 
3.4420 IL2RG 
Interleukin-2 receptor 
subunit gamma 
It is an important signaling component of many 
interleukin receptors, including those of interleukin -
2, -4, -7 and -21, and is thus referred to as the 
common gamma chain. Diseases associated with 
IL2RG include severe combined immunodeficiency, 
and gamma chain deficiency. 
3.4380 C1orf220 
Chromosome 1 Open 
Reading Frame 220 
Uncharacterized. 
3.3882 LOC646976 
 
LOC646976 is an RNA gene, and is affiliated with 
the antisense RNA class. 
Uncharacterized. 
3.2704 IFI6 
Interferon alpha-inducible 
protein 6 
It is involved in the cytokine-mediated signaling 
pathway and immune response It is a negative 
regulation of cysteine-type endopeptidase activity 
involved in apoptotic process. It is induced by alpha 
and beta interferons. 
3.1780 PDE9A 
High affinity cGMP-
specific 3',5'-cyclic 
phosphodiesterase 9A 
It hydrolyzes the second messenger cGMP, which is 
a key regulator of many important physiological 
processes. It is widely expressed except blood. 
Highest levels in brain, heart, kidney, spleen, 
prostate and colon.  
3.0934 FGF18 
Fibroblast growth factor 
18 
It plays an important role in the regulation of cell 
proliferation, cell differentiation and cell migration. 
Required for normal ossification and bone 
development. Stimulates hepatic and intestinal 
proliferation. 
 
 
 
 
 
 98 
  BOTTOM 10 DOWN-REGULATED GENES 
A_log2ratio Gene Symbol Short description 
-2.2286 APOBEC3B 
DNA dC->dU-editing 
enzyme APOBEC-3B 
It is a DNA deaminase (cytidine deaminase) which 
acts as an inhibitor of retrovirus replication and 
retrotransposon mobility via deaminase-dependent 
and -independent mechanisms. 
-2.2035 S100A8 
S100 Calcium Binding 
Protein A8 
It is a calcium- and zinc-binding protein which plays 
a prominent role in the regulation of inflammatory 
processes and immune response. It can induce 
neutrophil chemotaxis and adhesion. Its role as an 
oxidant scavenger has a protective role in preventing 
exaggerated tissue damage by scavenging oxidants. 
Can act as a potent amplifier of inflammation in 
autoimmunity as well as in cancer development and 
tumor spread. 
-2.0823 MIR205 
MicroRNA 205 
It is an RNA gene, and is affiliated with the 
undefined RNA class. Diseases associated with 
MIR205 include esophageal squamous cell 
carcinoma. 
-1.9117 CLCA2 
Calcium-activated 
chloride channel regulator 
2 
It plays a role in modulating chloride current across 
the plasma membrane in a calcium-dependent 
manner, and cell adhesion. Involved in basal cell 
adhesion and/or stratification of squamous epithelia. 
May act as a tumor suppressor in breast and 
colorectal cancer. Plays a key role for cell adhesion 
in the beginning stages of lung metastasis via the 
binding to ITGB4. 
-1.9091 HIST1H3F 
Histone Cluster 1, H3f 
Core component of nucleosome.  Thereby plays a 
central role in transcription regulation, DNA repair, 
DNA replication and chromosomal stability. 
-1.8617 TMEM156 
Transmembrane protein 
156 
Uncharacterized. 
-1.7855 STC2 
Stanniocalcin-2 
It has an anti-hypocalcemic action on calcium and 
phosphate homeostasis. It is expressed in a wide 
variety of tissues and the expression of this gene is 
induced by estrogen and altered in some breast 
cancers. 
-1.7818 FAM72D 
Family With Sequence 
Similarity 72, Member D 
It is up-regulated in gastric cancer. An important 
paralog of this gene is FAM72C. 
-1.7344 MTSS1 
Metastasis suppressor 
protein 1 
It may be related to cancer progression or tumor 
metastasis in a variety of organ sites, most likely 
through an interaction with the actin cytoskeleton. 
It is classified as a tumor suppressor. 
-1.6886 SLC7A11 
Solute Carrier Family 7 
(Anionic Amino Acid 
Transporter Light Chain, 
Xc- System), Member 11 
It is a member of a heteromeric, sodium-
independent, anionic amino acid transport system 
that is highly specific for cysteine and glutamate. It 
is the predominant mediator of Kaposi sarcoma-
associated herpesvirus fusion and entry 
permissiveness into cells. The expression of this 
gene is increased in primary gliomas. 
 
Table 4. Top 10 up-regulated and bottom 10 down-regulated genes in MCF-10A cells 
expressing RAB5A WT. 
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The expression of RAB5A WT in growth-arrested, polarized three-dimensional 
acinar structures induces re-initiation of proliferation in a MAPK/ERK1-2-
dependent manner. 
 
 Most of human carcinomas, including breast cancer, are caused by the malignant 
transformation of epithelial cells. Our data are consistent with the expression of RAB5A in 
the entire MCF-10A cell population since the beginning of the morphogenetic process. 
However, carcinoma may arise from a secondary event within a context of an established 
epithelium, when disruption of tissue integrity and epithelium polarity may synergize with 
oncogenes and induce invasive properties (Chatterjee, Seifried et al. 2012). Within this 
context, for example, it has been already shown that acute activation of ErbB-2, a member 
of EGFR family frequently amplified or over-expressed in DCIS cases, triggers re-
initiation of proliferation and disruption of cell-to-cell junctions and polarity in terminally 
differentiated acini (Muthuswamy, Li et al. 2001). 
To determine whether the expression of RAB5A WT affects well-differentiated and 
growth-arrested 3D acinar structure, MCF-10A EV or RAB5A WT cells were plated on 
Matrigel without doxycycline. After 21 days in culture we did not observe any change in 
size of acini derived from both cell lines, indicating a growth-arrested state was reached 
under these conditions. Next we added doxycycline to the media to induce the ectopic 
expression of RAB5A WT (Fig. 28A, Schematic of the experiment), which was verified by 
Western Blotting (Fig. 28B). Under these conditions, we observed a thickening of the outer 
polarized layer of cells in RAB5A WT-expressing acini, suggesting re-initiation of 
proliferation (Fig. 28C).  
As previously described, MCF-10A cells expressing RAB5A WT showed an 
increased ERK1-2 phosphorylation both in 2D and 3D; to investigate whether re-entry into 
the cell cycle was dependent on MAPK/ERK1-2 pathway, post-mitotic acini media was 
replaced with media containing doxycycline and a MEK specific inhibitor (1 µM 
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PD325901). MAPK/ERK1-2 inhibition completely abolished the phenotype induced by 
RAB5A WT expression (Fig. 28C, right panels). The effectiveness of the specific inhibitor 
was detected by Western Blotting. RAB5A WT expressing acini showed increased levels 
of pERK1-2, not detectable in the same cells co-treated with PD325901 (Fig. 28D). 
 
Figure 28.  The re-initiation of proliferation induced by RAB5A WT expression in post-
mitotic acini is MAPK/ERK1-2 dependent. 
(A) Schematic of the experimental procedure, adapted from (Leung and Brugge 2012). Single cell suspension 
was plated on Matrigel and fed with complete media. After 21 days growth-arrested acini were doxycycline-
induced 6 days. (B) 30 µg of lysates of the cell lines used to perform 3D experiments were loaded on a 15% 
polyacrylamide gel. Nitrocellulose membrane was blot by mouse monoclonal anti-human vinculin antibody 
or rabbit polyclonal anti-human RAB5A antibody. Vinculin was used as loading control. (C) As described by 
the experimental procedure, acini were fed 21 days till reaching of the post-mitotic state. Subsequently, they 
were induced 6 days by 2.5 µg/ml DOX in the presence or absence of MEK1 inhibitor (PD325901, 1 µM). 
Representative phase contrast images are shown (Scale bar, 200 µm). (D) PD325901 treatment abolished the 
increase in pERK1-2 level induced by RAB5A WT expression. 50 µg of lysates of MCF-10A EV or RAB5A 
WT cells, treated as indicated, were loaded on an 8% polyacrylamide gel. Nitrocellulose membrane was blot 
by mouse monoclonal anti-human pERK1-2 antibody or rabbit polyclonal anti-human total ERK1-2 
antibody. Total ERK1-2 was used as loading control. The experiment was performed 3 times.  
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Cell cycle re-entry was confirmed by Ki-67 staining performed on these acini. Thus, upon 
expression of RAB5A WT, post-mitotic, growth-arrested acini re-initiated proliferation 
and repopulated the lumen (Fig. 29A, B). 
Collectively these evidences suggest that RAB5A WT expression in post-mitotic acini 
induces MAPK/ERK1-2 dependent re-initiation of proliferation. 
    
 
Figure 29.  RAB5A expression in post-mitotic acini induces re-initiation of proliferation. 
(A) Un-induced (no DOX) or induced (DOX) post-mitotic acini derived from the indicated cell lines were 
fixed and immunostained with DAPI (blue) and Ki-67 (green). Representative merged fluorescence images 
acquired by confocal microscopy are shown (Scale bar, 50 µm). (B) Quantification of the number of acini 
with at least 2 Ki67+ cells, expressed as percentage on the total number of acini analyzed/condition. Error 
bars represent standard deviation. The experiment was performed 3 times.  
 
 
Impaired RAB5A function promotes EGF-independent growth of MCF10-A 
cells both in 2D and 3D cultures. 
 
By testing cell proliferation we uncover an unexpected phenotype following 
impairment of RAB5A function. The expression of RAB5AS34N induced cell 
proliferation in the absence of EGF both in 2 D (Fig. 21C) as well as in 3D Matrigel 
culture (Fig. 30). 
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Figure 30. MCF-10A cells expressing RAB5AS34N proliferate in 3D in the absence of EGF.  
(A) Doxycycline-induced MCF10A EV (on the left) and RAB5AS34N (on the right) cells were plated on 
Matrigel as a single-cell suspension and fed with media without EGF. RAB5AS34N expressing cells are able 
to proliferate and form acini even in the absence of EGF, confirming data collected in 2D.  Representative 
phase contrast images are shown (Scale bar, 400 µm). The experiment has been performed 5 times with 2 
technical replicates. (B) RAB5A expression levels of induced-MCF-10A acini quantified by qRT-PCR are 
shown. GAPDH was used as normalizer and EV acini as calibrator. Error bars represent standard deviation. 
 
 
 
 
Conditioned media derived from MCF-10A cells expressing RAB5AS34N 
sustain EGF-independent growth of control MCF-10A cells. 
 
Growth factor-independent cell proliferation can be brought about either by 
activation of intrinsic signaling pathways or through the autocrine release of soluble 
growth factors. We initially tested this latter possibility. We cultured doxycycline-induced 
MCF-10A EV and RAB5AS34N cells in the absence of EGF for 4 days and collected 
supernatants, which were added to control MCF-10A cells. Strikingly, conditioned media 
derived from MCF-10A RAB5AS34N cells was sufficient to promote cell proliferation in 
the absence of EGF (Fig. 31A, right panels). As controls, cells were also plated in fresh 
media in the presence or absence of EGF. (Fig. 31A, left panels). Cell proliferation was 
monitored by acquiring images every 2 days and quantified counting the number of 
cells/field in each condition (Fig. 31B).  
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Figure 31. The supernatant derived from MCF-10A RAB5AS34N cells allows the EGF- 
independent growth of MCF-10A cells, suggesting the secretion of soluble growth factors. 
(A) On the left, control MCF-10A cells were seeded in fresh media in the absence or presence of EGF, as 
proliferation control. On the right, doxycycline-induced MCF-10A EV or MCF-10A RAB5AS34N cells were 
cultured 4 days in the absence of EGF. Conditioned media were collected and applied onto control MCF-10A 
cells, plated in equal numbers. Cells were proliferating only in fresh media +EGF or in RAB5AS34N derived 
conditioned media. Representative phase contrast images are shown (Scale bar, 400 µm), illustrating the 
starting point (T0) and ending point (6 days) of the experiment. (B) Quantification of the number of 
cells/field that were counted at each time-point: control MCF-10A cells growth curves in fresh media (graph 
on the left) or in conditioned media (graph on the right) are shown. Error bars represent standard deviation. 
MCF10A cells proliferate only when cultured in RAB5AS34N derived conditioned media or in the presence 
of EGF. The experiment was performed 4 times with quadruplicate technical replicates. 
 
 
 
Thus, impairing RAB5A activity triggers the release of soluble growth factors. To 
corroborate this finding, we performed a cell mixing experiment using GFP-positive MCF-
10A EV cells. This strategy allowed us to easily distinguish the two cell populations. Cell 
lines were grown in the absence of EGF either separately or mixed in a 1:1 ratio. 
RAB5AS34N cells were able to proliferate and form acini when culture in 3D on Matrigel 
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without EGF, as expected. Interestingly, control cells (Fig. 32, green) also were capable of 
generating acini, but only when co-culture with RAB5AS34N-expressing cells, as shown 
by proliferation of both not-tagged RAB5AS34N and GFP-positive EV cells (Fig. 32, 
white dashed inset). Thus, RAB5AS34N expression in MCF-10A cells induces the 
expression and the release of soluble growth factors that endowed MCF-10A cells with the 
ability to proliferate in the absence of growth factors. 
 
 
Figure 32. MCF-10A RAB5AS34N cells sustain the EGF-independent growth of control  
MCF-10A cells. 
RAB5AS34N expressing cells enable EGF-independent growth of neighboring non-expressing cells. MCF-
10A EV (GFP tagged) and MCF-10A RAB5AS34N cells (not tagged) were cultured on Matrigel either 
separately or as a 1:1 mixture for 7 days without EGF. Representative phase contrast and fluorescence 
microscopy images, and relative magnification, are shown (Scale bar, 200 µm). The experiment was 
performed 3 times with technical duplicate. 
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Identification of AREG as the candidate secreted diffusible factor in the 
conditioned media of RAB5AS34N expressing cells. 
 
Amphiregulin (AREG), another known ligand of EGFR, has been recently 
identified as one of the soluble factors capable of sustaining EGF-independent growth in 
MCF-10A cells (Zhang, Ji et al. 2009; Yang, Morrison et al. 2012). Thus, we initially 
tested by qRT-PCR whether AREG mRNA was altered by RAB5AS34N expression. We 
plated control EV- and RAB5AS34N MCF-10A cells in the absence of EGF and extracted 
their mRNA at different time-points (Fig. 33A). Of note, already after 3 days of culture, a 
strong induction of RAB5AS34N corresponded to a strong increase in AREG transcript. 
This effect was completely absent in doxycycline treated control cells, suggesting a 
RAB5AS34N-dependent effect. To assess whether AREG was secreted into the 
supernatant, conditioned media of doxycycline-induced MCF-10A EV or RAB5AS34N 
expressing cells were collected and secreted-AREG was detected by ELISA (Fig. 33B). 
Remarkably, RAB5AS34N supernatant contained nearly ten times more AREG than 
control. 
 
Figure 33. EGF-independent growth induced by RAB5AS34N expression relies on AREG 
secretion.  
(A) MCF-10A EV or RAB5AS34N cells were plated without EGF and collected at different time-points. 
Induced RAB5A and AREG mRNAs detected by qRT-PCR are shown. RAB5AS34N expression induces an 
up-regulation of AREG transcript. GAPDH was used as normalizer. (B) Human Amphiregulin ELISA was 
performed on 4 days conditioned media collected from the indicated doxycycline-induced cell lines grown in 
the absence of EGF. The relative AREG secretion level referred to EV conditioned media is shown. The 
experiment was repeated 3 times. Error bars represent standard deviation. 
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To establish whether AREG up-regulation and increased secretion is necessary and 
sufficient to confer EGF-independent cell proliferation, firstly we added recombinant 
AREG (rAREG) to EGF-deprived MCF-10A EV cells. Under these conditions we showed 
that AREG alone was able to sustain cell proliferation (Fig. 34, left panels). Second, we 
tested if neutralizing antibody against AREG were able to suppress growth induced by 
rAREG (Fig. 34, left panels) or by RAB5AS34N induced AREG secretion (Fig. 34, right 
panels). Treatment with anti-AREG IgG suppressed proliferation in both the conditions. 
Additional controls were included into the experiment; further confirming that AREG 
secretion is dependent on doxycycline induced RAB5AS34N expression (Fig. 34, “Not 
induced” panels on the right). These phenotypes were already detectable after 3 days. The 
sum of these observations indicates that EGF-independent growth induced by 
RAB5AS34N expression relies on AREG secretion. 
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Figure 34.  AREG-neutralizing antibody blocks EGF-independent growth. 
Equal number of cells was plated in the indicated conditions, in the absence of EGF. Left panels: MCF-10A 
EV cells grow both in the presence of EGF or recombinant AREG. AREG-neutralizing antibody, but not 
control IgG, inhibits AREG induced growth. Right panels: RAB5AS34N expressing cells were cultured as 
illustrated; AREG-neutralizing antibody abolishes RAB5AS34N induced EGF-independent growth. 
Representative phase contrast images are shown, at 2 different time-points (Scale bar, 400 µm). The 
experiment was performed 3 times with quadruplicate technical replicates. 
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AREG sustains EGF-independent growth of MCF-10A cells through EGF 
receptor activation. 
 
To test whether AREG sustains EGF-independent growth by binding and activation 
of EGF receptor, control EV and MCF-10A cells expressing RAB5AS34N were plated in 
equal number in the presence or absence of EGF. Cells were simultaneously treated with 
two different concentrations of the EGFR inhibitor Cetuximab. In the presence of EGF, the 
inhibitor impaired EGF-dependent growth in both cell lines, as expected. In EGF-deprived 
conditions, instead, only cells expressing RAB5AS34N were able to grow but treatment 
with Cetuximab inhibited their proliferation (Fig. 35A, right panels). We obtained similar 
results, in 3D culture of MCF-10A RAB5AS34N cells. Under these conditions, Cetuximab 
blocked cell proliferation and acini formation sustained by AREG secretion or by EGF 
supplemented media (Fig. 35B). Importantly, Cetuximab effectively inhibited EGFR 
activation as witnessed by impaired phosphorylation of EGFR (Fig. 35C). Collectively 
these evidences suggest that AREG sustains EGF-independent proliferation through 
canonical EGFR activation. 
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Figure 35. AREG sustains non-cell autonomous growth of MCF-10A cells through canonical 
EGFR activation. 
(A) Doxycycline-induced cells were plated in equal number in the indicated conditions and images were 
acquired every 2 days to monitor cell growth. Two different concentration of Cetuximab were used to assess 
dose-dependent effects. RAB5AS34N expressing cells treated with Cetuximab are not able to proliferate. 96 
hours images are shown (Scale bar, 200 µm). (B) Cetuximab treatment inhibits MCF-10A RAB5AS34N cells 
growth in 3D cultures. Representative phase contrast images of 3 days acini are shown (Scale bar, 200 µm). 
(C) Effectiveness of Cetuximab was assessed by starvation of control MCF-10A cells and stimulation by 
acute dose of EGF for the indicated time. 10 µg/ml Cetuximab was enough to abolish completely EGFR 
activation (pEGFR). Nitrocellulose membrane was immunoblotted as indicated. Actin was used as loading 
control. The experiment was performed 3 times. 
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RAB5AS34N-dependent AREG induction is not mediated by signaling 
pathways known to regulate AREG expression. 
 
Previous studies identified AREG as a transcriptional target of different signaling 
cascades. Indeed, AREG was shown to be a downstream effector of the Hippo pathway 
either as a consequence of YAP direct binding to AREG promoter as demonstrated by 
Chip assay (Zhang, Ji et al. 2009) or as a target of TAZ through TEAD binding to AREG 
promoter (Yang, Morrison et al. 2012). In hypoxic conditions, AREG expression may also 
be regulated by HIF-2α, driving an autonomous breast cancer cell growth via EGF 
receptor family (Bordoli, Stiehl et al. 2011; Stiehl, Bordoli et al. 2012). To assess whether 
these pathways are similarly regulated by interference with RAB5A, doxycycline-induced 
control EV and RAB5AS34N-expressing MCF-10A cells were collected at different time 
points and processed by qRT-PCR (Fig. 36A). 
We chose CTGF (connective tissue growth factor) as one of the main target genes of 
YAP/TAZ signaling pathway (Fig. 36B), HIF-2α for hypoxia induced AREG modulation 
(Fig. 36C) and Estrogen (Martinez-Lacaci, Saceda et al. 1995; Ciarloni, Mallepell et al. 
2007) and Progesteron Receptors (Aupperlee, Leipprandt et al. 2013), well known 
mediators of mammary gland development during puberty through AREG (Fig. 36D). 
However, none of the screened mRNAs resulted to be significantly modulated by 
RAB5AS34N expression. 
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Figure 36. RAB5AS34N-induced AREG modulation is not mediated by already characterized 
signaling pathways that regulate AREG expression. 
(A) Doxycycline-induced MCF-10A EV or RAB5AS34N cells were plated without EGF and collected at 
different time-points. Time-course of induced RAB5A and AREG mRNAs detected by qRT-PCR are shown. 
Corresponding modulation of (B) CTGF, a specific YAP/TAZ target gene; (C) HIF-2α , a mediator of 
hypoxia and (D) Estrogen Receptor mRNAs, detected by qRT-PCR are shown. Progesteron Receptor 
mRNA was not detectable.  GAPDH was used as normalizer and EV 12h DOX sample as calibrator. Error 
bars represent standard deviation. The experiment was performed 3 times.  
 
 
 
Genetic ablation of RAB5 does not mimic its functional impairment in AREG 
modulation. 
 
We collected evidences suggesting a modulation of AREG induced by endocytosis 
impairment. In an attempt to confirm this observation, we assessed AREG modulation in 
MCF-10A cells interfered with different sets of oligos that target specifically RAB5 
isoforms. Surprisingly, neither the knockdown of the single RAB5 isoforms (Fig. 37A, C) 
nor the simultaneous interference with all three RAB5A, B and C gene transcript 
recapitulated the effect of the RAB5 dominant negative (Fig. 37A, B, C).  
As previously described, RAB5AS34N is locked in a GDP-bound, non-functional form.  
However, its over-expression may result in the sequestration of specific GEFs that may 
also utilize others RABs of the same subfamily of RAB5 as substrate. Thus, we 
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hypothesized that AREG modulation might be the result of a more complex mechanism 
involving also additional RABs. However, neither the single nor the combined knockdown 
of the closer RAB5 family member, RAB21, RAB22A and RAB31 (also known as 
RAB22B), was sufficient to induce AREG expression (Fig. 37 A, C).   
 
 
Figure 37. Genetic depletion of RAB5 and other related RABs does not phenocopy 
RAB5AS34N-induced AREG modulation. 
(A) MCF-10A EV cells were interfered by specific siRNAs targeting the single or a combination of the 
indicated genes. RABs mRNAs levels detected by qRT-PCR 48 hours after interference are shown. (B) 
Efficiency of RAB5S34N induction and AREG modulation are shown. (C) Corresponding modulation of 
AREG detected by qRT-PCR in RNAi conditions is shown, GAPDH was used as normalizer and NCi (in A 
and C), or RAB5AS34N-dox cells (in B), as calibrators. The experiment has been repeated 3 times. NCi, 
negative control; RNAi, RNA interference; i, interference. 
 
 
It is important to point out that in mouse hepatocytes, it is necessary to reduce the 
expression or the activity of RAB5 by more than 80% in order to impair endosome 
biogenesis, suggesting that this system has evolved to be extremely robust and is thus 
proficient even under condition that severely limits the expression of the master regulator 
of these organelles (Zeigerer, Gilleron et al. 2012). Thus, we hypothesized that 
RAB5AS34N-expressing MCF-10A cells may display a hypomorfic phenotype, that 
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cannot be recapitulated by the complete ablation of its function achieved through siRNAs. 
To investigate this possibility, we compared the impact of functional (by expression of 
RAB5AS34N) or genetic manipulation of RAB5 (by concomitant down-regulation of all 
three isoforms) on endosome biogenesis. EEA-1 staining confirmed that a complete 
displacement of EEA-1 from early endosomes could be achieved by knocking-down of 
RAB5 family members (RAB5A/B/C-RAB21-RAB22A-RAB31) or by concomitant 
interference with RAB5A/B/C (Fig. 38A). Conversely, the expression of RAB5AS34N 
caused a readily detectable, but incomplete displacement of EEA-1 (Fig. 38B). These 
findings indicate that the expression of the dominant negative likely cause a hypomorfic 
effect. They further suggest that complete loss of RAB5 wipes completely out endosomal 
and lysosomal activity, which is likely to impact deeply on a wide array of cell biological 
activity impeding the emergence of proliferation phenotypes. While further experiments 
are required to establish this notion firmly, it is likely that different levels of alteration of 
the endocytic system obtained by genetic or functional impairment of RAB5A may explain 
the diverse effect observed on AREG modulation.  
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Figure 38. Genetic or functional depletion of RAB5 and other related RABs differently 
impact on the endosomal compartment. 
Cells were seeded on coverslips and interfered for the indicated genes. (A) 48 hours after RNAi treatment, 
coverslips were fixed in 4% paraformaldehyde and stained with anti-human EEA-1 antibody, to be analyzed 
by wide field microscopy. (B) EEA-1 displacement was compared with un-induced or induced MCF-10A 
RAB5S34N cells. Representative images are shown (Scale bar, 20 µm). The experiment has been performed 
3 times. 
 
 
RAB5A expression increases collective cell migration in MCF-10A cells. 
 
Clinical data and in vitro studies collected by other and by our lab concordantly 
demonstrates that RAB5A is required for invasion and metastasis, suggesting that in 
certain pathological conditions, RAB5 may act as promoter of tumor progression rather 
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than as tumor suppressor. Tumorigenesis is a multistep process; cancer cells progressively 
acquire different properties that transform a normal cell into a neoplastic cell. Among the 
typical hallmarks of cancer, cell migration and tissue invasion are specific traits correlated 
with tumor progression and metastasization (Hanahan and Weinberg 2000; Hanahan and 
Weinberg 2011). Notably, RAB5A has been shown to promote the formation of migratory 
protrusion as well as of invasive structures, that are required and instrumental to induce a 
mesenchymal program of individual cell invasion (Palamidessi, Frittoli et al. 2008; Frittoli, 
Palamidessi et al. 2014). To extend and explore a potential pro-metastatic role of RAB5A, 
we investigated the impact of deregulation of the expression of this GTPase on a form of 
locomotion that is typically used by tumor of epithelial origin. In addition to disseminate as 
individual cells that detach from the tumor mass, frequently epithelial-derived tumors can 
invade as collective entities (Theveneau and Mayor 2013). Under these conditions, cell-to-
cell junctions are dynamic and constantly remodeled, but remain functionally proficient in 
keeping cell together and in promoting a coordinated mode of cell motility. One in vitro 
assay that recapitulates certain aspect of this mode of locomotion is the wound healing 
assay, whereby confluent monolayers of epithelial origin are induced to migrate into the 
void created by a scratch into the epithelial sheet. We initially utilized normal mammary 
epithelial cells in an effort to understand and capture fundamental, physiological role of 
RAB5A. To this end, control and RAB5A WT expressing MCF-10A confluent monolayers 
were scratched with a pipette tip to induce epithelial collective cell migration. Wound 
closure was monitored overtime by time-lapse microscopy. Strikingly, compared with 
control MCF-10A EV cells, RAB5A expression enhanced the speed of migration of the 
epithelial cell sheet (Fig. 39 and Movie 1).   
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Figure 39. Collective migration of MCF-10A epithelial layer is increased by RAB5A 
expression and impaired in RAB5 knockdown cells. 
(A) Wound-healing assays. MCF-10A cells were grown at confluency and doxycycline induced 16 hours 
before the experiment. Induced-monolayers were mechanically scratched by a pipette tip and cell migration 
was monitored by time-lapse phase contrast microscopy. Images were recorded every 5 minutes using a 10x 
objective. Representative images just after the scratch (0 hour) and at 7 hours from the incision are shown. 
Dashed lines represent the wound edge. Scale bar, 100 µm. (B) Motility was quantified by measuring the 
increase in the percentage of area covered by cells overtime (MatLab software) (C) The distribution around 
the value of mean wound front speed for each cell line is shown. MCF-10A RAB5A WT cells were 
significantly faster than control EV cells. Conversely, RAB5ABCi cells were less motile. Data are the mean -
/+ SEM. ****p<0.0001. (D) RAB5A, RAB5B and RAB5C mRNA levels in the indicated cell lines and in the 
same experimental conditions used for the experiment, are shown. GAPDH was used as normalizer and 
control EV or NCi cells as calibrators. The experiment was performed 3 times in duplicate.  
 
 
To exclude any contribution of cell proliferation to wound healing, we interfered with cell 
division. Inhibition of cell division with Mitomycin C did not alter the effect of RAB5A on 
collective locomotion (Fig. 40A). Wound healing assay was also performed on un-induced 
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cells, to confirm the two cell lines have a comparable behavior when not induced. Both 
EV- and RAB5A WT-MCF-10A cells migrate with comparable speed, in the absence of 
doxycycline, further confirming the role of RAB5A in promoting collective cell migration 
(Fig.40B). 
Conversely, when RAB5A, B and C were genetically silenced by small interfering RNAs 
(siRNAs), collective cell migration was impaired and wound closure was severely delayed 
as compared with cells interfered with scrambled siRNAs (Fig.39 and Movie 1).  
         
Figure 40. The increase in wound healing velocity is dependent on RAB5A expression, 
without any contribution of cell proliferation. 
(A) Wound-healing assays on induced MCF-10A cells treated with Mitomycin C. Representative images just 
after the scratch (0 hour) and at 4 hours from the scratch are shown. Scale bar, 100 µm. (B) Wound-healing 
assays of un-induced MCF-10A cells. Representative images just after the scratch (0 hour) and at 7 hours 
from the incision are shown. Dashed lines represent the wound edge. The distribution around the value of 
mean wound front speed for each cell line is shown. Data are the mean -/+ SEM. ns, not significant. Scale 
bar, 100 µm.  
 
RAB5A selectively enhances collective cell migration. 
 
RAB5A has been shown to impact on the migration of different kind of tumor 
derived cells moving as single entities. To exclude the possibility that the collective 
motility phenotype resulted from alteration of single cell motility within the epithelial 
monolayer, we directly measured a number of parameters of locomotion by plating sparse 
cells and monitoring their single cell motility upon deregulation of RAB5A expression.  
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Single cells were seeded sparsely in complete media in the absence of added 
chemotractants and monitored for 24 hours by time-lapse microscopy. Random migration 
was quantified by single cell tracking and analyzed by ImageJ software. Notably, RAB5A 
WT expression in MCF-10A cells was insufficient to alter single cell migration. 
Conversely, as expected, RAB5 depletion abrogates cell motility (Fig. 41 and Movie 2). 
These finding indicates that while RAB5A is essential for optimal cell motility regardless 
of the mode of locomotion, it elicit cell locomotion only when cell are forced to move in a 
coordinated and directional fashion, such as during wound sheet closure. These evidences 
further suggest that the topographical constrain of an epithelial sheet may be instrumental 
to cooperate with altered endosomal function that is brought about by elevation of RAB5 
expression. 
         
Figure 41. RAB5A does not increase the velocity of randomly migrating single cells. 
(A) MCF-10A cells were seeded sparsely in the absence of any diffusible gradient. Random cell migration 
was recorded by time-lapse phase contrast microscope every 5 minutes over a 24 hours period. Cell tracking 
was performed manually and analyzed by Chemotaxis Tool ImageJ software plugin. Single cells per each 
condition were tracked for 3 consecutive hours and plotted in the correspondent graph. (B) Single cell 
velocity is not affected by RAB5A expression but its knockdown strongly decreases migration speed. The 
analysis was conducted on 40 single cells/experiment/genotype of three independent experiment; data are the 
mean ± SEM. ns not significant; ****p < 0.0001. (C) RAB5A, RAB5B and RAB5C mRNA levels in the 
indicated cell lines used for the experiment, are shown. GAPDH was used as normalizer and control EV or 
NCi cells as calibrators. 
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Cell coordination is increased in migrating epithelial sheets expressing 
RAB5A. 
 
Collective locomotion is the result of a tightly regulated set of processes that 
strictly depends on complex and dynamic cell-to-cell interactions occurring during the 
migration of epithelial sheet. To further characterize the phenotype induced by RAB5A 
WT expression in MCF-10A cells, we analyzed movies recorded in wound healing assay 
by Cell Image Velocimetry software (Milde, Franco et al. 2012). Exploiting this 
bioinformatic approach, we determined cell position overtime within a monolayer, 
detecting the progression of migrating cells in consecutive frames (Fig 42A). As it is 
shown by the specific color-coding that reveals the direction of migration of group of cells, 
relative to the orientation of the wound, RAB5A expression greatly enhanced cell 
coordination (Fig. 42B, C and Movie 3). Furthermore, the increase in mean angular 
correlation, a specific measure of the coherence in cell movement, indicated that 
neighboring cells move in a highly coordinated fashion (Fig. 42D, E). On the contrary, 
genetic ablation of RAB5 impairs not only wound healing speed, but also cell 
coordination, as it is shown by a decreased mean angular correlation value (Fig. 42 and 
Movie 3). 
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Figure 42. RAB5A levels affect collective migration dynamics of MCF-10A cells. 
(A) Overview of the CIV (Cell Image Velocimetry) analysis (Milde, Franco et al. 2012). Wound edges are 
detected in a segmentation step and cell layers are masked. PIV (Particle Image Velocimetry) is used to 
quantify the dynamics of the cell monolayer. Coherence plots are obtained by comparing the movement of 
few cells to the neighboring regions. Color code indicates direction of movement. (B) Kymographs taken 
perpendicular to the wound (as indicated by the white line in A) are shown. Homogeneous colors indicate 
high coherence; in-homogeneous colors indicate less coeherent dynamics. (C) Cell coherence of the 
indicated cell lines are shown at 2 and 5 hours after wound. (D) Angular correlation of the cell movements 
for the different phenotypes overtime (bin distance: 100µm) and (E) mean angular correlation during entire 
wound closure are shown. 
 
 
 
RAB5A promotes collective cell streaming in the epithelial monolayer 
 
Collective cell movement is an important strategy in several physiological 
processes, including development, morphogenesis and regeneration. Furthermore, it also 
plays a central role in pathological events such as tumor progression and metastasis. To 
further characterize the role of RAB5A in collective locomotion, we plated control (EV) 
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and RAB5A WT expressing MCF-10A cells at confluency in order to generate a tight 
monolayer that recapitulate epithelial tissues in vivo, and monitored cell behavior within 
the monolayer by time-lapse microscopy. Indeed, fully confluent monolayers closely 
resemble the situation in mature epithelia with stable adhesive contacts. 
Interestingly, un-wounded MCF-10A cell sheets underwent steaming like locomotion only 
when RAB5A WT expression was induced (Fig. 43A and Movie 4). Single cells were 
manually tracked and the analysis of migration parameters demonstrates that in cells 
expressing RAB5A both migration speed and directionality are improved, resulting in a 
higher accumulated distance (Fig. 43B). 
  
  
Figure 43. RAB5A promotes collective cell streaming in un-wounded MCF-10A cells 
monolayer. 
(A) Stable MCF-10A monolayers were doxycycline induced 16 hours before the experiment. Cell migration 
was monitored by time-lapse phase contrast microscopy. Images were recorded for 12 hours with a 5 minutes 
interval using a 10x objective. Single cells within the monolayer were manually tracked by ImageJ plugin 
software. Representative overlay of 30 cell tracks/condition are shown. Scale bar, 100 µm. (B) Quantification 
of migration parameters was performed by Chemotaxis tool ImageJ software plugin, to determine single cell 
velocity, directionality and accumulated distance. The distribution around the mean is shown. The 
experiment was performed 3 times. Data are the mean -/+ SEM. ****p<0.0001. 
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RAB5A alters E-cadherin pattern in the epithelial monolayer, without 
affecting its expression levels. 
 
So far, we showed a specific role of RAB5A in promoting cell streaming in un-
wounded monolayer as well as the speed and coherence of migrating cells in wound 
closure. Previous works on collective wound locomotion, revealed the relevance of cell-to-
cell adhesion and of adhesion molecules in sustaining and coordinating sheets migration 
(Simpson, Selfors et al. 2008). Indeed, cadherins perturbation by siRNA-mediated 
knockdown or by calcium chelation was shown to cause strong alteration of coordinated 
motion in epithelial sheets (Ng, Besser et al. 2012; Czirok, Varga et al. 2013). 
Thus, we chose to investigate the possible involvement of E-cadherin, specific of epithelial 
tissues, in our system. Although E-cadherin expression level was not affected by RAB5A 
WT expression, E-cadherin staining of MCF-10A cells monolayers revealed different 
patterns of adherens junctions (Fig 44A,B). Compared with control MCF-10A cells, 
RAB5A WT expressing cells show straighter and more delineated cell-to-cell contacts, 
suggesting a possible increase in cell-to-cell adhesion strength. Cell images were 
quantified by measuring the straightness index of the junction, considered as the ratio 
between the junction length and the junction tracking obtained by ImageJ software (for 
more details refer to Materials and Methods). RAB5A WT-expressing cells show a mean 
index value closer to one (Fig 44C). 
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Figure 44. RAB5A expressing cells show higher organization of E-cadherin mediated 
homotypic adherens junctions.  
(A) Equal amount of protein lysates derived from 16 hours doxycycline-induced monolayers of MCF-10A 
EV and RAB5A were loaded on 8% polyacrylamide gel. Nitrocellulose membrane was blot by mouse 
monoclonal anti-human E-cadherin antibody or mouse monoclonal anti-human tubulin antibody, as loading 
control. (B) Cells were seeded as a monolayer and doxycycline-induced for 16 hours. Samples were fixed in 
4% paraformaldehyde and stained as indicated. Representative confocal microscopy images are shown (Scale 
bar, 10 µm). (C) Confocal images were analyzed by ImageJ software. The straightness index of the junction 
has been quantified as the ratio of the junction length and the manual tracking of the junction. The 
experiment was performed 3 times. Data are shown as the mean ± SEM. ****p < 0.0001.   
 
 
RAB5A induces the formation of bigger and more persistent protrusions in 
cells at the leading front. 
 
Lamellipodial protrusions are essential in guiding cell motility (Small, Stradal et al. 
2002; Ridley, Schwartz et al. 2003). It has been shown that RAB5A promotes the 
activation and spatial restriction of RAC1 to the plasma membrane, leading to the 
formation of polarized actin signaling which fuels the formation of migratory cellular 
protrusions (Nobes and Hall 1995; Palamidessi, Frittoli et al. 2008 ).  
We thus performed a wound healing assay to monitor at higher magnification and with a 
shorter time-frame the morphology and dynamic of the protrusion at the leading front of 
 124
the migrating epithelial sheet. Strikingly, RAB5A WT-expressing monolayer showed 
larger and longer-lived protrusions, characterized by an altered protrusion dynamics (Fig. 
45A, B and Movie 5). We quantified these dynamic behaviors by kymograph analysis. 
Although the rate of protrusion extension was nearly identical between control and 
RAB5A WT expressing cells, elevation of RAB5A was sufficient to significantly decrease 
the rate of retraction and increase the persistence of migratory protrusion extension (Fig. 
45C, D).  
 
Figure 45. RAB5A expression increases protrusion area and persistence. 
Snapshots of the leading front of control EV- or RAB5A WT- expressing MCF-10A cells at 10x (A) and 32x 
(B) magnification. Scale bar, 20 µm. (C-D) Cell migration was monitored for one hour with 30 seconds 
timeframe. Quantification of protrusion dynamics was performed, by kymograph ImageJ software plugin, to 
determine the rate of protrusion extension, the rate of retraction and persistence. The distribution around the 
mean values of protrusion parameters of each of at least 20 cells/genotype is shown. Protrusion area was 
measured manually by ImageJ software. The distribution around the mean values of protrusion parameters is 
shown. The experiment was performed 3 times. Data are the mean -/+ SEM. ***p < 0.001; ****p<0.0001; ns 
not significant. 
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Focal Adhesions morphology is affected by RAB5A expression in polarized 
migrating MCF-10A cells. 
 
Migrating cells interact with the extracellular matrix to anchor their cytoskeleton to 
the substrate and sustain locomotion. Focal adhesions are signaling platform that sense 
biochemical and physical properties of the surrounding microenvironment allowing cells to 
respond and adapt to different matrices. The dynamic assembly and disassembly of these 
structures plays an important role in cell locomotion and RAB5 activation controls focal 
adhesions turnover (Mendoza, Ortiz et al. 2013) (Palamidessi, Frittoli et al. 2013). 
Importantly, in cell protrusions, FAs undergo rapid dynamic remodeling. They form as 
focal contacts near the advancing leading edge, to mature in FAs as the edge advances and 
actomyosin contractility builds up just behind the lamellipodia periphery. Since RAB5A 
WT-expressing cells display altered protrusion dynamics we explored whether these was 
mirrored by a concomitant alteration of focal adhesions size, as one would expect.  
To this end, we wounded control and RAB5 WT-expressing MCF-10A monolayers and 
fixed them 5 hours after the scratch. Control and RAB5A WT-epithelial sheets were 
stained with antibodies recognizing vinculin and paxillin, fundamental components of 
these adhesive structures (Fig. 46A, B, C). Focusing the attention on cells at the leading 
front, RAB5A WT-expressing cells showed EEA-1 positive enlarged endosomes 
accumulated at the leading front, resulting from the RAB5A-induced fusion of early 
endosomes (Fig. 46D), and smaller focal adhesions compared to the control. This latter 
observation suggests that the enlarged and persistent protrusions brought about by RAB5A 
are accompanied by smaller FAs that resemble focal contacts. Whether such alteration in 
FAs size is a consequence or a cause of altered protrusion dynamics remains to be further 
explored.  
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Figure 46. RAB5A expressing cells at the leading front show smaller focal adhesions and 
enlarged endosomes. 
MCF-10A cells were grown as monolayer and scratched with a pipette tip. Samples were fixed in 4% 
paraformaldehyde and stained with specific antibody combinations: (A) DAPI for nuclei (blue), vinculin for 
focal adhesions (green) and TRITC-phalloidin for actin (red); (B) DAPI (blue), paxillin for focal adhesions 
(green) and TRITC-phalloidin (red) and analyzed by confocal microscopy. (C) Quantification of focal 
adhesions size was performed by ImageJ software plugin and it is shown as relative focal adhesions size 
referred to control cells. (D) Staining with DAPI for nuclei (blue), EEA-1 for early endosomes (green) and 
TRITC-phalloidin for actin (red) revealed enlarged endosomes in migratory protrusion of RAB5A WT-
expressing cells. Representative confocal fluorescence images and merged signals are shown (Scale bar, 10 
µm). 
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Generation and characterization of stable inducible MCF-10.DCIS.com cell 
lines expressing RAB5A WT or RAB5AS34N. 
 
Our findings indicate that RAB5A specifically alters collective locomotory 
behavior of normal mammary human cells. Given the potential pro-tumorigenic role of 
RAB5A, we next tested whether the increase collective locomotory activity could also be 
observed in the tumorigenic variant of MCF10A cells. 
MCF-10.DCIS.com cells, a well-characterized H-Ras transformed cell line (Miller, 
Santner et al. 2000), expressing ectopic RAB5A WT or RAB5AS34N were generated and 
characterized with the same strategy described for the generation of inducible MCF-10A 
cells: both the efficiency of the inducible system (Fig. 47A), and the expected alteration of 
the endosomal compartment induced by manipulation of RAB5A (Fig. 47B) were 
confirmed. 
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Figure 47. RAB5A WT or RAB5AS34N expression in MCF-10.DCIS.com alters the 
endosomal compartment.  
(A) 30 µg of protein lysates of the indicated cell lines were loaded on a 15% polyacrylamide gel. 
Nitrocellulose membrane was blot by rabbit polyclonal anti-human RAB5A antibody or mouse monoclonal 
anti-human vinculin antibody, as loading control. (B) Cells were seeded on coverslips and induced 72h by 
2.5 µg/ml doxycycline, fixed in 4% paraformaldehyde and stained as indicated, to be analyzed by wide field 
microscopy. Representative images are shown. Scale bar, 20 µm. 
 
 
RAB5A promotes collective cell locomotion in MCF-10.DCIS.com cells. 
 
RAB5A role in collective cell locomotion was further confirmed performing a 
wound healing assay on this oncogene-transformed cell line, MCF-10.DCIS.com. Control 
and RAB5A WT-expressing cells were seeded as monolayer and scratched by a pipette tip. 
Cell migration of doxycycline-induced cells was monitored overtime by time-lapse 
microscopy (Fig.48A and Movie 6).   
MCF-10.DCIS.com cells showed an evident increase in wound front speed when RAB5A 
expression was induced (Fig. 48B).  
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Figure 48. RAB5A expression enhances collective cell migration in the oncogene-transformed 
cell line MCF-10.DCIS.com. 
(A) MCF-10.DCIS EV or RAB5A WT cells were seed as monolayer and analyzed for migration by wound 
healing assay. Images were recorded every 5 minutes using a 10x objective; scale bar, 100 µm. 
Representative images acquired just after the scratch (0 hour) and at 6 hours from the incision are shown. 
Dashed line represents the wound edge.  (B) Wound closure speed was measured by MatLab software, 
calculating the percentage of area coverage overtime. Mean wound front speed is represented for each 
condition. 10 movies were analyzed for each condition and the experiment was repeated 3 times. (C) RAB5A 
expression was detected by Western Blotting. 70 µg of lysates of MCF-10.DCIS.com EV or RAB5A WT 
cells treated as indicated were loaded on a 15% polyacrylamide gel. Nitrocellulose membrane was blot by 
mouse monoclonal anti-tubulin and rabbit polyclonal anti-human RAB5A antibody. Tubulin was used as 
loading control.  
 
 
CIV analysis showed an improvement in cell coordination in RAB5A WT-
expressing cells (Fig. 49 and Movie 7). Data collected in the tumorigenic variant of MCF-
10A cells further confirm the role of RAB5A in promoting collective cell migration.  
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Figure 49. RAB5A promotes cell coordination of collectively migrating MCF-10.DCIS.com 
cells. 
(A) Cell coherence of the indicated cell lines are shown after 1 hours or 3 hours after the wound.  (B) 
Angular correlation of the cell movements for MCF-10.DCIS.com EV or RAB5A WT cells overtime (bin 
distance: 80µm) and mean angular correlation during entire wound closure are shown. 
 
 
Perturbation of RAB5A function impairs the formation of HGF-induced 
invasive outgrowth. 
 
We collected evidences showing the role of RAB5A in promoting collective 
migration and tumor progression. To further confirm the involvement of RAB5A in the 
process of tumorigenesis, we investigated its effect on cancer invasion. Thus, MCF-
10.DCIS EV and RAB5AS34N cells were seed into a Matrigel/Collagen matrix to monitor 
their invasive potential, when treated with HGF (Edakuni, Sasatomi et al. 2001; Jedeszko, 
Victor et al. 2009). We observed that DCIS EV cells developed invasive outgrowth when 
stimulated with HGF, on the contrary RAB5AS34N expressing cells did not form any 
protrusion, even in the presence of HGF (Fig. 50). Thus, perturbation of RAB5A function 
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in an oncogene-transformed context impairs the formation of HGF-induced invasive 
outgrowth, corroborating the hypothesized pro-metastatic role of RAB5A. 
      
Figure 50. RAB5AS34N expression in an oncogene-transformed cell line impairs the invasive 
growth induced by HGF. 
(A) Equal number of MCF-10.DCIS EV or RAB5AS34N cells was cultured in 3D into Matrigel/Collagen 
matrix, in un-induced condition. After 4 days, cells were doxycycline-induced in the absence or presence of 
HGF. RAB5AS34N expression inhibits the formation of invasive protrusion in MCF-10.DCIS stimulated by 
HGF. Representative phase contrast images, after 4 days from the induction, are shown. The arrow indicates 
a typical invasive protrusion (Scale bar, 400 µm). (B) Quantification of the percentage of invasive 
outgrowths in each condition. Data are mean -/+ SEM. (C) Induced RAB5A mRNA levels in MCF-10.DCIS 
EV or RAB5A S34N cells, as detected by qRT-PCR are shown. GAPDH was used as normalizer and EV 
cells as calibrator. The experiment was performed 3 times with 2 technical replicates. 
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DISCUSSION 
 
 
1. RAB5A as a tumor suppressor. 
 
A critical hallmark of tumorigenesis is the acquisition of growth factor independent 
proliferation. In the first part of the present study, we provide evidences that alteration of 
endocytosis brought about by interference with RAB5A activity induces an EGF 
independent growth phenotype in MCF-10A cells. We have identified Amphiregulin 
(AREG), a ligand of the EGFR, as the specific secreted factor that is responsible for 
proliferation in the absence of EGF. Both the conditioned media collected from 
RAB5AS34N-cells and recombinant AREG are capable of sustaining EGF-independent 
proliferation of parental MCF-10A cells. Conversely, the phenotype is reverted by the 
concomitant presence of a specific AREG-neutralizing antibody. Finally, the EGF-
independent growth achieved by the autocrine or paracrine production and secretion of 
AREG is dependent on the ability of this ligand to bind and activate the EGF receptor. 
In physiological conditions, Estrogen and Progesteron Receptor dependent up-regulation 
of AREG has been shown to be an indispensable mechanism to sustain pubertal 
development of mouse mammary gland (Martinez-Lacaci, Saceda et al. 1995; Ciarloni, 
Mallepell et al. 2007; McBryan, Howlin et al. 2008; Aupperlee, Leipprandt et al. 2013). In 
pathological conditions, AREG expression appears, instead, to be modulated by other 
signaling pathways, including those triggered by hypoxia (Bordoli, Stiehl et al. 2011; 
Stiehl, Bordoli et al. 2012) and by the YAP/TAZ signaling cascades (Zhang, Ji et al. 2009; 
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Yang, Morrison et al. 2012). Quantitative RT-PCR analysis, however, indicated that the 
expression of RAB5AS34N does not significantly alter the expression of genes that are 
typically regulated by these signaling cascades, suggesting that AREG expression is 
controlled by RAB5A through alternative mechanisms, the molecular nature of which 
remains to be further investigated. 
 
In Drosophila, genetic interference with RAB5 expression or activity has been 
shown to induce a hyper-proliferative phenotype, suggesting that RAB5 may possess 
tumor suppressor-like function during normal, physiological developmental processes of 
certain epithelial tissues (Lu and Bilder 2005; Robinson and Moberg 2011). 
Mechanistically, alterations of the endocytic machinery by RAB5 null mutant or RAB5 
deletion was shown to cause abnormal membrane trafficking and aberrant delivery of 
various proteins, such as the polarity determinant Crumbs and the Notch signaling 
receptor. Both eye discs and follicle cells homozygous for RAB5-null deletion mutant 
showed multilayered, overproliferative phenotypes and accumulation of these proteins at 
the cell surface, induced by a failure in endosomal entry and progression to lysosomal 
degradation (Lu and Bilder 2005). Furthermore, loss-of-function mutants of RAB5 and 
other key endocytic mediators have also been reported to promote the deregulated 
activation of Yorkie (YAP/TAZ in vertebrates) and JNK (Rodahl, Haglund et al. 2009; 
Robinson and Moberg 2011). The former co-transcriptional regulator, in particular, has 
emerged as a factor of paramount importance in the control of tissue homeostasis, sitting at 
the core of complex networks of biochemical as well as mechanical cues that all converge 
in fine tuning its activity, ultimately dictating the proliferation, survival and differentiation 
fate of cells (Yu and Guan 2013). JNK pathway, among the numerous functions it controls, 
may, instead, act upstream of Yorkie in cells with alteration in polarity (Robinson and 
Moberg 2011), suggesting that the apparently disparate, biological functions of RAB5 may 
all be rationalized within its originally described role as a central hub in membrane 
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trafficking. Indeed, the acquisition and maintenance of polarity, which represents a 
defining distinguishing property of epithelial cells and tissues, strictly depends on the 
appropriate delivery through membrane trafficking of various polarity determinants (Lu 
and Bilder 2005). Hence, disruption of endocytic networks may not only causes loss of 
epithelial tissues identity, but may also liberate proliferation-inhibitory signals and trigger 
differentiation programs, that can culminate into a change of identity, typified by the 
epithelial to mesenchymal transition process. Whether the functional consequences linked 
to RAB5 perturbation are also relevant in the development of mammalian cancer remain, 
however, entirely unclear. In particular, no evidence has so far been provided of loss of 
RAB5 neither in mammalian tumors nor in experimental models of tumor cell lines in 
culture. Notwithstanding this, a conserved potential onco-suppressive role of RAB5 
remains plausible. 
Our finding, in mammary epithelial cells are somewhat in line with the notion outlined 
above and lend support to the general paradigm that disruption of RAB5 in the context of a 
normal epithelium may lead to the acquisition of growth factor-independent proliferation, a 
distinctive hallmark of tumor development. Whether similar altered auto/paracrine 
secretion of growth factor may also account for the hyper-proliferation that accompanies 
RAB5 disruption in Drosophila or in murine liver remain to be firmly assessed. 
Conversely, while in epithelial tissues of the fly Drosophila and in murine hepatocytes 
disruption of RAB5 and some of its interaction partners is sufficient to cause loss of 
polarity and to promote neoplastic-like hyper-proliferation, this does not appear to be the 
case in mammary epithelial MCF-10A cells in culture, suggesting that additional events 
may be required to unleash a full pro-proliferating role caused by the disruption of 
endocytic pathways. 
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2. RAB5A as a tumor promoter. 
 
In normal mammary epithelia, we also observed that RAB5A expression induces S-
phase entry delay, impairing MCF-10A cells proliferation when cells are grown in 2D. 
Intriguingly, this phenotype was accompanied by a robust increase in ERK 
phosphorylation that was observed both in 2D and in 3D cultures, pointing to the 
involvement of MAPK/ERK1-2 pathway in the regulation of G1/S transition. Previously, 
numerous studies have reported of a possible correlation between cell cycle defects and 
ERK signaling pathway (Chambard, Lefloch et al. 2007). In normal conditions, the proper 
attachment to ECM is fundamental for cell survival, while loss of contact with the 
substrate induces a BH3-only protein Bim-mediated cell death by anoikis. The direct 
association of Bim expression with ERK inhibition identifies this signaling pathway as a 
key regulator of Bim and may account for the observation that these proteins might be 
hijacked under pathological conditions. Indeed, the expression of certain oncogenes 
confers anoikis resistance by inducing cell cycle arrest in G1/S stage and sustaining ERK 
activation. This mechanism protects metastatic cells from anoikis and promotes cell 
survival outside of the natural microenvironment. More specifically, G1/S-arrested, MCF-
10A cells either growing attached to a substrate or kept in suspension were shown to 
display elevated ERK phosphorylation, which, in turn, is essential to bypass anoikis 
through the suppression of the pro-apoptotic Bim (Collins, Reginato et al. 2005). This 
mechanism may also provide protection from apoptosis induced in response to growth 
factor withdrawal and ERK–mediated modulation of Bim is predicted to be essential for 
cells that must detach from their basement membrane in order to undergo normal 
morphogenetic processes, such as during the formation of a lactating gland (Debnath, Mills 
et al. 2002). Notably, the same mechanism may also be harnessed by certain oncogenes, 
first and foremost activated ErbB-2 (Reginato, Mills et al. 2005), which, in addition to 
deregulating cell proliferation, also disrupt cell polarity and ECM attachments virtually 
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generating pro-apoptotic conditions that must be overcome in order to achieve full 
transformation. 
In this context, RAB5A elevation of ERK pathway may be a way to enable cells to resist 
anoikis occurring during the morphogenesis of mammary cells in 3D. However, we found 
that: i) the morphogenetic program of 3D acini is not drastically perturbed by elevation of 
RAB5A expression as RAB5A-expressing cells invariably form hollow acini. ii) 
Furthermore, the few but large RAB5A-MCF10A acini show no alteration in the extent of 
activated caspase-3 positivity, indicating that anoikis induced by ECM detachment of the 
inner subpopulation of cells is not impaired. Clearly, further investigations are required to 
identify the molecular mechanisms through which RAB5A modulates ERK 
phosphorylation and assess its biological consequences.  This latter point is particularly 
challenging considering the complexity and the temporal dynamics of the regulation of this 
signaling cascade. Indeed, both the frequency and intensity of ERK activity pulses have 
been recently shown to be important for the regulation of cell responses to proliferation 
signals, such as EGF. For example, dynamic analysis of ERK activity in MCF-10A cells 
revealed that the decision to enter S-phase in response to EGF addition is determined by 
the duration, rather than by the frequency of its activity pulses (Albeck, Mills et al. 2013). 
In keeping with these considerations, RAB5A may play a role in the control of cell cycle 
progression by impinging on ERK signaling dynamics or affecting cell sensitivity to EGF, 
as it has already been shown for other oncogenes. How these signaling are temporally 
associated and the molecular mechanisms underlying this correlation remain to be further 
investigated.  
 
Intriguingly, our data show that RAB5A expression in 2D cultures delays S-phase 
entry and cell proliferation, while in 3D assay on reconstituted basement membrane 
RAB5A reduces the number of acini, but the one that grow are significantly larger, 
reflecting the fact that they do not cease proliferation, which is invariably observed in acini 
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that have completed the morphogenetic differentiation program. One possibility to 
rationalize these finding is to hypothesize that RAB5A expression elicits a cell stress 
response possibly accompanied by alterations in DNA repair processes, somewhat 
resembling the situation observed with certain oncogenes, which, when introduced into 
primary cells, can cause proliferation-dependent stress that ultimately results in 
accumulation of DNA damage and a blockade in cell expansion (Hills and Diffley 2014). It 
is interesting in this respect that gene profiling obtained by Affymetrix analysis of RAB5A 
expressing cells revealed that genes involved in DNA repair are significantly down-
regulated, suggesting that RAB5A may impair such a process and thereby lead to the 
accumulation of DNA damage that in most cases would be so detrimental to cause the 
elimination of the damaged cell, accounting for the reduced acini number. In few 
instances, however, RAB5A-dependent DNA repair-defective cells may acquire mutation 
that are positively selected enabling the emergence of single clones of cells that have lost 
their differentiation-induced proliferation arrest and keep on growing to a large size.  
Alternatively, once acini has reached a minimal size and cell-number, the cell cycle defect 
may be overcome in a cell-context dependent manner, with a mechanism similar to the one 
observed in cell-competition. In Drosophila, for example, it has been shown that mutant 
cells are viable and continue to proliferate only when surrounded by other mutant cells, 
conversely they are eliminated by cell-competition if surrounded by normal cells 
(Ballesteros-Arias, Saavedra et al. 2014). The importance of the interface between normal 
and mutant cells has been also confirmed in mammalian: RASV12-transformed MDCK 
cells when surrounded by normal cells are apically extruded or invade the basal matrix 
through the formation of basal protrusion (Hogan, Dupre-Crochet et al. 2009). Thus, cell 
displacement has been proposed as a protective mechanism to remove aberrant cells from 
the epithelia, likely hijacked by cancer cells to facilitate clonal outgrowth (Leung 2013). 
RAB5A cells, in this framework, would need a minimal number of surrounding cells to 
overcome the cell cycle defect and proliferate. Our data on re-initiation of proliferation in 
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post-mitotic acini when RAB5A is expressed, further suggest that the cell-context may 
play an important role in the control of RAB5A-dependent cells proliferation. In post-
mitotic acini, the critical cell number composing the structure may be sufficient to sustain 
cell proliferation and induce the repopulation of the lumen that we observed in RAB5A 
expressing acini. 
 
In summary, on one hand we observed that RAB5A expression delays S-phase 
entry and impairs MCF-10A cells proliferation. On the other hand, in oncogenic 
mammalian epithelial tumor cell line and tissues, elevated expression of RAB5A is 
frequently selected to confer pro-invasive and metastatic propensity (Lanzetti, Palamidessi 
et al. 2004; Palamidessi, Frittoli et al. 2008; Torres and Stupack 2011). Consistently with 
this latter notion, elevated RAB5A expression levels have been correlated to the increased 
migration potential of hepatocellular carcinomas (Fukui, Tamura et al. 2007), with ovarian 
cancer (Zhao, Liu et al. 2010), and with the metastatic potential of lung (Yu, Hui-chen et 
al. 1999), breast (Yang, Yin et al. 2011; Frittoli, Palamidessi et al. 2014) and gastric cancer 
(Li, Feng et al. 1999).  
 
This apparently contradictory observation may be reconciled within the notion that 
frequently oncogene expression in normal tissues elicits a stress response that leads to 
growth proliferation delays and in some occasion to apoptosis or senescence. Conversely, 
in a pre-tumorigenic setting the same oncogene promotes neoplastic transformation. 
Whether this notion is applicable also to RAB5A remains to be established and the 
dissection of the molecular mechanisms through which this master regulator of endocytosis 
act may provide clues to answer this conundrum. 
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3. RAB5A plays an essential role in cell locomotion and tumor progression. 
 
Besides the well-characterized role of RAB5A in endosome biogenesis and 
trafficking (Zerial and McBride 2001), a substantial amount of evidences identified 
additional non-canonical functions of this small GTPase. Most notably, RAB5 has been 
implicated in controlling cell migration where it may act at different steps of the process, 
including the control of FAs turnover (Mendoza, Ortiz et al. 2013; Palamidessi, Frittoli et 
al. 2013), integrins trafficking (Frittoli, Palamidessi et al. 2014) and actin cytoskeleton 
remodeling. In this latter case, our lab showed that RAB5A is necessary for spatial 
restriction of RAC1 activity to the plasma membrane, in turn required for the acquisition of 
polarized membrane protrusion driving cell locomotion (Palamidessi, Frittoli et al. 2008). 
Consistent with its central role in directed cell migration, RAB5A has also been shown to 
promote cancer progression, by enhancing the dissemination potential of different cancer 
types, including stomach (Li, Feng et al. 1999), lung (Yu, Hui-chen et al. 1999) and breast 
cancer (Yang, Yin et al. 2011; Frittoli, Palamidessi et al. 2014). 
 
 
3.1. Epithelial collective locomotion is sensitive to RAB5A expression levels. 
 
Cancer progression and metastatization is accompanied and promoted by the 
acquisition of cell locomotory ability that allows tumor cells to detach from the primary 
tumoral mass and disseminate into the organism toward a distant cancer niche, where 
proliferation is reinstalled leading to the generation of metastatic clones (Hanahan and 
Weinberg 2000). Indeed, cancer metastatization is best described as a multistep process or 
metastatic cascade, that include rupture of the confining basement membrane, interstitial 
stromal, local dissemination, intravasation and survival into the lymphatic and blood 
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stream, extravasation and growth at distant “niche” site (Hanahan and Weinberg 2000). In 
carcinoma arising from epithelial tissues, the first of these steps leading to metastasis 
involves local invasiveness and the acquisition of major phenotypic changes in a subset of 
cells within the primary tumor.   
The morphological phenotypic changes that enable a sessile epithelial cell to become 
highly migratory can be extremely diverse and flexible. Indeed, multiple migratory modes 
are utilized by tumors cells. These modes are: i) morphologically distinct, ii) bio-
mechanically diverse and iii) respond and are driven by a variety of different biochemical 
circuitries. The ability of tumors cells to plastically change their mode of cell locomotion 
enables them to adapt to diverse micro-environmental conditions and represent a 
prerequisite for stromal dissemination. Among the diverse migratory strategies, cell 
motility has been classified into two main broad categories: i) in collective locomotion, 
cancer cells migrate as whole “clumps” of tightly adherent cells advancing as an invasive 
front; alternatively, ii) individual cells can detach from the tumor mass and adventure into 
the surrounding tissues adopting either a round, blebbing, amoeboid motility mode strictly 
dependent on actomyosin contractility; or a mesenchymal migration associated with 
RAC1-dependent, F-actin-rich protrusions that drive directional motility coupled with 
pericellular proteolysis (Friedl 2004). 
Our lab previously showed that RAB5A, in a variety of tumor, promotes a single cell 
program of proteolytically-dependent mesenchymal dissemination. Indeed, RAB5A 
expressing cells, autonomously, rewire trafficking circuitries so as to couple RAC1-
dependent cell protrusion and pericellular proteolysis, which is essential in the initial phase 
of cancer dissemination (Palamidessi, Frittoli et al. 2008). However, epithelial tumors cells 
frequently utilized a collective mode of cell migration where cell-to-cell junctions are not 
broken apart, but rather exploited to coordinate the motility of entire sheets of isolated 
clusters that in highly coordinated manner invade the space of least resistance, enabling 
effective local invasion into surrounding tumor stroma. Based on this latter observation, 
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we initially elected to investigate whether deregulation of RAB5A in normal mammary 
epithelial cells would impact, not only on single cell locomotion, but also on collective 
motility mode. The normal genetic background of MCF10A cells allowed us to exclude 
any potential confounding contribution of other transforming hits and to further explore 
fundamental mechanisms that RAB5A may control in physiological setting that may be 
deranged in late tumorigenic stages.  
The data we collected in this study, using a non-transformed model system, are consistent 
with the notion that RAB5A plays an important function in promoting cancer progression. 
We showed that RAB5A elevated expression increases significantly cell speed, 
directionality and coordination of un-wounded sheets of motile cells. When a directional 
cue is generated by scratching a wound into an otherwise intact monolayer, RAB5A 
elevation is sufficient to promote a highly coordinated mode of collective locomotion; 
whereas, migration is impaired by genetic ablation of the three isoforms of RAB5. These 
results support a role of RAB5A in promoting collective epithelial locomotion, and provide 
a rational base to account for the potential pro-metastatic role exerted by this GTPase in 
human invasive breast cancer. 
Importantly, sparsely seeded cells migrating randomly in the absence of any 
chemoattractant did not show alterations in single cell velocity when RAB5A expression 
was induced by doxycycline. The observation that RAB5A elevation is sufficient to 
promote an increase in the wound front speed without significantly affecting single cell 
velocity, provides a solid evidence that RAB5A plays a specific role in collective cell 
migration, presumably affecting molecular and cellular mechanisms that become 
absolutely needed during collective motility, i.e. under conditions where cells are 
mechanically linked through cell–to-cell junctions, and thus their movement must be 
coordinated for efficient locomotion to occur. 
Interestingly, an improvement in collective cell locomotion has also been observed in 
RAB5A expressing MCF-10A cells when plated as a confluent but un-wounded monolayer 
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that display a cell movement reminiscent of viscous flow in fluid dynamics. This latter 
observation suggests a role of RAB5A in collective locomotion, even in the absence of a 
directional cue that promotes cell polarization and directional motility. 
 
 
3.2. RAB5A promotes cell coordination of the migrating epithelial sheet 
possibly by cadherin-mediated transmission of migratory cues. 
 
In vivo, when epithelial sheets are damaged, surrounding cell layers migrate to heal 
the open space and restore the initial integrity of a tissue, furthermore the coordinated 
movement of the epithelium plays vital roles in embryogenesis and development of 
complex tissues. Our observations and previous studies demonstrate the importance of 
coordination of cells migrating as collective entities to ensure their efficient movement. 
CIV analysis on wound healing assay performed on MCF-10A cells, confirmed this 
hypothesis. We showed that RAB5A enhances cell velocity by promoting coherent and 
directional cell migration within the epithelial sheet. On the contrary, RAB5 ablation 
dramatically impairs sheet cohesiveness and the correspondent mean angular correlation 
value, a measurement of how coordinated is the cell motility, is decreased, compared with 
control cells. 
Epithelial sheets are kept together by cell-to-cell adhesion structures. A key component of 
epithelial junctions in vertebrates is the transmembrane protein E-cadherin, which defines 
the so-called adherens junctions (AJs). Within these structures, E-cadherin connects 
adjacent cells through homophilic interactions and associates with the cytoskeleton 
through a multiprotein complex (Reynolds and Roczniak-Ferguson 2004; Cavey and 
Lecuit 2009). AJs are not immobile, unflexible, glue-like structures; rather these junctions 
undergo rapid assembly and disassembly to enable epithelial tissue morphogenesis and 
rearrangement, as well as the acquisition of cell motility during epithelial-to-mesenchymal 
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transition (Cavey and Lecuit 2009; Thiery, Acloque et al. 2009). Previous works 
demonstrated the importance of AJs in promoting the coordination and the transmission of 
motogenic stimuli during collective cell locomotion (Vitorino and Meyer 2008; Ng, Besser 
et al. 2012). The importance of adhesive junctions in the mechanical cohesion of a 
monolayer has been documented not only in epithelial tissues but also in the endothelium, 
and the observation that the excessive reinforcement of cell-to-cell adhesions slows down 
wound closure underlines the importance of a tight control of AJs dynamics (Vitorino, 
Hammer et al. 2011). For example, fine modulation of the mechanical adhesion between 
endothelial cells, mediated by the member of cadherin family Vascular Endothelial 
Cadherin (VEC) was shown to be critical to sustain collective locomotion together with the 
integrity of the monolayer (Franco, Milde et al. 2013).  
Recent studies on the motility of endothelial and kidney epithelial cells within monolayers 
have highlighted the existence of peculiar motility behavior, in which groups of cells, that 
compose the intact monolayer, move together as a unique element that exhibit a globally 
undirected but locally correlated streaming behavior. In collective cell streaming indeed, 
transient cell chains move together as groups with similar direction and persistence, and 
their velocity correlations extend over several cells that compose the whole cell sheet 
(Vitorino and Meyer 2008; Szabo, Unnep et al. 2010). Interestingly, while the direction of 
cell migration in the monolayer was random because of the absence of any directional cue, 
the relative movement between neighboring cells was highly coordinated. Such a 
collective flow within a monolayer has been shown to be strongly influenced by cell-to-
cell adhesions and the dynamics of the cohesive interactions between cells are reminiscent 
of the typical reversible interactions connecting individual molecules in fluids.  Hence, the 
coordinated flow-like movement detected in MCF-10A cells monolayers can be 
understood and interpreted using fluids dynamics, which is influenced primarily by the 
dynamics and coordination of AJs. Consistently, perturbation of adherens junctions by 
calcium chelation or genetic ablation of cadherins reduce spontaneous collective cell 
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streaming in confluent epithelial monolayer and compromised cell adhesions lead to cells 
movements in opposite and anisotropic directions (Czirok, Varga et al. 2013).  
Based on these considerations, we hypothesized that RAB5A-dependent increase in 
coordination of collective cell migration would be provided by increased mechanical 
connection mediated by adherens junctions. Of note, E-cadherin expression levels were not 
affected by RAB5A expression. Thus, we investigated whether RAB5A may affect the 
cellular distribution of E-cadherin in MCF-10A monolayers. Strikingly, RAB5A-positive 
confluent cells showed a narrower localization of E-cadherin along the periphery of the 
cell. In addition, AJs were linear and significantly straighter than in control cells, which 
display a more diffuse and a wavy distribution of E-cadherin along cell contacts. These 
results suggest that RAB5A increases adhesion strength, and thus improves cell cohesion, 
accounting, at least in part, both for the enhanced collective locomotion of wounded 
monolayer as well as for the increased cell streaming in intact epithelial sheets. 
 
The involvement of endocytosis in the control of E-cadherin turnover and adherens 
junction dynamic is well established. For example, we recently identified CDC42-
Interacting Protein 4 (CIP4), a member of the FCH-Bin-Amphiphy-sin-Rvs (F-BAR)-
domain containing proteins family, as a key endocytic molecule in the control of E-
cadherin trafficking and junctional stability (Rolland, Marighetti et al. 2014). Although E-
cadherin levels were not significantly different between control and CIP4-depleted cells, 
the amount of junctional E-cadherin was controlled by CIP4 through endocytosis and 
SRC-dependent regulation of junctional tension, an important event to promote adherens 
junctions disassembly and subsequent endocytosis of E-cadherin. At the cell biological 
level, removal of CIP4, but not of the other two family members FBP17 (formin-binding 
protein 17) and TOCA1 (transducer of CDC42-dependent actin assembly 1), induces 
compaction of MCF10A breast epithelial cells into tightly organized cell clusters. We 
further demonstrated that EGF-induced cell scattering, motility and invasion are impaired 
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in CIP4-depleted cells. These latter cell biological phenotypes are mirrored by the finding 
that CIP4 elevated expression is selected in ErbB-2 positive breast cancer tumors and 
correlates with increased distant metastasis (Rolland, Marighetti et al. 2014).  
The maintenance of junctional stability is a dynamic process ensured by a fine balance of 
internalization and recycling of adherens junction components, a mechanism already 
described in Drosophila where RAB11 recycling is required for epithelial integrity (Roeth, 
Sawyer et al. 2009). Multiple routes mediate E-cadherin entry into cells, including clathrin-
dependent and clathrin-independent pathways, both converging to early endosome 
compartment, as confirmed by EEA-1 and RAB5 enrichment in E-cadherin-positive 
vesicles after internalization through one of these pathways. From this sorting station, E-
cadherin may than be directed either to lysosomal degradation, or recycled back to the 
plasma membrane via RAB11-dependent recycling (Paterson, Parton et al. 2003; de Beco, 
Gueudry et al. 2009).  
The role of CIP4 in promoting E-cadherin trafficking and actomyosin contractility, thus 
sustaining cell migration and invasion, points to the fundamental function of endocytosis in 
intracellular trafficking and signaling. Additionally, the observations that RAB5A, 
similarly to CIP4, drives tumor progression and improves collective locomotion affecting 
adherens junctions distribution and possibly dynamics, rise the possibility of a similar 
process involving RAB5A-mediated endocytosis in the control of AJ remodelling. 
Despite further work is required to address the precise molecular mechanism linking 
RAB5A expression and E-cadherin, our current data reinforce the notion of a central role 
of endocytosis in the control of E-cadherin internalization and dynamics, and thus of AJs 
remodeling mediated by this small GTPase. Whether RAB5A-dependent circuitry that 
modulates epithelial cell-to-cell adhesions relies on a fast RAB4 recycling route, similarly 
to what we have recently shown in the case of metalloprotease MT1-MMP (Frittoli, 
Palamidessi et al. 2014), it is an intriguing possibility that remains to be investigated. 
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It is also of note that in the MCF-10.DCIS.com model system, we observed similar 
RAB5A-induced phenotypes as the one observed in the non-transformed cell counterpart. 
Indeed, collective cell migration toward the artificial gap created by scratching of the 
monolayer was enhanced by RAB5A expression in MCF-10.DCIS.com. This phenotype 
was also mirrored by an increase in the wound front speed and cell-cell coordination, 
similarly to what we observe in normal MCF-10A cells. Although further investigation 
would be needed to better characterize how RAB5A modulates E-cadherin pattern and 
localization, this latter finding suggest that RAB5A promotes collective cell migration and 
cell coordination also in a relevant breast cancer model system. Of note, MCF-
10.DCIS.com cells are known to display an altered distribution of junctional E-cadherin 
with respect to MCF-10A cells that renders these cells more prone to undergo individual 
cell locomotion (Li and Mattingly 2008). Whether the up-regulation of RAB5A is 
sufficient to switch the mode of cell motility from individual to collective remains to be 
assessed and represents an interesting aspect to be investigated in future studies. 
 
 
3.3. RAB5A sustains cell migration by modulating the protrusive activity of 
cells at the leading front. 
 
Cell migration requires a tight coordination of protrusive and adhesive activities to 
generate forward migration of the epithelial sheet.  
Actin polymerization drives the formation of thin sheet-like protrusion, the lamellipodium, 
by pushing the plasma membrane forward. This protrusive and migratory structure, 
observed in many different cell types, depends primarily on the small GTPase RAC1 and 
RAC1-mediated actin remodeling. We previously showed that RAB5A-dependent 
endocytic/exocytic cycles (EECs) of RAC1 is key to promote the spatial restriction of 
RAC1 signaling, leading to the formation of polarized migratory protrusions (Palamidessi, 
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Frittoli et al. 2008). More specifically, we showed that upon addition of motogenic stimuli, 
RAB5A mediates the concomitant recruitment of RAC1 and its GEF Tiam1 into early 
endosomes; endosomally- located, active RAC1 is then recycled back to the plasma 
membrane via an Arf6 mediated recycling route (Palamidessi, Frittoli et al. 2008). Thus, an 
endo/exocytic RAB5A-dependent flux of RAC1 appears to be required to spatially confine 
its activity and the acquisition of polarized actin remodeling, needed for directional 
migration. Hence, we tested whether RAB5A mediates RAC1 activation also in the context 
of epithelial collective locomotion. The majority of wound edge cells of collective 
migratory MCF-10A cell sheets showed a dramatic increase in protrusion area and 
persistence upon RAB5A expression. This suggests that cells at the leading front remodel 
actin and polarize the protrusive machinery along the advancing leading front, possibly in 
endo/exocytic and RAC1 dependent fashion. To explore this possibility, we will employ 
RAC1 FRET-biosensor that will allow us to obtain direct quantification of locally, 
activated RAC1 at the leading front.  
It must be pointed out that the mechanism controlling RAC1 activation and localization in 
a group of collective migrating cells is likely more complex, since recent reports indicate 
that RAB5A/Tiam1/RAC1 is not the only circuitry responsible for RAC1 modulation. 
Studies performed on collective migration of border cells showed that RAB5 and RAB11 
are important regulators of RAC activity and cell polarization during locomotion. In these 
cell system also, RAB5 is involved in RAC activation and the expression of its dominant 
negative form (RAB5S34N) abolished RAC-mediated protrusion formation. Conversely 
the small GTPase RAB11, involved in vesicles recycling, has been shown to be a key 
regulator of cell-cell communication critical to achieve spatiotemporal restriction of RAC 
activity in the entire cluster, preventing it from becoming uniformily distributed and thus 
inefficient for migration (Ramel, Wang et al. 2013). Similarly, in our system RAB5A may 
be involved in a more complex mechanism controlling RAC1 activation, thus cooperating 
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with other endocytic protein in the activation and localization of RAC1 in specific regions 
of the epithelial migrating sheet. 
 
3.4. RAB5A expression affects cell to ECM adhesions of migrating cells at the 
wound edge. 
 
Migrating cells need to establish dynamic contact with the ECM to anchor actin 
cytoskeleton to the substrate and exert motile forces. The main anchor structures are 
integrin-based focal adhesions (FAs). FAs are dynamic multiprotein assemblies that 
physically link the ECM with the actin cytoskeletal network of a cell protrusion, serving as 
a clutch that translates the pushing forces of actin polymerization into net traction forces 
(Nobes and Hall 1995). FAs undergo a constant turnover, particularly in migrating cells. 
These structures form at the leading edge of the migrating cell as focal contacts, mature 
and become enlarged, establishing more stable, yet dynamic attachment to the ECM. The 
subsequent disassembly of FAs allows detachment and forward locomotion (Ridley, 
Schwartz et al. 2003). Increasing evidences demonstrates the involvement of RAB5 in 
promoting migration of normal or transformed cells, in the latter case promoting an 
essential step in metastasis formation (Palamidessi, Frittoli et al. 2008; Mendoza, Ortiz et 
al. 2013; Palamidessi, Frittoli et al. 2013). Different groups collected evidences showing 
that RAB5 expression leads to an increased integrin trafficking and focal adhesion 
turnover (Palamidessi, Frittoli et al. 2008; Mendoza, Ortiz et al. 2013; Palamidessi, Frittoli 
et al. 2013).  Indeed, RAB5 positive endosomes, particularly the active pool of RAB5, 
accumulates at the leading edge of cells undergoing directional migration [(Mendoza, Ortiz 
et al. 2013) and this work]. In particular, RAB5 was shown to transiently localize and 
associate in a complex with FAs components and to promote FAs disassembly, thereby 
affecting cell locomotion. FAs turnover, modulated by focal adhesion kinase (FAK) 
phosphorylation/dephosphorylation circuitry, was accelerated by RAB5 in migrating and 
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invasive cells. Hence, RAB5 is proposed as regulator of FAs disassembly thus promoting 
coordinated cell locomotion (Mendoza, Ortiz et al. 2013). In agreement with this notion, 
RN-tre, a GAP of RAB5A has been shown to be involved in FAs turnover during 
chemotactic cell migration. In RN-tre KO fibroblast, FAs turnover was indeed accelerated 
and cells were highly motile compared with controls, thus pointing to a role of RN-tre in 
the control of integrin endocytosis and FA stability, by turning off RAB5A (Palamidessi, 
Frittoli et al. 2013).  
In our study, we show a reduction of FAs size in cells at the leading front of the collective 
migrating sheet when RAB5A is overexpressed. Vinculin and paxillin staining, typical 
component of FAs, evidenced smaller structures at the leading edge of RAB5A-MCF-10A 
cells after wounding, suggesting a faster turnover of FAs that shifts the balance between 
adhesion and motility toward a more motile phenotype. Although further investigation on 
the kinetic of FAs assembly/disassembly in our model system would be required to 
definitely prove the hypothesis we postulated, our observation are in agreement with 
previous work that demonstrate the involvement of RAB5A in FAs dynamics, through 
FAK activity (Mendoza, Ortiz et al. 2013) or RN-tre modulation (Palamidessi, Frittoli et 
al. 2013). Thus, we may hypothesize a signaling cascade where RAB5A activity is 
controlled by its GAP RN-tre, and sequentially controls FAK 
phosphorylation/dephosphorylation rate, thus promoting FAs disassembly and migration 
and invasiveness of cancer cells.  
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4. RAB5A functional perturbation abrogates the generation of invasive outgrowth 
in MCF-10.DCIS.com cells. 
 
To further dissect the potential dual role of RAB5A as suppressor of tumor 
initiation and promoter of tumor progression, MCF-10.DCIS.com cells represent an 
optimal model since they allow us to recapitulate the transition from pre-invasive to 
invasive breast carcinoma that is frequently observed in human breast cancer (Miller, 
Santner et al. 2000). Three dimensional culture on reconstituted basement membrane has 
been used to mimic DCIS growth and progression to IDC occurring in vivo. Under these 
conditions, activation of c-Met by conditioned media from infiltrating fibroblasts secreting 
HGF or by recombinant HGF induces the development of invasive outhgrowth from DCIS 
structures (Edakuni, Sasatomi et al. 2001; Jedeszko, Victor et al. 2009). Using this model 
system, we show that perturbation of endocytosis by RAB5AS34N expression in MCF-
10.DCIS.com cell line impairs the formation of HGF-induced invasive outgrowth, when 
cultured in three-dimensional reconstituted basement membrane overlay assay in 
agreement with clinical data that correlates RAB5A expression and metastatic potential 
(Frittoli, Palamidessi et al. 2014). This phenotype was also confirmed in vivo by 
subcutaneous injection of RAB5AS34N-expressing MCF-10.DCIS.com cells in 
immunodeficient mice; the myoepithelial organization was used as readout of cancer 
progression (Hu, Yao et al. 2008). One week after RAB5S34N induction, control and 
RAB5AS34N tumors were comparable in size and presented the typical DCIS 
morphology, with a core of cancer cells delimited by a smooth muscle actin (SMA)-
positive myoepithelial layer. However, although MCF10.DCIS.com control lesions lost the 
myoepithelial layer and progressed to become invasive tumors after 3 weeks, 
RAB5AS34N-expressing cells maintained the typical DCIS histology and their 
invasiveness was significantly impaired. Furthermore, to assess whether the elevation of 
RAB5A expression was sufficient to promote lung dissemination, control and RAB5A 
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WT-expressing MCF10.DCIS.com were injected into mice tail vein and monitored for 
their ability to colonize the host lung. After 96 hours, the number of RAB5A-expressing 
MCF10.DCIS.com cells was significantly higher than that of control cells.  Hence, 
RAB5A was sufficient to enhance the ability of these cells to extravasate and adhere to 
lung tissue (Frittoli, Palamidessi et al. 2014). 
Collectively, in vitro and in vivo observations indicate that RAB5A promotes, at least in 
this model system, local and distal invasiveness of breast cancer cells, typical hallmarks of 
tumor aggressiveness.  
 
 
 
Concluding remarks 
 
Taken together, our evidences are consistent with a dual, temporally, distinct 
function of RAB5A in tumor development. RAB5A may act as a tumor suppressor gene, 
critical for the control of the morphogenetic processes and homeostasis of epithelial 
tissues, with a major impact on initiation of tumorigenesis in pathological conditions. On 
the other hand, clinical data together with in vitro and in vivo studies demonstrate that 
RAB5A is sufficient to promote an invasive and metastatic phenotypes relevant for cancer 
progression, ultimately sustaining both an individual mesenchymal mode of cell 
locomotion as well as enhancing coordinated collective motility, thereby impacting on the 
early steps of tumor dissemination. 
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